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Stem cell-originated therapeutic products, such as in vitro manufactured red blood cells 
(mRBC), offer a novel route to treating disease by administration of a viable somatic cells that 
have been selected and manipulated outside the body. Cell-based therapeutics are different to 
traditional biopharmaceutical products and that presents a challenge of developing robust and 
economically feasible manufacturing processes, especially in sample purification. To address 
this challenge, I investigated label-free separation methods based on cell endogenous properties 
such as size and deformability as sorting parameters. In this study the mechanical properties of 
umbilical cord blood CD34+ cells undergoing in vitro erythropoiesis were characterised to 
identifying the best route for mRBC purification. For the first time it has been demonstrated 
how deformability-induced lift force affects and contributes to particles separation in spiral 
microchannels. These findings were translated and incorporated into a new route for high-
throughput (processing millions of cells /min and mls of medium/ min) continuous purification 
strategy for separating mRBC from contaminant by-products (purity >99%). This work is 
anticipated to bring the benefits of mRBC to a wide range of patients by enabling their 
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Chapter 1. Introduction 
1.1.  Project motivation 
Rapid development in the field of stem cell research has led to the development of new 
treatments and highly innovative cellular therapeutic products. These new cell-based medicinal 
products have a high potential where there is a previously unmet medical need [1].  
Despite an annual 112.5 million blood donations collected across 176 countries in over 
13000 blood centres, increased demand for safe blood for transfusion might not be satisfied by 
donated blood [2], hence there is a niche for unconventional solutions such as manufacturing 
red blood cells (RBC) from stem cells. Stem cells- derived red blood cells could constitute an 
attractive pathogen- free and sustainable alternative for donated blood for rare blood groups 
and patients requiring systematic transfusions[3]. In many cases, such as sickle cell anaemia, 
myelodysplasias and leukaemia, multiple blood transfusions are regarded the only available 
symptomatic treatment and that can lead to immunization against the allogenic red blood cells 
and transfusion impasses [4].  
The efficient production of manufactured red blood cells (mRBC) is an ambitious goal 
for blood services around the world, and production of a single therapeutic dose (~2×1012 cells) 
still remains a significant bioprocessing challenge [5][6]. The main challenge for future clinical 
applications of mRBC is to identify and develop technological solutions that would allow 
production of mRBC at a satisfactory scale and quality in compliance with good manufacture 
practice (GMP) regulations within the realms of economic feasibility [7][8][9][10][11]. New 
strategies for the large-scale automated expansion [10] [12], purification and formulation will 
have to be implemented [13] and the choice of adequate methods is strongly motivated by cost 
considerations [14][3]. 
To date, numerous customised differentiation protocols have been developed to 
produce mRBC from several sources of starting material: CD34+ hematopoietic stem cells 
from peripheral blood (PB) [15] and umbilical cord blood (CB) [16][17][18], peripheral blood 
mononuclear cells (PBMC) [19], embryonic [20][21] and induced pluripotent stem cells [22] 
and recently immortalised adult human erythroid line (Bristol Erythroid Line Adult BEL-A) 
[23]. In the last fifteen years, considerable progress has been achieved in terms of optimising 
the biological processes underpinning erythroid cells’ expansion and maturation [24]. The 
selection of starting cell material has been expanded of iPSC and BEL-A cell line, providing a 
potentially unlimited source for in vitro erythroid differentiation with the flexibility to mitigate 
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blood-compatibility challenges. Moreover, all xenogeneic culture compounds, like serum, 
transferrin, insulin and growth factors have been replaced, resolving the associated risks of 
virus, prions and immunological complications [25][26][27][28][28]. In 2011 a mini-
transfusion (1011 cells) of autologous CB CD34+- derived under GMP conditions mRBC was 
given to a volunteer [29][30] providing data and the proof of principle of mRBC feasibility for 
clinical use.  
Despite the considerable progress in improving the expansion rate and yield of mRBC, 
all of these approaches lack a sufficient enucleation rate (Table 1.1). In other words, the 
efficiency of the current differentiation protocols is lower than 100% which means that the 
end-product is a heterogeneous mixture containing enucleated mRBC, nucleated cells that 
remain at earlier developmental stages as well as free-floating nuclei expelled during the 
enucleation process, which in in vivo situation would be removed by macrophages [31]. In 
2008 Fujimi et al. reported CB CD34+ differentiation strategy providing an almost complete 
enucleation (99.4%) [17], however that was achieved by co-culture with macrophages, making 
the protocol impossible to scale-up [32]. 
 
Source Culture period Enucleation rate Ref 
CB CD34+ 21 days 4% [18] 
20 days 75-80% [25] 
21 days 44-84% [33] 
- >90% [26] 
38 99.4% [17] 
PB CD34+ 18 days 68% [29] 
18 days 55-95% [34] 
21 days 63% [35] 
PBMC 20 days 80-90% [19] 
hESC 59 days 1.5-16% [36] 
42 days 10-65% [21] 
60-125 days 2-10% [37] 
hiPSC 26 days 4-10% [22] 
60/125 days 2-10% [37] 
52 days 20-26% [38] 




Examples of published in vitro erythroid differentiation protocols and reported enucleation 
rates.  
 
Presence of free-floating nuclei in large quantities may prove particularly problematic 
in large-scale culture systems by fouling surfaces and entangling the desired cell product in 
DNA [39]. Most importantly, the presence of residual nucleated cells and the expelled nuclei 
constitute potentially harmful by-products if transfused into patients [40][41]. Undifferentiated 
nucleated cells can give rise to teratomas (benign tumours of differentiating cells) and 
teratocarcinomas (malignant metastatic tumours composed of highly proliferative cells). Thus 
they have to be removed from the sample and require adequate purification approaches 
[13][42].  
As stem cell-originated mRBC progress into clinical trials and commercialisation [43], 
that creates new issues for bio-production and processing, requiring a re-think of the current 
manufacturing strategy [44]. To meet the demand for high-quality mRBC, development of 
bioprocesses compliant with current GMP standards and operating at satisfactory scale (ml of 
medium/min and millions of cells/ min) is required. To address the need for efficient and safe 
manufacturing processes, this project aims to develop a label-free continuous and scalable 
separation protocol, suitable for industrial-scale cell purification.  
1.2.  Label-free markers 
The label-free description implies purification processes that do not require cell 
modification for detection and discrimination. The indigenous properties such as cell size and 
deformability (defined as the ability of a cell to change shape under applied load without cell 
lysis) have been recognised as promising label-free markers [45]. In many cases, alterations in 
cell mechanical properties are correlated with their molecular activity, such as cell cycle 
regulation [46], differentiation [41], immune-cell activation [47], malignant transformation 
[48] and disease (e.g. osteoarthritis [49] and malaria [50]). The mechanical properties of cells 
have been shown to be useful label-free markers of cell state. Since there is no need to add 
costly antibodies to revel the label-free markers and the number of processing steps (washing 
and centrifugation) is reduced, they are seen as a potential route for developing industrially-
viable cell enrichment approaches [51].  
Cell mechanical phenotype is determined by their intracellular components and the way 
they interact with each other, with a particular importance given to the cytoskeleton. The 
cytoskeleton is a dynamic protein scaffold supporting the cell membrane and organelles, 
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providing spatiotemporal flexibility of cells, required to respond and adapt to their physical 
environment and maintain their integrity [52]. There are three main cytoskeletal building 
blocks: microfilaments (helical protein structures providing cell motility and governing 
movements of the organelles within the cell due to high speed of polymerization/ 
depolymerisation), intermediate filaments (provide mechanical support for of cell membrane 
for cell-cell and cell-microenvironment interactions) and microtubules (provide resistance to 
external stimulus) [53]. Overall the cytoskeletal mechanical characteristic is a consequence of 
relative content of each cytoskeletal protein as well as filament network organisation [54].  
The cell membrane has a significant mechanical characteristic at the nanoscale 
(deformation is not deep enough to be applicable to underlying cytoskeleton). However, in an 
holistic mechanical approach its function is dependent on its interaction with cytoskeleton. 
Additionally the cell-nucleus ratio significantly influences whole-cell mechanical properties. 
A large nucleus undermines the cell membrane overall stiffness, and when this is the case, cell 
deformability is dominated by nuclear mechanical traits [55]. A popular example are human 
pluripotent stem cells, where nucleus occupies most of the cell volume, and it is the defining 
feature of cell  mechanics [56]. The nuclear mechanical properties are determined by content 
of lamins, proteins found in nuclear envelope, as well as chromatin architecture and compaction 
[57]. Lamins are an extended part of the LINC (Linker of Nucleoskeleton and Cytoskeleton) 
complex, which is believed to be the ultimate mechanosensory unit in cell by which 
transmission of forces between the nucleus and cytoskeleton are enabled, resulting in altered 
gene expression [58]. Studying the LINC complex led to identification of the correlation 
between content of the nucleoskeletal protein lamin-A, which stabilizes the nucleus, with cells 
stiffness [59].  
Because of the increased interest in cell mechanics as separation parameter, a range of 
approaches have been applied to measure the viscoelastic properties of individual cells (as 
outlined in Table 1.2).  
There is a variety of tools available for assessing cell deformability at a single cell level. 
Most of those methods (Atomic Force Microscopy (AFM), optical stretching, Magnetic 
Twisting Cytometry (MTC) and micropipette aspiration) operate at very low throughputs 
(<100 cells/min) as they rely on time-consuming, manual protocols. These approaches, 
developed for basic biophysics research on tens of cells, are not expected to be directly 
translatable to bioprocessing of heterogeneous samples. AFM, MTC and micropipette 
aspiration techniques probe locally on cell surface, thus the position of the probe can yield 
different measurements even among a single cell population. Optical stretching throughput is 
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limited by intense manual operation as well as limitations to the maximum applied optical 
force- its increase leads to significant heating of the measured sample.  
The accurate characterisation of complex samples, in a statistically relevant manner, is 
possible by overcoming the throughput limitation with introduction of microfluidic platforms 
(microconstrictions, hydrodynamic cytometry, real-time deformability cytometry (RT-DC)) 
for high-throughput (tens-thousands of cell/ min) mechanotyping. A short processing time is 
valuable to minimise the physical changes introduced by prolonged incubation in processing 
buffers or exposure to suboptimal environment (e.g. humidity, temperature and CO2 and O2 
content). In contrast to AFM, MTC and micropipette aspiration microfluidic platforms deform 
the entire cell, providing a holistic insight into cells mechanical behaviour. 
Cell transit through microconstrictions is sensitive to changes in cell size and 
adhesiveness (softer, smaller and non-sticky cells travel faster through the constrictions). The 
size of constriction has to be well-matched to measured cells because small cells will pass 
through the constriction without deformation and too large cells will clog the channel.  
Hydrodynamic approaches measure cell deformability by using fluid-dynamic stresses 
generated by the design of the microfluidic channel. Due to throughput reaching those of 
standard flow cytometers (thousands of cells / min) and contactless measurement mode, in this 
study, the end-product of CB CD34+ in vitro erythropoiesis, was thoroughly characterised by 

























Using scanning probe (cantilever with 
a sharp tip) for poking/ touching 
surface of the sample with a resolution 





















   
 
 
Optical stretcher is a dual-beam 
optical trap where a particle/ cell is 
trapped by optical forces generated by 
two opposite laser beams. 
 
 






























Magnetic bead is strongly attached to 
cell surface and by applying and 
manipulating magnetic field a portion 
of cell is twisted. 
 
 























Applying suction pressure on a cell 
membrane and measuring extension 
into the bore of glass micropipette.  
 



























Cells are pushed through custom-
made constrictions smaller than cell 
size , it can be aspiration-, fluid- and 
electrically induced process 
 























Deforming cell at high strains in a 
stretching extensional flow filed  


































Cells are deformed by pressure 
gradient and shear stress in a 










Summary of commonly used currently available methodologies for cell meachanotyping. The 
table contain the name of a technique, a graphical representation of the method accompanied 
by a description, throughput (a number of cell that could be assessed in a given time) as well 




1.3. Traditional cell separation  
Traditionally, cell purification is performed using Fluorescent and Magnetic Activated 
cell sorting (FASC and MACS) and density gradient centrifugation [82] Both, FACS and 
MACS are well-established, commonly-used and very precise (cells are purified based on their 
molecular features), however, they have limited throughput (only millions of cells per hours 
are purified), and they are not cost-effective due to the addition of fluorescence-conjugated 
antibodies (immuno-labelling). Immuno-labelling is a laborious multi-step process consisting 
of numerous centrifugation, washing and incubation steps often resulting in a significant 
(reported up to 70%) cell loss [82] and post-isolation cell quality impairment [83]. 
Additionally, currently a limited number of fluorophore-conjugated antibody reagents suitable 
for clinical processing[84]. The effects of introducing these probes into patients are unknown, 
but it is generally recognised that they could potentially trigger immune and toxic responses, 
thus they have to be removed prior clinical application [85]. FACS and MACS generate highly-
defined, purified cell populations with a low number of unwanted cells in the final product, 
however the requirement for cell-specific ligands constrains adaptation of these methods to 
industrial-scale processing due to the high cost of antibodies.  
 The most commonly used large-scale separation approach- density gradient 
centrifugation- makes use of the cells’ physical properties such as density and size. It is a rapid 
process (processing time ~1 hour) with a low technical hurdle suitable for a crude debulking 
of large number of cells (e.g. 1–3 × 1010 input cells). However it is a heavily manual process, 
operating in batch mode, proving it challenging for automation, maintaining sterility and 
scaling-up. Scale-up requires a transition from batch to continuous operation, which is not 
easily compatible with density gradient [86]. 
Another golden standard in cell separation is filtration. This process removes solid 
particles of desired size from a liquid-solid mixture. The mixture is passed either through a 
filter medium or a porous membrane of defined pore size. Filters are rated based on cut-off 
point, which represents  the size of the largest spherical glass particle (expressed in mm) that 
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can pass through the filter under laboratory conditions [87]. There are two approaches, dead-
end filtration (where feed is passed through the filter, particles larger than cut-off point are 
captured on the surface of the filter creating “filter cake”) and tangential-flow filtration 
(considered as advanced and improved filtration, as this operates in a continuous fashion, the 
feed travels tangentially across the surface of the filter subsequently “filter cake” is washed 
away by the flowing media) [88]. 
Centrifugation and filtration are traditionally used methods in laboratory setting and for 
industrial applications. They are well-established and they serve the purpose however with a 
development of the biological field more sophisticated and cost-effective technologies are of 
interest.  
1.4.Microfluidic label-free separation 
Cell sorting and isolation from a heterogeneous mixture is a crucial task in many aspects 
of cell biology, biotechnology and medicine. Recently, there has been interest in methods 
allowing cell separation upon their intrinsic properties (label-free) without the need of use of 
biochemical labels [86][51]. In order to satisfy the increased demand for label-free sorting, as 
shown in Fig. 1.1 numerous microfluidic platforms have been developed.  
Label-free sorting operates based on differences in an intrinsic property of the cell to 
be separated including size, density, shape, hydrophobicity, net charge, sedimentation density, 
intrinsic hydrodynamic forces, differential magnetic susceptibility, refractive index, 
polarisability, membrane properties such as surface charge, cytosol conductivity, and cell 
deformability/stiffness [89]. Label-free sorting approaches can be further classified as (1) 
active- externally applied forces are used for cell manipulation and (2) passive- rely on flow 
characteristics determined by channel geometry.  
Recently, due to their operating simplicity, accuracy, high-throughput (ml/min) and low 
cost, inertial focusing (IF) microfluidic platforms have gained recognition for label-free 
continuous passive cell separations [90]. IF devices do not use any external forces (except a 
pump, for injecting fluid into the device) for cell ordering and separation, as the process is 





Classification of currently available microfluidics platforms for label-free cell separation.   
 
1.5. Inertial microfluidics  
Inertial focusing (IF) and ordering happen in confined channels at intermediate 
Reynolds number (1< 𝑅𝑒 <1000)), where inertia and viscous forces are finite and inertial 
migration and secondary flow are generated, although they remain within the laminar flow 
realm [91]. 












where 𝜌- is medium density, 𝑈- medium velocity, 𝜇- dynamic viscosity and 𝐷ℎ is hydraulic 
diameter defined as 
 
𝐷ℎ =  
2 × 𝐻 × 𝑊
𝐻 + 𝑊
 (2) 
where 𝐻- channel height and 𝑊- channel width. 
An additional dimensionless parameter- particle Reynolds number (𝑅𝑒𝑝), which includes 
parameters describing both the particle and the channel, describes particle flow in a closed 
channel system and allows determination of a minimum particle size in relation to the channel 
geometry for IF to occur, 
 
𝑅𝑒𝑝 =  𝑅𝑒 × 𝜆
2 (3) 
where the particle confinement ratio is 𝜆  and 
 
𝜆 = 𝑎/𝐷ℎ (4) 
where 𝑎 is a particle diameter.  
The first evidence of inertial focusing was reported in 1961 by Segre et al. [92] 
examining particle behaviour in a 1cm circular cross-section pipe. They noted that at 
sufficiently high flow rates particles are focused around the centreline (Fig. 1.2 a). Back then, 
the main postulate preached that since microfluidics systems operate at very low 𝑅𝑒 ≪ 1, 
inertial effects are irrelevant and negligible [93].  
 
Fig. 1.2 
Randomly dispersed particles at given equilibrium position, following different patterns 
depending on the cross-section geometry. In circular channels particles equilibrate as 
presented in (a). In a square cross-section (b) particles are focused at four preferential 
symmetrical positions near the centre of each wall. When the cross-section is narrowed to 
rectangular shape (c), number of equilibrium positions decreases to two in the middle of the 
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longest wall. It is believed that is occurs because in changes in the velocity gradient that is 
stronger along the shorter dimension. Red arrows indicate the direction of the flow.  
 
In 2007, Di Carlo et al. for the first time demonstrated the counterintuitive contribution 
of inertial effects to particles ordering in a micrometre scale [94]. They studied behaviour of 2-
17 µm particles in a straight microchannel with square cross-section at 𝑅𝑒𝑝ranging between 
0.075 and 225. Based on their observation they tried to explain key forces contributing to the 
focusing mechanism in straight microchannels. As shown In Fig. 1.3, particles flowing through 
a straight channel at intermediate 𝑅𝑒, experience asymmetric shear gradient lift force (𝐹𝐿) from 
the Poiseuille flow profile, which pushes the particles toward the channel walls, and a 




Schematic showing particle migration in a straight microchannel as an effect of balance of 
shear gradient lift force (FL) and wall-induced lift force (FW) 
 
When a particle travels a distance long enough, the balance of these two forces defines 
particles equilibrium positions within the channel symmetric cross-section [95] (in a straight 
channel with a circular cross-section (Fig. 1.2 a)- a ring of equilibrium positions at a fixed 
distance from the wall, with a square cross-section (Fig. 1.2 b) - four preferential equilibrium 
positions near the centre of each wall and a rectangular cross-section (Fig. 1.2 c) reduces the 
number of equilibrium positions to two in the middle of the longest wall). 
The current understanding of inertial focusing in straight microchannels with 
rectangular cross-section was proposed and verified experimentally by Zhou and Papautsky in 
2013 [96]. As shown in Fig. 1.4, in this model the inertial migration process is dissected into 





Two stages inertial focusing mechanism in a low aspect ratio microchannel at intermediate 
Re, reproduced form Zhou, J. and I. Papautsky “Fundamentals of inertial focusing in 
microchannels”, Lab Chip, 2013. 13(6): p. 1121-32.[96], with permission from the Royal 
Society of Chemistry (license: 4563030210617). During stage I chaotically dispersed particles 
at the inlet assemble equilibrium positions near wall under the influence of shear-induced lift 
force (FL) and wall-induced lift force (FW). In stage II, particles migrate into wall centred 
equilibrium positions due to the action of rotation-induced lift force (FΩ) 
 
In stage I- fast migration- particles are influenced by FL and FW as proposed by Di Carlo 
et al. 2007. During the stage II-slow migration- particles migrate to the centre of the channel 
as their motion is dominated by the rotation-induced lift force FΩ (due to particle rotation 
dictates particle motion near sidewalls). The combination of FL and FW is collectively called 
the net lift force (FN). Asmolov et al.1999  introduced a dimensionless lift coefficient (CL) to 
relate FN to its dependent variables [97].  
 
𝐹𝑁 = 𝐶𝐿 × 𝐺
2 × 𝜌 × 𝑎4 (5) 






Despite the fact that inertial focusing was observed in straight microchannels, multiple 
equilibrium positions hindered the application of the design. To overcome this limitation it has 
been proposed to add curvature to the channel [98][99][100]. The enhanced channel geometry 
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results in a centrifugal effect that shifts the fluid toward the inner wall, where more pressure is 
applied and to satisfy the mass conservation law and release the pressure, the liquid bounces 
off the wall in the centre and is shifted toward the outer wall, consequently a secondary flow 
is generated manifested in a form of two counter-rotating Dean vortices- perpendicular to the 
liquid main flow (Fig. 1.5).  
 
Fig. 1.5 
Characteristic secondary re-circulating flow (Dean flow) profile generated due to curvature 
of the channel. Graphic reproduced form Dino di Carlo “Inertial Microfluidics”, Lab Chip, 
2009. (9): p.3038-3046 [91], with permission from the Royal Society of Chemistry (license: 
4563040055452). 
Consequently, the maximum velocity at the centreline of the symmetric Poiseuille flow 
shifts from centre to the boundaries of the system. Particles travelling through the spiral 
microchannel follow the direction of Dean vortices in addition to the main stream since they 
experience a supplementary fluid force- the Dean drag (FDD)- proportional to the net fluid 







Particles of different size interact with different sections of this characteristic velocity 
profile, moving the same direction as the velocity. As shown in Fig. 1.6 small particles interact 
with the section of the Dean vortices pushing them towards inner wall, while sufficiently larger 






Fig. 1.6 Mechanism of size-selective separation in curved microchannels. Graphic reproduced 
from adapted from Yoon et.al 2009 “Size-selective separation of micro beads by utilizing 
secondary flow in a curved rectangular microchannel.,” Lab Chip, (9)1, p. 87–90 [102] with 
permission from the Royal Society of Chemistry (license: 4563050175771) . Inertial focusing 
within spiral microchannels occur due to balance of shear gradient lift force (FL), wall-induced 
lift force (FW) as well as Dean drag (FDD). Particles of different sizes (indicates as diameter 
D) interact with different section of the characteristic cross-sectional velocity profile (Dean 
vortices).  
Both FN and FDD are a function of the fluid velocity and consequently strongly depend 
on the applied flowrate. Inertial focusing within spiral channels is determined by balance of FN 
and FDD, which in turn are influenced by a relation of channel dimensions and particle size (λ). 
In previous research, minimum thresholds for inertial focusing in spiral microchannels with 
rectangular cross-section, have been empirically determined and found to be 𝜆 > 0.07 and the 
𝑅𝑒𝑝 ≥ 1 [91][103]. All forces involved in particles gathering at their cross-sectional 
equilibrium positions are function of particles’ size (
𝐹𝐿
𝐹𝐷𝐷
∝ 𝑎3) [101] meaning that the 
equilibrium position predominantly depends on their size and this principle has been 
successfully translated for multiple applications in biological particles separation. Table 1.3 
below outlines examples of spiral channel application translated into medicine and research 
purpose protocols. Label-free separation in spiral microchannels, utilizing size becomes 
popular since it is a gentle (cell viability maintained >90%) and precise method (recover >80-
85%) and is in most cases efficient (purity of target cells >80%). 
 
Cell type/ process Channel specifications Process specifications Ref. 
Cell cycle synchronisation 
of several cell lines (HeLa, 
KKU-100, CHO-CD36 and 
hMSCs) 
Spiral channel (9 loops, 40cm long, 
single inlet, 8 outlets) 
500µm wide 
Height was fine tuned for each cell 
type to satisfy a/Dh>0.07 
Throughput: 15×106 cells/h 
Flow rate: 2.5ml/min 






Made of PDMS Viability: 95% 
 
Focusing and ordering of 
HL-60 and K562 cells to 
facilitate deterministic single 
cell encapsulation in 
droplets  
Spiral channel (5 loops, 7.2cm long), 
50µm wide, 29µm high, initial radius 
of 1500µm  
Made of PDMS 
Flow rate: 15µl/min 
 
[105] 
Separation of tumour cells 
(MCF-7 and HeLa) from 
spiked blood sample  
Double spiral channel (12 loops: 6 
loops counter-clockwise & 6 loops 
clockwise, one inlet, three outlets), 
300µm wide, 50µm deep 
Made of PDMS 
Throughput: 3.33×107 





Isolation of CTC from 
whole diluted blood (20-
25% hematocrit) from 
cancer patients. 
 
Spiral channel (2 loops, 10cm long, 2 
inlets, 2 outlets), 500µm wide, 160µm 
deep 
Made of PDMS 
Flow rate: 3ml/hr 
Efficiency: 88% 
Detection rate: 100% (cells 
detected in all cancer 
patients’ blood samples, 
n=20) 
[107] 
Separation of single cells 
from cell clumps for murine 
neurosphere assay 
Spiral channel (5 loops, one inlet, 8 
outlets), 500µm wide, 150µm deep, 
initial radius of curvature 1cm. 
Made of PDMS 
Efficiency: 75% 
Flow rate: 3ml/min 
Viability: >97% 
[108] 
Separation of plasma from 
whole blood sample ×20 
diluted  
Spiral channel (5 loops, 16cm long, 
one inlet, two outlets), 150µm wide, 
50µm deep, the initial radius was 
3500µm. 
Made of PDMS 
Throughput: 700µl/min 
Efficiency: 38.5% 
Plasma purity: 99.9% 
[109] 
Separation of non-motile 
sperm cells from RBC in 
TESE/mTESE samples 
Spiral channel (4 loops, 1 inlet, 4 
outlets), 150µm wide, 50µm deep, the 
initial radius was 700µm 
Made of PDMS 
Throughput: 520µl/min 
Efficiency: 81% for sperm 
cells, 99% for RBC 
[110] 
Separation of higher quality 
sperm from lower quality 
sperm without using sperm 
motility  
Spiral channel (4 loops, 1 inlet, 4 
outlets), 150µm wide, 50µm deep, 
initial radius 853µm. 




Higher quality sperm was 
4 times enriched in 





sporangia (fungal plant 
phatogen, Ø30µm)  
Spiral channel (3 loops, 1 inlet, 2 
outlets), 600µm wide, 200µm deep, the 
radius of curvature was 2cm on 
average 
Made of thermoplastic polymer 
Throughput: 2ml/min 
5.3-fold increase in 





Separation of algae (sub-
millimetre phytoplankton) of 
two specimens: 
Monoraphium griffithii from 
Cyanothece aeruginosa.  
Spiral channel (3 loops, 1 inlet, 2 
outlets), 350µm wide and 100µm deep, 
initial radius 5mm, total length ~14cm 
Made of PDMS 




Isolation of blood plasma, 
blood sample diluted 1:20 
A cascade of two spiral channels, each 
with 1 inlet,3 outlets and 5 loops: 
1st: 500µm wide, 60µm deep 
2nd: 250µm wide, 60µm deep 
Made of PDMS 
Flow rate: f 1.25ml/min 
Efficiency: 
1st: 55% of blood cells 
removed  




Concentration of E.coli and 
1µm beads  
Spiral channels (3 loops, 1 inlet and 2 
outlets): 
1st part : 10 × 24µm2 cross-section 
2nd part: 10 × 60µm2 cross-section 
Made of glass to withstand high 
pressure (up to 200 bar) 
Flow rate:  
50µl/min (generated 70 
bars) 




Separation of neural stem 
cells derived from induced 
pluripotent stem cells from 
spontaneously differentiated 
non-neural cells 
Spiral channel (1 inlet, 8 outlets and 10 
loops), 500µm wide and 160µm deep, 
total length ~ 50cm 
Made of PDMS 
Flow rate: 3ml/min 
Efficiency: 2.5× 
enrichment of neural stem 
cells with 38% recovery 
[116] 
Enrichment of mesenchymal 
stem cells from bone 
marrow  
Spiral channel (1 inlet, 8 outlets, 10 
loops), 500µm wide and 160µm deep, 
total length ~50cm 
Flow rate: up to 3 ml/min 
Efficiency: the best 
performance at 1.6ml/min, 





Examples of published data using IF in spiral channels with a symmetrical cross-section for 





One commonly overlooked factor in IF research is the fact that biological particles, 
such as mammalian cells, are deformable in contrast to rigid polymer beads used in the basic 
studies. The first evidence of appreciating the cells’ dynamic response to experienced 
hydrodynamic force within IF microsystems was reported by Hur et al. 2011 [117]. They 
described the joint action of FN and deformability-induced lift force (FD) in straight 
microchannels and adapted the observation to classify and enrich cells based on deformability. 
In 2018, I [118] described the contribution of FD to the focusing mechanism in spiral 
microchannels, demonstrating for the first time, that cells can be sorted within spiral 
microchannels based solely on deformability.  
 




Demonstrating IF of spherical particles at high flow rates in a circular cross-
section pipe at cm scale 
[92] 
2007 
Demonstrating inertial effect in microscale channels (straight and serpentine) for 









Demonstrating applicability of the effect of Dean vortices in spiral microchannels 
to differential particle focusing based on size differences 
[99] 
2011 Adapting straight microchannels to deformability-based particles separation [117] 
2013 
Introducing two stage model explaining mechanism of inertial focusing within 
straight microchannel with square and rectangular cross-section 
[96] 
2018 
Demonstrating contribution of FD to the focusing mechanism within spiral 





Chronological summary of research contributions to understating and advancing IF 
microfluidics.  
 
As described above and summarised in Table 1.4, since the introduction of the IF in 
microfluidic devices for particles manipulation, substantial progress has been achieved towards 
understanding the governing forces and underpinning mechanisms and enhancing design of IF 
microfluidics. The advanced knowledge has been adapted and translated into practical 




1.6.  Thesis structure 
Stem cell-derived RBC are a potential supplementary source to donated blood for 
transfusion. However they will not become an economically viable therapeutic product unless 
bioprocess limitations (discussed in Project Motivation section) are addressed. This thesis 
focuses on challenges associated with formulation step of the cell therapy manufacturing 
process as indicated in pink dashed line in Fig. 1.7. In order to develop a novel, label-free 
purification strategy for mRBC it was first necessary to thoroughly characterise- by means of 
mechanical phenotyping- the therapeutic cells, to ensure most optimal solutions.  
 
Fig. 1.7 
An outline of the cellular product derivation process. The dashed pink circle indicates stages 
of the workflow that will be addressed by this project. 
 
Chapter 2 focuses on the detailed methodology used for the experimental studies. It 
presents the detailed procedures used universally throughout the studies, like RT-DC, 
microfluidic set-up and morphological and flow cytometric assays. Procedures specific for 
individual chapters are described accordingly in the end of each chapter.  
Cost-effectiveness was one of the main assumptions for the process development. 
Currently, target cell purification requires addition of costly protein labels to distinguish 
desired cells from contaminant cellular by-products. Hence, the first step focused on finding 
the correlation of molecular identity biomarkers and cell mechanical properties. Chapter 3 
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describes mechanical properties of the end-product of CB CD34+ cells undergoing in vitro 
erythropoiesis and relates them to the underlying molecular and architectural changes.  
Due to numerous advantages offered by IF microfluidic devices, a spiral microchannel 
was the method of choice for the core purification unit. Chapter 4 investigates the contribution 
of deformability-induced lift force (FD) to the focusing mechanism within spiral 
microchannels, which is further translated and incorporated into a complete purification 
strategy for mRBC, as described in Chapter 5.  
Throughout the course of the study some bioprocessing challenges have been identified 
regarding the nature of processed sample, used technology as well as processing conditions. 
Understanding of such issues will enable future improvements to the purification process and 
therefore key challenges were discussed in detail in Chapter 6 and Chapter 7.  Chapter 8 




Chapter 2. Materials and methods  
2.1. Cell culture  
2.1.1. Cord CD34+ stem cell culture 
All methods were carried out in accordance with relevant guidelines and regulations 
and were approved by the Heriot-Watt Engineering and Physical Sciences Ethics Committee 
as well as the Heriot-Watt Engineering and Physical Sciences Biosafety Review. The cells used 
in this work were commercially obtained from donated cord blood and therefore consented to 
the research use. The CD34+ hematopoietic stem cells were primarily purchased from Stem 
Cell Technologies, expanded and cryopreserved after 6 days in culture using a variation of the 
method previously described [34]. A master cell bank from one healthy donor was created with 
D6 cells cryopreserved in fresh medium supplemented with 30% Knockout Serum 
Replacement and 10% DMSO. Cells at day 6 were resuscitated, washed and re-cultured in fresh 
pre-warmed growth medium: Iscove’s basal medium (VWR, cat. BCHRFG0465), 5% human 
AB+ Serum (Sigma Aldrich, cat. H4522), 3 U/ml heparin (Sigma Aldrich, cat. H5515), 10 
µg/ml insulin (Sigma Aldrich, cat. 19278) and 200 µg/ml human holotransferrin (VWR, cat. 
616397-500) supplemented with 60 ng/ml recombinant human stem cell factor (SCF) 
(PeproTech, cat. 300-07), 5 ng/ml recombinant human IL-3 (PeproTech, cat. 200-03), 3 U/ml 
Erythropoietin (EPO) (clinical grade material, Roche) and 1 µM hydrocortisone (Sigma 
Aldrich, cat. H0888) until day 8. At day 8 cell culture medium was replaced with fresh ISHIT 
cell culture medium supplemented with 10 ng/ml SCF, 3U/ml Erythropoietin, 1 µM 
Hydrocortisone and 300 µg/ml Transferrin and cultured until day 14. At day 14, a cell count 
was performed using the trypan blue exclusion technique, cells centrifuged at 300g for 5 min 
and re-seeded in fresh culture medium containing 3 U/ml erythropoietin and 300 µg/ml 
holotransferrin. After a further four days of culture (day 18) cells were re-seeded in fresh 
medium (the same composition as day 14). Each time cells were harvested, they were 
transferred into a centrifuge tube (Corning, UK) and centrifuged at 300g for 5 min. All cell 
culture manipulations were carried under aseptic conditions in a cabinet with a laminar air flow.  
2.1.2.  Jurkat cells 
Jurkat cells were cultured in Roswell Park Memorial Institute (RPMI) medium 
(ThermoFisher Scientific) supplemented with 10% (v/v) fetal bovine serum (FBS, Gibco) in a 
humidified incubator at 37°C in 5% CO2. Cells from the same batch were collected when at 
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their exponential growth phase, split into fresh cell culture flask to maintained researched 
conditions.  
2.1.3. HEK cells 
HEK cells were cultured in basal Dulbecco's Modified Eagle's medium (DMEM, 
ThermoFisher Scientific) supplemented with 10% (v/v) FBS (Gibco) and 1% (v/v) 
GlutaMAXTM (ThermoFisher Scientific) in a humidified incubator at 37°C in 5% CO2. 
 
2.2. Real-time deformability cytometry  
While there are many available well-established technologies for assessing cell 
mechanotype such as Atomic Force Microscopy (AFM) [121], micropipette aspiration [64], 
magnetic tweezers and optical stretchers [68], these methods  suffer from low-throughput 
[122]. To assess a high number of cells (thousands of events per minute), we used a 
microfluidic-based Real-Time Deformability Cytometer (RT-DC) [46]. RT-DC is a contactless 
technique, allowing gain of thousands of events per minute, which is convenient for the global 
characterisation of complex samples [79]. As shown in Fig. 2.1, in the RT-DC set-up, a PDMS 
(Polydimethylsiloxane) channel consisting of three sections, two reservoir sections and one 
constriction channel (20 µm × 20 µm or 30 µm × 30 µm cross section), where cells undergo 
deformation and measurements are undertaken.  
 
Fig. 2.1 
A schematic adapted from Otto, Oliver, et al. 2015 "Real-time deformability cytometry: on-
the-fly cell mechanical phenotyping." Nature methods 12.3, p. 199-202 with permission from 
Springer Nature (license: 4563220521969). RT-DC consist of syringe pump that pumps cell 
suspension into a PDMS chip mounted on a microscope. Cells enter the chip through the 
reservoir section, next they are concentrated into a single stream by sheath fluid and enter the 
measurement channel where they experience deformation due to applied shear stress and 
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pressure. The degree of deformation is measured in ROI based on high-throughput real-time 
image analysis. 
 
The microfluidic chip is mounted on a microscope. A syringe pump is used to pump 
cells suspension in the chip, pulsing LED light enables high-speed image acquisition (4000 
fps), for a standard measurements, the images are acquired at ×40 magnification. Cells are 
introduced in the chip through central reservoir channel and they are directed into the 
measurement channel by sheath flow (both flow liquid and cell carrier are viscous solution of 
methylcellulose). Measurement channel has a cross-section slightly bigger than the cell 
diameter, thus cells entering the channel experiences shear stress that causes cell deformation. 
The images are captured in the Region of Interest (ROI) at the end of the measurement channel 
and processed in real time. 
The RT-DC system employs image processing algorithms which enable the 
measurement of cell area and deformation. Deformation (𝐷) is expressed as a deviation from 
a perfect circle 
 
𝐷 = 1 − 𝑐 (8) 
where 𝑐 is the circularity defined as  
 
𝑐 = 2√𝜋𝐴/𝑙 (9) 
𝐴 being the projected cell area and 𝑙 the cell perimeter 
Deformation (𝐷) in the channel is independently measured from the initial cell shape 
and therefore any treatment-induced morphological changes to shape. Consequently, when 
possible, a differential deformation (𝐷𝐷) parameter has been introduced [123]. 𝐷𝐷 includes 
morphological information acquired in the reservoir section of the RT-DC chip (where applied 
shear is negligible) by subtracting this value from the deformation measured in the channel. 
Subtraction is done by statistical representations of channel and reservoir measurements and 
using a bootstrapping approach [123] [124].  
2.3. Real-time fluorescent and deformability cytometry 
RT-FDC is an enhanced high-throughput (thousands of events per minute) microfluidic 
platform that enables mechanotype analysis of cells within a heterogeneous sample with no 
necessity of pre-sorting into pure populations, due to the integration of fluorescent signal for 
confirmation of cell identity [125]. As in the conventional real-time deformability cytometry 
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(RT-DC) [46], cells are deformed in a contactless manner by experiencing shear stress 
generated by flowing in a viscous buffer through the measurement channel which is only 
slightly larger than the actual cell dimensions. As shown in Fig. 2.2, in RT-FDC, when cells 
pass through the region of interest an image is acquired for the size and deformability 
information and in addition to the image acquisition cell is illuminated by lasers and detectors 
collect emitted fluorescence.  
 
Fig. 2.2 
Real-time fluorescence and deformability cytometry setup (graphic adapted from P. Rosendahl 
et al.2018 , “Real-time fluorescence and deformability cytometry,” Nat. Methods, vol. 15, no. 
5, p. 355–358 [125] with permission from Springer Nature (license: 4563220817805)). (1) 
Immuno-labelled cells are introduced into the microfluidic chip mounted on a microscope and 
while passing through the measurement channel (2) in the ROI they are imaged by bright-field 
microscopy (3). Information about cells size (expressed as projected cell area [µm2]) and 
induced by applied shear stress deformability (understood as 1- circularity) is generated by 
image processing in real time for each captured event and reported as a scatter plot. 
Additionally, cells passing through the ROI are illuminated by focused lasers (4) which excite 
signal detected and measured in the detector array. (5) The fluorescent signal is correlated 
with the acquired image, which allows cell identity confirmation.  
 
2.4. Cell morphology- cytospin 
To visualise cells’ morphology and structure, cells were transferred onto microscope slides 
using a cytocentrifuge then fixed and stained using Giemsa-Wright staining (Rapid 
Romanowsky Stain Pack, TCS Bioscience, cat. SW167/500). Cells at selected time points 
(D11, D14, D18 and D21) were harvested by centrifugation at 300 g for 5 min and re-suspended 
at 2 × 106 cells/ml in PBS-/- (Dulbecco’s Phosphate-Buffered Saline buffer without calcium 
and magnesium, Gibco). 100µl of cell suspension was transferred into a cytocentrifuge cell 
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funnel and centrifuged at 450 rpm for 4 min in a cytocentrifuge (Cellspin I Tharmac, Germany) 
to transfer the cells onto the slide. Slides were then air-dried for 15 min, fixed and stained 
according to the manufacturer’s instructions. After staining, slides were air-dried then fixed 
with DePeX mounting medium (Sigma Aldrich, cat. 06522). Slides were photographed for 
further image analysis either using an EOS 60D Canon camera (Canon, UK) mounted on an 
AXIO Scope.A1 Zeiss microscope (Zeiss, Germany) at ×100 magnification. Images were 
analysed in Matlab R2016b using a custom-made script or using a Canon 650d camera (Canon, 
UK) mounted on a Motic AE31 microscope (Motic, UK) at ×40 magnification. Images were 
analysed using bespoke LabView software (kindly provided by Dr Graeme Whyte, Heriot-
Watt University) which detected the outline of the cells and nuclei by thresholding. The 
detected objects were classified into nucleated cells, enucleated cells and free floating nuclei, 
and the measurements of the morphological features extracted for further processing 
2.5. Flow cytometry and FACS-staining protocol  
The end-product of the CB CD34+ differentiation protocol is a heterogeneous mixture 
of enucleated cell, nucleated cells (cells that did not differentiate fully, still contain a nucleus) 
and free-floating nuclei expelled during the enucleation process. Each population is 
characterised by a combination of molecular markers such as presence/absence of DNA 
(DNA+/ DNA-) and expression/lack of expression of Glycophorin A (CD235a+/ CD235a-). 
Enucleated cells are DNA- and CD235a+, nucleated cells are DNA+ and CD235a+, free-
floating nuclei are DNA+ and CD235a+, however, they express lower levels of CD235a than 
nucleated cells. To reveal those markers cells were stained with fluorescent probes. To each 
100 µl aliquot of cells at concentration around 1 × 107 cell/ml in PBS-/- (Gibco) supplemented 
with 0.5% bovine serum albumin (BSA, Sigma-Aldrich), 0.625 µl of FITC-conjugated Mouse 
Anti-Human CD235a (BD, cat. 559943) and 0.5 µl of 5 mM DRAQ5™ DNA Fluorescent 
Probe (BD, cat. 564902) was added to obtain a final concentration of 5 µM. Cells were 
incubated for at least 20 min at room temperature in darkness. The excess fluorescent stain was 
not removed to prevent cell damage. 
The same staining strategy was used for cell sorting by FACS (FACSAria IIu flow 
cytometer, Beckton Dickinson Immunocytometry Systems (BD, UK) running BD FACSDiva 
v6 Software. FACS sorting was performed in University of Edinburgh FACS Facility by Dr 




2.6. Microfluidic system 
Throughout the course of this work, two configurations of an Archimedean spiral with 
six loops and rectangular cross-sections (design I: 360 × 60 µm, design II: 170 × 30 µm), one 
inlet and four outlets, were used (Fig. 2.3). A single inlet was located at the centre of each 
spiral channel. The radius of the curvature (measured as the distance from a centre of the 
channel to the inner wall of a loop) varies between design I: 0.515 mm (loop I)- 3.805 mm 
(loopIV) and design II: 0.325 mm (loop I)- 1.95 mm (loop VI). The microfluidic devices were 
fabricated by lithography in Poly(methyl methacrylate (PMMA, Epigem, UK). 
 
Fig. 2.3 
(a) Schematic of the spiral channel with six loops, one inlet and four outlets for size and 
deformability-based separation. (b) Picture of the microfluidic chip manufactured in 
PMMA.(c) Cells are introduced into the system via inlet. Hydrodynamic behaviour of cells is 
assessed in the end of the spiral channel in the ROI and it is expressed as lateral position within 
the cross-section of the channel, measured as a distance from the outer wall of the channel 
[µm].  
 
Cell suspensions were introduced into the device with a mid-pressure syringe pump 
(neMESYS 1000N, Cetoni, Germany) through 1/1600 PTFE tubing of 0.5 mm internal 
diameter (Thames Restek, UK). Hydrodynamic behaviour of cells was assessed in terms of 
lateral equilibrium position (measured as a distance from the particle centre to the outer wall 
[µm]) obtained at the end of the spiral channel by monitoring the ROI, by high-speed 
microscopic imaging. Images of cells inside the spiral channels were recorded either at ×20 
magnification using objective with 4.9 mm free working distance (421251-9911-000 LD A-
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Plan 20x Ph1, Zeiss) facilitating access to observe the channels through 2 mm thick PMMA 
layer. Images of cells were recorded by a high-speed CMOS camera (MC1362, Mikrotron, 
Germany), mounted on a microscope (Zeiss Axio Observer 3, Zeiss, Germany), at a speed of 
2000 frames per second. Lateral position within the channel was recorded for more than 10000 
events at three independent occasions, for each researched condition, using a custom-written 
program ShapeIn and quantified using ShapeOut version 0.8.4 (available at 
www.zellmechanik.com) 








of each cell type in each outlet, where [𝐶𝑡𝑦𝑝𝑒] is the concentration of given cell type cells in a 
given outlet i (i=A, B, C or D). 
 
𝑃𝑢𝑟𝑖𝑡𝑦[𝐶]𝑜𝑢𝑡𝑙𝑒𝑡𝑖 =  
[𝐶𝑡𝑦𝑝𝑒]𝑜𝑢𝑡𝑙𝑒𝑡𝑖
 [𝐶𝑎𝑙𝑙]𝑜𝑢𝑡𝑙𝑒𝑡𝑖
× 100% (11) 
indicating a fraction of each subset in a sample collected after processing, where [𝐶𝑎𝑙𝑙] is 
concentration of all cell types found in the sample and  
 







2.7. Receiver Operating Characteristic (ROC) curves  
Receiver Operating Characteristic (ROC) curves and Area Under the Curve (AUC) 
were generated using Prism GraphPad 7, to discriminate the degree of overlap in terms of 
properties (such as sizes, deformability, lateral positions) of events from different samples, 
where AUC=1 means total separation and AUC=0 means total overlap. As shown in Fig. 2.4 
a, a ROC curve, is a graphical plot that illustrates the relationship between True Positive Rate 
(y-axis) and False Positive Rate (x-axis), for a given cut-off point (indicated as green ellipse 
and blue vertical line in Fig. 2.4 b). True positive rate is defined as fraction of true positives 
divided by total number of control events and True Negative Rate is defined as fraction of true 





Illustration explaining Receiver Operating Characteristic (ROC) curves. (a) ROC curve is a 
graphical plot showing the relationship between True Positive Rate and False Negative Rate, 
for a different cut-off points (indicated as a green ellipse on the ROC curve) The area under 
the ROC curve ( AUC ) is a measure of how well a parameter can distinguish between two 
diagnostic groups (b) ROC curve is generated by plotting the True Positive Rate against the 
false Positive Rate at various threshold settings (indicated as a blue vertical line) (c) True 
positive rate is defined as fraction of true positives divided by total number of control events 




Chapter 3. Assessment of mechanical properties of stem 
cell-derived red blood cells 
Highlights 
 The changing mechanical properties of umbilical cord blood CD34+ cells undergoing 
in vitro erythropoiesis were quantified in a high-throughput manner by real-time 
deformability cytometry for the first time. 
 For each subpopulation present in the end-product of the CD34+ differentiation into 
mRBC (enucleated and nucleated cells as well as nuclei) a unique combination of size 
and deformability has been identified that could serve as label-free markers to 
distinguish between them. 
 Distinct mechanotypes are correlated with specific morphological features, such as 
content of cytoskeletal protein F-actin and nucleus-to-cytoplasm ratio. 
 
Published work:  
Ewa Guzniczak, Maryam Mohammad Zadeh, Fiona Dempsey, Melanie Jimenez, Henry 
Bock, Graeme Whyte, Nicholas Willoughby and Helen Bridle,  
High-throughput assessment of mechanical properties of stem cell derived red 
blood cells, toward cellular downstream processing.  
Sci. Rep. 7, 14457 (2017). 
licensed under a Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/)- please consult Research Thesis 
Submission form for authors contribution. 
 
3.1. Introduction 
Stem cell products, such as manufactured red blood cells (mRBC), require efficient 
sorting and purification methods to remove components potentially harmful for clinical 
application. However, standard approaches for cellular downstream processing rely on the use 
of specific and expensive labels (e.g. FACS or MACS). Techniques relying on inherent 
mechanical and physical properties of cells offer high-throughput scalable alternatives but 
knowledge of the mechanical phenotype is required. Deformability is emerging as a novel 
homogeneity marker that could serve to identify subpopulations within complex cell samples 
such as mRBC [127]. However, while qualitative observations have noted changes in 
phenotype throughout the differentiation protocol of CD34+ cells, little is known about their 
mechanical phenotype changes.  
The in vitro manufacture of RBC from hematopoietic stem cells (CD34+) follows an 
in vitro protocol which is a recapitulation of in vivo erythropoiesis through distinct 
developmental stages [128][129] (for details of the protocol and the different stages involved 
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consult Fig. 3.1). Initially, the culture is expanded for the first ten days (D0 to D10) before 
differentiation is induced at D11, resulting in drastic cell phenotype changes during the final 
11 days of differentiation.  
 
Fig. 3.1 
Schematic showing stem cells differentiation into red blood cells. The process starts (day 0) 
with hematopoietic stem cells, CD34+ subpopulation obtained from umbilical cord blood. 
Basal medium always contains 5% AB+ human serum, Heparin and Insulin. Over the course 
of the differentiation protocol cell culture medium is supplemented with different cytokines and 
growth factors. Those changes in medium composition push stem cell through distinct 
developmental stages (in vitro recapitulation of in vivo erythropoiesis). By day 18 cells lose 




Observed changes are induced stage-wise, by adjusting cell culture medium 
components. The presence of biological markers at different points in the differentiation has 
been studied [130][37][17] , underpinning the label-based separation approaches, and it is 
known that between D0 and D11, CD34+ cells extensively proliferate without changing their 
identity. Around D14 cells start producing haemoglobin and reduce their intracellular 
structures (the cytoplasm becomes simplified) and size. By D18, chromatin becomes 
compacted, cellular division slows and in the final stages, the nucleus is expelled. Based upon 
this, four distinct time points (at D11, D14, D18 and D21) were selected to assess the changing 
mechanotype of CD34+ during in vitro erythropoiesis to determine the potential for mechanical 
properties to act as a homogeneity marker upon which passive cell separation methods can be 
developed. 
Here, I characterized, for the first time, deformability and size changes in CD34+ cells, 
and expelled nuclei, during their differentiation process into red blood cells at four key stages 
(days 11, 14, 18 and 21). This chapter provides extensive quantitative analysis of these changes, 
combining both high-throughput microfluidics as well as traditional biophysical 
characterisation. Data was collected determining the size and deformability of enucleated cells, 
nucleated cells and free-floating nuclei using real-time deformability cytometry (RT-DC) and 
bright field/fluorescent imaging. Furthermore, staining of the nucleus and cytoskeletal proteins 
was undertaken to investigate the potential contribution of these factors to the observed 
mechanotypical changes. 
 
3.2. Results and discussion 
3.3.1. High-throughput size and deformability assessment  
CD34+ cells size and deformability at D11, D14, D18 and D21 were assessed using 
RT-DC for both individual and mixed populations of nucleated and enucleated cells as well as 
expelled nuclei. Free-floating nuclei and undifferentiated cells constitute the two main 
contaminants that must be removed from the sample, prior to clinical application, to leave 
purified mRBCs. A global view of mechanical changes using mixed populations, directly from 





Scattered plots obtained from RT-DC for CD34+ undergoing in vitro haematopoiesis 
corresponding to four time points: D11, D14, D18 and D21. Cells are flowing at 0.12 µl/min 
through a 20 µm × 20 µm channel. Each dot represents a single event (the total number of 
collected events is displayed on the top of each diagram). Colours indicate a density scale. 
Grey isoelasticity lines on the scatter plots represent a predicted cell deformability for cells of 
the same elasticity and different size  
 
The results indicate that as the differentiation process progresses, deformability 
increases while size decreases and the emergence of a greater number of different cell 
populations can be observed. At D11 cells are strongly heterogeneous in size (cell areas ranging 
between 25 and 175 µm2) while deformability is low (< 0.2). At D14 the first spontaneous 
enucleation events are observed characterized by a new emerging subpopulation on the 
deformation axis (events with deformation > 0.2) and the reduction in cell size (very few cell 
areas above 100 µm2). Closer to the end of the differentiation process (D18 and D21), the 
enucleated cell subpopulation becomes dominant (deformability > 0.25) and another 
population corresponding to expelled nuclei appears (deformability < 0.03). In in vivo 
differentiation, nuclei would be removed by macrophages [31][131].  
Utilising the above data, I compared the size and deformability of enucleated and 
nucleated cells and nuclei at each of the time points. Firstly, I confirmed the identity of the 
three subpopulations by collecting data from a mixed sample as well as from samples which 
were sorted into pure populations by FACS and assessed using the RT-DC separately (Fig. 
3.3). Regions corresponding to each subpopulation were therefore identified and used for 






Gating strategy. Presented data was generated using RT-DC with a 20 µm × 20 µm cross-
section channel and a flowrate of 0.12 µl/ min. Each dot represents the measurement for one 
cell at D14, with the total number of events indicated on the top of each diagram. Grey 
isoelasticity lines on the scatter plots represent a predicted cell deformability for cells of the 
same elasticity and different size. On the first dot plot (a) three subpopulations can easily be 
distinguished, corresponding to enucleated and nucleated cells as well as nuclei. Properties 
for nuclei (c), enucleated cells (d) nucleated cells (e) were assessed separately on the RT-DC 
after being sorted into pure subpopulations by FACS. Predicted populations from (a) were 
gated using the polygon tool in the ShapeOut software and their contour were compared with 
the contour plots (b) generated for the pure subpopulations (c, d, e). The contour for each 
population consist of a smaller inner contour representing 50% density and a larger outer 
contour corresponding to 90% density.  
 
The populations identified from the mixed sample (Fig.3.3 a) correspond to the 
individual gated enucleated (Fig. 3.3 d) and nucleated (Fig. 3.3 e) cells and nuclei (Fig. 3.3 c) 
populations. In general, the individual populations of cells are slightly stiffer than those from 
the mixed population, due to the extra processing undertaken [132]. However, Fig. 3.3 b shows 
that the three different subpopulations plot in different regions suggesting that there is potential 
to utilise size and deformability changes as a basis for separation and sorting. Secondly, to 
confirm that software could utilise size and deformability differences to classify cells, events 
from the scatter plot of a mixed sample were analysed using a Gaussian mixture model also 
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By analysing raw data with a Gaussian mixture model at least three subpopulations within 
sample from D18 were detected and colour-coded, corresponding to nucleated (purple), 
enucleated cells (pink) and nuclei (grey). Remaining events (blue) are considered unclassified 
events, artefacts and cell debris. 
 
To further analyse the data, box plots were generated showing the average and range of 
the size and deformability characteristics for each of the subpopulations. Fig. 3.5 a illustrates 
the size variation of the three populations at the selected time points (D11 only appears for 
nucleated cells as this is before the enucleation step). Nuclei are much smaller (with area 22.8 
± 3.8 µm2, mean ± SD) than the nucleated cells (D11 72.9 ± 25.8, D14 71.6 ± 12.8, D18 54.7 
± 7.2 and D21 52. 2 ± 7.5 µm2)  and enucleated cells (D14 57.6 ± 8.6, D18 50.9 ± 9 and D21 
47.9 ± 7.5 µm2) with little size overlap (p < 0.0001). In terms of the size of cells, there is a 
statistically significant difference between enucleated and nucleated cells (p < 0.0001). 
However, there is an overlap between events from both subpopulations.  
Fig. 3.5 b considers the deformability differences between the three populations and 
demonstrates greater discrimination potential. Nuclei deformability is 0.03 ± 0.01 whereas that 
of nucleated cells is greater than 0.1 (D14 0.13 ± 0.04, D18 0.18 ± 0.05 and D21 0.12 ± 0.05) 
and enucleated cells greater than 0.25 (D14 0.26 ± 0.05, D18 0.34 ± 0.05 and D21 0.33 ± 0.05) 
and the difference is statistically significant (p < 0.0001). Additionally, a significant difference 
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in deformability (p < 0.0001) is observed for nucleated (deformability 0.1-0.25) and enucleated 
(deformability > 0.25) cells.  
 
 
Fig. 3.5  
Box plots summarizing (a) cell area and (b) deformation respectively. Values for each 
subpopulation are extracted from raw data by gating enucleated, nucleated cells and nuclei as 
justified in Fig. 3.3. P-values were calculated using a generalized mixed model (*** p < 
0.0001). The line in the box represents the median and the box itself represents data from lower 
and upper quartile while the whiskers correspond to the lowest and highest extreme values. 
For summary of triplicate results please consult Appendix A.   
 
To quantify the degree of the size and deformability overlap, receiver operating 
characteristic (ROC) curves were plotted and the corresponding area under the curve (AUC) 
calculated (Fig. 3.6). Using this approach we determined that enucleated cells are 100% 
separated (AUC=1) from the nuclei population in terms of size (Fig. 3.6 a) and deformability 
(Fig. 3.6 b). Microfluidic systems have been designed to separate particles in the same range 
of sizes (diameter) as nuclei (6 µm) and enucleated cells (7-10 µm) [89][51] and the data 
supports the potential for a size-based separation as a route for nuclei removal. Fig.3.6 a shows 
that within a population classified in terms of size as enucleated cells, ~20% of those cells 
belong to the nucleated cell population (AUC= 0.82, 0.83 and 0.75). Therefore size-based 
separation between nucleated and enucleated cells would be possible but would result in a 
significant contamination. The deformability difference between enucleated and nucleated 
cells (Fig. 3.6 b) is close to 100% (AUC=0.99) suggesting the feasibility of deformability to 





Receiver Operating Characteristic (ROC) curves were plotted for (a) size (expressed as area 
[µm2]) and (b) deformation [-] for enucleated versus nucleated cells (purple) and nuclei (grey) 
at D18.The True Positive Rate is defined as the number of enucleated cells measured for a 
certain cut-off point (size or deformability) and divided by the total number of enucleated cells. 
The False Positive Rate is the corresponding number of nucleated cells (resp. nuclei) divided 
by the total number of enucleated cells (resp. nuclei) for the same cut-off. The Area Under the 
Curve (AUC) was calculated to quantify the size overlap between enucleated and nucleated 
cells population, enucleated cells and nuclei as well as deformation overlap between 




3.3.2. Correlation between mechanotype and biology 
Cell deformability is determined by the structural components of the cell, particularly 
the cytoskeleton [52]. The cytoskeleton is a protein network (mostly actin and spectrin in RBCs 
[133]) supporting the cell structure and providing mechanical integrity to the cells. This 
network underlies the cell membrane and connects with the nucleus by extending through the 
cytoplasm and plays a crucial role in the enucleation, which is a dynamic process lasting 
approximately 10 min [134]. During the process, F-actin and myosin filaments undergo re-
arrangements to facilitate the act of enucleation. Paraformaldehyde fixed cell samples were 
stained at D11, D14, D18 and D21 for F-actin (Fig. 3.7 a), one of the most abundant 
cytoskeletal protein, and imaged. At D11 and D14 F-actin assembles into a uniform shell 
surrounding the cell interior. By the end of the differentiation protocol, at D18 and D21, the 
shell becomes thinner and less visible with small aggregates visible, which support the 
observed softening of nucleated cells between those days.  
 
Fig. 3.7 
To visualise changes in cell morphology over the course of the differentiation procedure (Day 
11, 14, 18 and 21) (a) cytoskeletal protein F-actin (green) and nuclei (blue) were stained with 
fluorophores and (b) cytoplasm and nuclei were stained with Romanowsky stain. Scale bars 
represent 10 µm; (c) cytospin images of Rmanowsky’s stained cells were analysed using 
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Matlab for cell and nucleus area (mean ± SD) and nucleus/ whole cell ratio were calculated 
(mean ± SD).  
 
Observed thinning is in agreement with literature evidence, where cytoskeletal protein 
levels were quantified by Western Blot [128]. It was reported that actin is downregulated during 
erythropoiesis with α-spectrin and β-spectrin expressed in higher quantities. Together, those 
rearrangements are believed to be an adaptation of RBCs to change their shape under the 
applied stress they experience during the vascular circulation, without haemolysis. The lack of 
a nucleus is the main feature providing optimal cell deformability for oxygen transfer in tissues 
[135]. The presence of a nucleus, its changing characteristics and eventual expulsion 
throughout differentiation, could contribute substantially to the overall cell mechanical 
behaviour [56].  
The contribution of the nucleus to the mechanotype is determined by its relative size 
[136]. To assess the nucleus/whole cell ratio, cytospin cell slides prepared at D11, D14, D18 
and D21 were stained with rapid Romanowsky stain and visualised using a bright field 
microscope (Fig. 3.7 b). Approximately 1000 events per condition were analysed and results 
are presented in Fig. 3.7 c. Nuclei become smaller over time and at D11, on average, they 
constitute around 60% of the cell. The cytoplasm becomes simplified at later days and the 
nucleus is more compacted and smaller (50% for D14 and 40% for D18).  
We further explored the contribution of nuclei to the mechanical behaviour of cells by 
looking at cell elongation within the RT-DC microfluidic device under shear stress (Fig. 3.8 a 
and b). In the RT-DC system, cells first pass through a reservoir section before being forced 
through a smaller channel where a sheath flow induces a shear stress on the cells (Fig. 2.1). As 
presented in Fig. 3.8, the y-axis for enucleated and nucleated cells is larger than nuclei in the 
reservoir. When cells enter the main channel, the nuclei y-axis remains unchanged while the 
enucleated y-axis is shortened and the nucleated y-axis remains above the length of the nucleus. 
The presence of the nucleus seems therefore to constitute a barrier to the capability of a cell to 





Cells at D14 were sorted on FACS into enucleated, nucleated cells and nuclei populations. 
Their minor and major axis (y and x respectively) were assessed by RT-DC image analysis. (a) 
Measurements were captured in both the reservoir (with negligible degree of shear stress) and 
in the channel (20 µm width) where shear stress exerted on cells causes them to deform from 
their original shape. (b) Changing x- and y-axis length for pure populations, in the reservoir 
and in the channel, were captured. Bar graph represents mean axis length with error bars 
showing SD from the mean. 
 
To verify if it would be possible to separate enucleated and nucleated cells based on the 
degree of deformation they undergo under hydrodynamic stress, the length of the y-axis of 
enucleated and nucleated was compared. The measurement was obtained in the reservoir 
section of the device where cells experience shear stress and by creating a ROC curve and 
calculating the AUC =1 (Fig. 3.9) we see that there is no overlap in the y-axis length. 
Deformability and size are coupled and the cell size, revealed by their original shape change 
under applied stress, could constitute a basis for cell separation (e.g. by passing through a filter 





Receiver Operating Characteristic (ROC) curves were plotted to compare enucleated and 
nucleated cells y-axis overlap (Fig. 3.8). The True Positive Rate is defined as length of y-axis 
for number of enucleated cells measured for a certain elasticity cut-off point and divided by 
the total number of enucleated cells. The False Positive Rate is the y-axis of corresponding 
number of nucleated cells divided by the total number of enucleated cells for the same cut-off. 
The Area Under the Curve (AUC) was calculated to quantify the overlap between the measured 
length of the y-axis for enucleated and nucleated cells. 
 
3.4. Conclusion 
Regenerative medicine, and cell therapy, in particular, are seen as a potential route to 
revolutionize medicine and to improve healthcare for patients who currently have either limited 
or no treatment options. The in vitro produced RBC are seen to address needs in transfusion 
medicine.  
For the wide-spread adoption of mRBC, and indeed other cell therapies, challenges 
related to cell source, maturation and viability need to be addressed by biologists, while 
advancements in cell processing technologies will be required to manufacture those cells in 
meaningful quantities and achieve satisfactory purity. Label-free separation techniques based 
on mechanical phenotype differences offer a promising route to large-scale purification. 
However, to design optimal downstream processing protocols we first need to understand the 
mechanical characteristics of subpopulations within the samples, how these relate to molecular 
and architectural changes and how those changes evolve with cell-state and progressing 
differentiation protocols. Thus, here I characterised the mechanical properties (size and 
deformability) of CD34+ cells from cord blood as they undergo in vitro erythropoiesis. Cell 
size and deformability are highly dynamic features, significantly changing during the 
differentiation process. Based on the observations, using novel high-throughput techniques 
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(RT-DC), cells become smaller and softer between D11 and D18 as different cell 
subpopulations emerge. The staining results, linked with data from the literature, suggest that 
this phenomenon is driven by changes in the nucleus properties, which is expelled towards the 
end of the protocol, coupled to morphological changes in the cytoplasm and cytoskeleton. 
Several key findings emerged from our mechanotype analysis. Firstly, there is no 
overlap between the sizes of the nuclei and the cells (both enucleated and nucleated). Data 
confirmed a 100% separation for both size and deformability. It could, therefore, be possible 
to design label-free systems to remove the nuclei exploiting the 2 µm difference in the average 
diameter of the cells and the nuclei at D18, a size at which there is plenty of evidence in the 
literature for successful separation approaches targeting different applications [51].  
Secondly, since the data showed a significant overlap of the enucleated/ nucleated cell 
populations in terms of size, the cell mechanotype marker of size might thus not be practical. 
Thirdly, we demonstrated a significant difference in deformability (from ROC curves 
AUC=0.99) between the enucleated/ nucleated cell populations. In order to purify enucleated 
cell from nucleated cells, methods which exploit observed differences in deformation under 
shear stress could be utilised.   
Overall, this study provides the first quantitative information regarding the 
mechanotype of CD34+ cells undergoing in vitro differentiation into mRBC, which could assist 
in the design of robust label-free purification approaches. 
3.5. Materials and methods 
3.5.1. Flow Cytometry 
Cells were assayed for expression of CD235a (Glycophorin A) and for the presence of 
a nucleus using flow cytometry during differentiation. At each control time point: day 11, 14, 
18 and 21 (D11, D14, D18 and D21), cells were collected and counted, centrifuged at 300 g 
for 5 min and re-suspended in basal medium supplemented with 0.5% BSA at a concentration 
of 1 × 107 cells/ml and fluorescently stained as per materials and methods Chapter 2. Cells 
were analysed on a BD FACSCalibur within two hours of staining and raw data analysed using 
FlowJo V10 CL. The same staining strategy was used for cell sorting by FACS (FACSAria IIu 
flow cytometer, Beckton Dickinson Immunocytometry Systems (BD, UK) running BD 
FACSDiva v6 Software.   
3.5.2. Mechanotype Characterisation- Real-Time Deformability Cytometry 
Cells size and deformability changes were assessed using a Real-Time Deformability 
Cytometer (RT-DC). Measurements were performed as described in Nat. Methods 2015 [46] 
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and Chapter 2. In this work, a PDMS chip with a 20 µm × 20 µm cross-section channel was 
used. Prior to measurements, cells were harvested by centrifugation at 300g for 5 min and 
resuspended in a 0.05% methylcellulose solution at 1-2 × 106 cells/ml. Cells were pumped into 
the channel at 0.12 µl/min. RT-DC data were analysed using original RT-DC software 
ShapeOut 0.6.9 (available at www.zellmechanik.com). Using the polygon tool built in the 
software, area and deformability values were obtained separately for day 11, 14, 18 and 21 as 
well as for separate subpopulations (enucleated cells, nucleated cells and nuclei). Data were 
then extracted from the software and further analysed using MatLab R2016b and GraphPad 
Prism 7. The significance of the results was calculated using a standardized mixed model that 
assumes non-normal distribution with three replicas of each experiment (Appendix A). The 
receiver operating characteristic curves were generated and the area under the curve was 
calculated using a customised MatLab script (MatLab R2016b). 
3.5.3. Widefield Microscopy  
To study the cytoskeletal changes in CD34+ cells undergoing in vitro erythropoiesis, 
cells at day 11, 14, 18 and 21 were fixed in 4 % paraformaldehyde (PFA) (ThermoFisher 
Scientific, cat. 28906) and imaged using a widefield microscope Olympus IX-81 TIRF+ with 
a x150 1.4 NA immersion oil lens and EMCCD camera (Hamamatsu, UK). First cells were 
stained for 30 min at room temperature against F-actin with Actin Green 488 Ready Probes 
reagents (Life Technologies, cat. R37110) then cells were transferred onto poly-D-lysine 
hydrobromide (Sigma Aldrich, cat. P6407, UK) coated cover slips to attach. Two minutes 
before the end of the incubation time, Hoechst 33342 (Sigma Aldrich, cat. 14533) was added 
to a final 10 ng/ml concentration. After 2 minutes the cover slip was gently washed with PBS 
-/- to unattached free-floating cells. Twenty stack images per differentiation day (D11, D14, 









Presented bar graphs show mean of area (a) and deformations (b) medians for three replicas of 
the RT-DC measurements for cells at D11.and enucleated, nucleated and nuclei populations 
from D14, D18 D21. Populations were identified from mixed samples by the gating scheme as 
described in the main body of the text. Error bars represent standard deviation from the mean. 
All measurements were performed in three replicas for cells at the same days of differentiation 
protocol. Cells come from three separate batches, from the same master bank created for one 
donor. Tables (c) and (d) show averaged medians for cell are and deformability values obtained 
at three separate occasion. Because deformation values are small, the SD is represented as % 




Chapter 4. Understanding contribution of 
deformability-induced lift force to cells focusing in 
spiral microchannels  
Highlights 
 A novel additional force, deformability-induced lift force (FD), involved in the cell 
focusing mechanism within spiral microchannels has been investigated and reported for 
the first time.  
 The effect of FD has been studied using a customised cellular deformability model 
consisting of cells of the same size and five degrees of gradually changing 
deformability. 
 The effect of FD is revealed at sufficiently elevated flow rates and it has been 
successfully applied for efficient deformability-based cells separation in spiral 
microchannels.  
Published work 
Presented data was partially published as referred conference papers:  
(1) E. Guzniczak, M. Jimenez, H. Bridle. Fluid flow in curvilinear microchannels 
for stem cell purification- understanding the deformability-induced lift force, 
German Physical Society annual meeting, 11-15 March 2018, Berlin, Germany- 
selected as top 10 research posters.  
(2)  E.Guzniczak, M.Jimenez, O.Otto, N. Willoughby, H.Bridle. Deformability-
induced lift force in curvilinear microchannels for stem cell-derived product 
purification. Micro Total Analysis Systems (µTAS) Conference 10-15 Oct 2018, 
Kaohsiung, Taiwan. [118] 
 
4.1. Introduction 
Separation of cells based on their indigenous properties, such as size and deformability 
(cell shape change as a response to applied load), have been recognised as a viable alternative 
to conventional techniques (e.g. FACS and MACS) [51][89]. This is especially true for novel 
cellular therapeutics, where the final products are not traditional biological molecules (e.g. 
monoclonal antibodies), but cells themselves (e.g. stem cell-derived red blood cells) [86]. 
Label-free biomarkers are cost-effective since there is no need to add costly antibodies to reveal 
cell identity markers and number of processing steps (staining, washing) is reduced [137]. Cell 
sorting is often used to enrich or purify cell samples into well-defined populations and recently 
various microfluidic platforms such as acoustophoresis, magnetophoresis, dielectrophoresis 
and passive sorting (inertial focusing (IF), pinch flow fractionation, deterministic lateral 
displacement and filtration) have been used for continuous label-free separation [51]. IF in 
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spiral microchannels represents one of the passive techniques used to manipulate cells on the 
microscale without an externally applied force [91]. Due to simplicity in operation, low 
manufacturing cost and proven scalability by parallelisation (millions of cells per minute) IF is 
considered as a very attractive approach for developing high-throughput industrially-viable 
processes for large-scale cell enrichment [138].  
Traditionally, fluid flow in microscale confined channels has been associated with a 
negligible inertia since fluid flow in microchannels occurs at low Reynolds numbers [95]. 
However previous work has shown useful physical phenomena occurring at commonly 
neglected intermediate flow regimes within spiral microchannels, namely secondary flow and 
IF [91]. Both of them are determined by channel geometry, particle size and applied flow rate. 
The interplay between fluid flow pattern and particles, if fine-tuned, leads to particles ordering, 
i.e. focussing into particular cross-sectional positions; separation based on size has been 
demonstrated and the effect has been exploited for myriad applications in point-of-care and 
clinical diagnostics as discussed in Chapter 1. However, biological particles due to their 
deformable nature add complexity to the focusing mechanism. 
This chapter presents an investigation of the contribution of the deformability-induced 
lift force (𝐹𝐷) to the mechanism of inertial focusing in a high aspect ratio spiral microchannel 
with rectangular cross-section. In order to study the phenomena of deformability as a migration 
mechanism, a cellular model of deformability has been derived. Cells of the Jurkat cell line 
were chemically treated to gradually change their deformability without alterations in the cell 
size. Treated cells were analysed using a high-throughput phenotyping technique, namely real-
time deformability cytometry (RT-DC), and that lead to identification of five optimal 
conditions within the cellular deformability spectrum (from stiff to soft), which were used to 
research 𝐹𝐷 in spiral channels. For the first time, it has been demonstrated that biological 
particles of the same size can be separated in spiral microchannels based on difference in 
deformability only.  
 
4.2. Theoretical background 
Inertial focusing and ordering happen in microscale confined channels at intermediate 
Reynolds numbers (Re), as defined in Equation (1), where inertia and viscous forces are finite 
and inertial migration and secondary flow are generated although they remain within the 
laminar flow realm [95]. 
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Particles travelling within a spiral microchannel channel experience an asymmetric 
shear gradient lift force (𝐹𝐿) from the Poiseuille flow profile, which pushes the particles toward 
the channel walls, and a competing wall induced lift force (𝐹𝑊) repulsing particles back toward 
the centre of the channel [91][96]. Additionally, due to the curvature of the channel, centrifugal 
forces create a secondary flow, manifested in a form of two counter-rotating Dean vortices 
perpendicular to the liquid main flow [99]. The secondary flow can be quantified by Dean 
number, defined in Equation (7). 
When a particle travels a sufficiently long distance, the balance of the net inertial lift 
force and the De force defines particles equilibrium positions within the channel cross-section 
[100]. Although the dynamics of internal focusing have been proven to depend significantly on 
size, it has been demonstrated that solid elastic particles flowing in a straight microchannel in 
Poiseuille flow, experience additional deformability-induced lift force (𝐹𝐷) that pushes them 
away from the channel wall [117]. As shown in Fig. 4.1 softer particles are positioned closer 
to the channel centre in comparison to their more rigid counterparts.  
  
Fig. 4.1 
Schematic adapted from [117] illustrating contribution of deformability-induced lift force to 
inertial focusing in a straight microchannel with rectangular cross-section.  
 
The magnitude of response to 𝐹𝐷 is associated with deformation as well as relative 
viscosity of fluid inside a cells in respect to the surrounding fluid [139][140]. To capture the 
degree of deformation, different geometrical measures have been proposed, e.g. (1) reduced 
volume (𝑣) [141] defined as the ratio of actual particle volume to that of a sphere with the same 















where, 𝑉 is deformed particle volume and 𝐴𝑆 is deformed particle surface area, and (2) excess 
area (∆) [142] defined as the differences in projected area between the particle and a sphere 















In this study cell deformability (𝐷) was measured with RT-DC (see Chapter 2) and it is 
expressed as 𝐷 = 1 − 𝑐𝑖𝑟𝑐𝑢𝑙𝑎𝑟𝑖𝑡𝑦, a deformable object will be characterised by c<1.  
Deformability-induced particles migration has been explored on numerous occasions 
for droplets, bubbles, vesicles and viscous capsules in straight channels [143]. To the best of 
my knowledge there is no literature describing this hydrodynamic mechanism in conjugation 
with Dean vortices in spiral microchannels. Exploring and understanding the contribution of 
𝐹𝐷 to the focusing and ordering mechanism in spiral microchannels opens up a new way to 




4.3.1. Cellular deformability model 
To study 𝐹𝐷 in spiral microchannels, a cellular model of deformability was derived by 
inducing gradual changes in cell deformability with chemical treatment (Fig. 4.2). We used 
Jurkat cells (round cells, Ø13 ± 2 µm, mean ± SD, cultured in suspension) and treated them 
with CytochalasinD (CytoD)), known for softening cell properties by alteration of cytoskeletal 
protein F-actin, Fig. 4.2 a), and Glutaraldehyde (Gluta), making cells stiffer by cross-linking 
proteins, Fig. 4.2 b. Both compounds were tested at gradually increasing concentrations in 
order to generate dose-response graphs and identify concentrations corresponding to half-





Exemplary contour plots for Jurkat cells treated with (a) Cytochalasin D (CytoD) and (b) 
Glutaraldehyde showing the controlled change in deformability without affecting size. Size is 
expressed as the projected cell area [µm2] vs deformation [-], measured in both the high-shear 
stress channel (green-CytoD and red- Glutaraldehyde) as well as inlet reservoir section (grey 
for both conditions) of RT-DC chip. All experiments were carried out at a flow rate of 0.16 μl/s 
in a 30 × 30 μm cross-section channel for around 10000 events for each replicate. 
 
Deformability was measured by RT-DC and here it is reported as differential 
deformation (DD) where deformation in the measurement channel is independently measured 
from the initial cell shape. Therefore any treatment-induced morphological changes to shape 
were neglected. DD includes morphological information acquired in the reservoir section of 
the RT-DC chip (where applied shear is negligible) and subtracts this value from the 
deformation measured in the channel. Interestingly, as in Fig. 4.3, cells treated with 0.1, 1 and 
10 µM CytoD appear more deformable (D= 0.019 ± 0.017 and D=0.023 ± 0.017, respectively) 
in in the reservoir of the RT-DC chip, in comparison to control cells (D=0.013 ± 0.006) with 
increased heterogeneity manifested by increased SD. Since in the reservoir section the amount 
of shear stress is negligible, the apparent elevated deformability could originate from loss of 
the typical spherical shape by some of the cells (as shown in Fig. 4.3) due to lack of cytoskeletal 




Fig. 4.3  
Exemplary images captured in the reservoir section of RT-DC chip for untreated control cells 
as well as cells treated with 1 and 10 µM CytoD. The red lines indicate a currently detected 
cellby the RT-Dc software.  The scale bar corresponds to 20 µm.  
 
Fig. 4.4 a displays mean ± SD DD for Jurkat cells treated with CytoD in relation to 
untreated control cells (0 µM, DD= 0.031 ± 0.001). Exposure of cells to a concentration of 0.01 
µM CytoD triggers a significant (p-value <0.01) change to cell deformability, towards 
increased DD=0.041 ± 0.001. Cell DD increases gradually with increasing CytoD 
concentrations to reach a plateau (maximal response) at 1 µM (DD=0.061 ± 0.007, p-value < 
0.001), corresponding to a relative change in DD of 96% along with increased heterogeneity 
as standard deviation increases from SD=0.001 (control) to SD=0.007. The half-maximal 
concentration (EC50) of 0.09 µM was extracted by using a sigmoidal fit to the data, 
corresponding to DD=0.046.  
  
Fig. 4.4 
Cellular deformability model was derived, using Jurkat cells, by chemical treatment triggering 
gradual changes in cell stiffness. Cells of Jurkat cell line (round cells in suspension, Ø~13µm) 
were treated with (a) CytochalasinD (CytoD) and (b) Glutaraldehyde. Both compounds were 
tested at different concentration to generate dose-response graphs (mean deformation ± SEM 
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measured with real-time deformability cytometry RT-DC). Sigmoidal fit to the data allowed 
identification of the half maximum (EC50) and maximum concentration for the effect of CytoD 
and Glutaraldehyde on the deformability. P-values were calculated using the linear mixed 
model (*p-value <0.01, ** p-value<0.001) 
 
Fig. 4.4 b summarises effect of increasing concentrations of the cross-linking 
Glutaraldehyde on Jurkat cells, which affects cell-surface particles, stress fibres, actin cortex, 
and inner structures, stabilising the whole cell structure [144]. At concentrations as low as 
0.0001% (v/v) cells become 22% stiffer (DD=0.031 ± 0.001, p-value<0.01) than control cells. 
Cells’ deformability decreases gradually with elevated Glutaraldehyde concentration, up to 
0.01% (DD=0.001 ± 0.002, p-value < 0.001) when cells do not deform any further (maximal 
response), corresponding to 97% drop in deformability. The EC50 for the effect of 
Glutaraldehyde was identified at 0.0007%, corresponding to DD=0.014. 
In order to verify if the chemically-triggered changes of deformability were decoupled 
from size alteration we used flow cytometry to quantify forward light scatter (FSC-A) - a 
measurement of the amount of a laser beam that passes around the cell – corresponding to a 
relative cell size. Since the RT-DC technique is based on image analysis it allows also size 
measurement, which is expressed as a projected cell area reported in µm2. Typically, cell size 
is obtained from images acquired in the reservoir section. Although accurate, the technique can 
at times be sensitive to changes in focus setting. Hence rather than reporting the projected cell 
area the FSC-A parameter was used instead. Additionally, to quantify the degree of size overlap 
Receiver Operating Curves (ROC) were generated and the corresponding Area Under the 
Curve (AUC) was calculated.  
As demonstrated in Fig. 4.5 proposed chemical treatments altering cell deformability 
have little if any impact on cell size. CytoD treatment (Fig. 4.5 a & b) introduced a minute 
(~10% ) shift in cell size distribution (AUC= 0.60, 0.60, 0.62 and 0.61 for 10, 1, 0.1 and 0.01 
µM, respectively). Treatment with Glutaraldehyde (Fig. 4.5 c & d) preserved cell size, and that 







Cell size of (a) CytochalasinD (CytoD) and (c) Glutaraldehyde- treated cells was assessed 
using forward light scatter parameter (FSC-A) measured using flow cytometer for 10000 
events per condition. (b & d) Receiver Operating Characteristic (ROC) curves were plotted for 
(size expressed as FSC-A. The True Positive Rate is defined as the number of control cells 
measured for a certain size cut-off point and divided by the total number of control cells. The 
False Positive Rate is the corresponding number of treated cells (with CytoD or 
Glutaraldehyde) divided by the total number of treated cells (CytoD or Glutaraldehyde, 
respectively) for the same cut-off. The Area Under the Curve (AUC) was calculated to quantify 
the size overlap between control and treated cells, where a value of 0.5 represents complete 
overlap and 1 represents complete separation.  
 
High-throughput investigation of CytoD and Glutaraldehyde impact on cell mechanical 
properties allowed us to establish the cellular deformability model, consisting of cells of five 
different degrees of deformability (see Table 4.1), but remaining within the same size ranges. 






Cellular deformability model derived for Jurkat cells, consisting of degrees of differential 
deformability (DD), induced chemically with CytoD (cells softening) or Glutaraldehyde (cells 
stiffening). 
 
4.3.2. Lateral equilibrium position as a function of cell deformability 
Cells of the cellular deformability model, were tested as pure populations in two designs 
of spiral microchannels at five different flow rates. Design I was a spiral channel with 360 × 
60 µm cross-section and it was tested at Re= 79, 119, 158, 197. Design II was a spiral channel 
170 × 30 µm cross-section, tested at Re= 33, 66, 97, 132 and 168. Next, the hydrodynamic 
behaviour of the cells (described as their lateral equilibrium position at the end of the spiral 
channel, measured as a distance from the outer wall [µm2]) was compared with reference rigid 
spherical polystyrene beads of corresponding 10 and 15 µm diameters (please note, 15 µm 





Hydrodynamic behaviour of cells of five different deformabilities (Soft max, soft half-max, soft, 
stiff half-max and stiff) in comparison to reference 15 µm beads, in design I spiral channel with 
360 × 60 µm cross-section at five different flow rates corresponding to Re=79, 119, 158, 198 
and 237. The lateral equilibrium positions were measured as a distance from the outer wall 
(µm) at the end of the spiral channel and there were generated by image analysis. Here, it is 
reported as median (represented as the symbols) and the interquartile range (indicated by the 
short vertical lines). Vertical dotted lines indicate four sections of the channel corresponding 
to four outlets of the channel (0-90 µm- outlet A, 90-180 µm- outlet B, etc.). Events belonging 
to a given section have the highest probability of being captured within the corresponding 
outlet. For summary of triplicate results please consult Appendix B 
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As shown in Fig. 4.6, in design I, at lower flow rates (Re=79, 119 and 158) cells of all 
five deformability degrees behave in a similar manner, i.e. they remain focussed in the side of 
the channel, closest to the inner wall of the channel, at around 270 µm. Increased flow rates 
(Re=198) triggered a shift of soft, soft half-max and soft max cells to lateral positions closer to 
the channel centreline (184 ± 60, 168 ± 87 and 219 ± 60 µm, respectively) accompanied by 
cells defocusing from the uniform streak of cells, manifested by cells occupying larger space 
within the channel. Stiff half-max and stiff max cells were not affected in the same way, and 
they remain focused close to the inner wall, with stiff max cells being focused in a tighter streak 
closer to the outer inner wall (304 ± 21 µm) in comparison to stiff half-max cells (269 ± 61 
µm). Further flow rate increases (Re=237) resulted in shift of soft, soft half-max and soft max 
cells closer to the outer wall of the channel (132 ± 50, 109 ± 44 and 121 ± 49 µm, respectively). 
The highest applied flow rate did not change hydrodynamic behaviour of stiff max cells, which 
were still focused closer to the inner wall (305 ± 45 µm), but interestingly stiff half-max cells 
started shifting towards centreline of the channel, with the characteristic defocusing indicated 
by wider spread of assembled lateral position (251 ± 77 µm), similarly to softer cells at Re=198. 
At all tested flow rates reference 15 µm beads remained tightly focused close to the inner wall.  
In design II (Fig. 4.7), due to cell diameter approaching height of the channel, Jurkat 
cells were geometrically forced towards centreline of the channel. At lower Re numbers 
(Re=33, 66 and 97) cells from all five conditions behaved in a similar manner, i.e. they 
remained focussed near the centre of the channel (85 µm). Increased flow rates (Re= 132) 
resulted in a noticeable stiff max cells deviation from the centreline (101 ± 25 µm). At the 
highest applied flow rates (Re=168) the difference between soft and stiff cells were revealed; 
soft cells were pushed closer to the outer wall (soft: 68 ± 21 µm, soft half-max: 80 ± 26 and 
soft max: 113 ± 21 µm) while stiff cells focussed close to the inner wall (stiff half max: 100 ± 
27 µm and stiff max: 113 ± 21 µm). The reference 10 µm beads behaved similarly to stiff max 
cells, i.e. they remained focused close to the centreline at lower applied flow rates (102 ± 8, 99 
± 17 and 108 ± 20 µm for Re= 33, 66 and 97, respectively), and slightly diverged towards the 





Hydrodynamic behaviour of cells of five different degrees of deformability (Soft max, soft half-
max, soft, stiff half-max and stiff) in comparison to reference 10 µm beads, in design II spiral 
channel with 170 × 30 µm cross-section at five different flow rates corresponding to Re=33, 
66, 97, 132 and 168. The lateral equilibrium positions were measured as a distance from the 
outer wall (µm) at the end of the spiral channel and there were generated by image analysis. 
Here, it is reported as median (represented as the symbol) and the interquartile range 
(indicated by the short vertical lines). Vertical dotted lines indicate four sections of the channel 
corresponding to four outlets of the channel (0-42. µm- outlet A, 42.5-85 µm- outlet B, etc.). 
Events belonging to a given section have the highest probability of being captured within the 




4.3.3. Deformability difference for sorting cells in spiral microchannel 
Using the significant differences in lateral equilibrium position adopted by soft and stiff 
max cells within spiral microchannels, we conducted label-free separation of these cells. The 
Design I spiral channel is divided into four balanced outlets (A, B, C and D) for cell collection. 
The spiral channel itself could be divided into four sections: 0-90 µm, 90-180 µm, 180-270 µm 
and 270-360 µm, measured from the outer wall, corresponding to the four outlets A, B, C and 
D, respectively. Due to the laminar flow regime, cells equilibrated at the end of the channel 
within the realm of one of the four sections, will travel to the corresponding outlet. This 
principle allows for prediction of sorting outcome without labour-intense outlet quantification, 
which is a common practice for optimising spiral channels performance. Prior to separation, 
pre-sorted/ pure populations are run separately at a range of flow rates and their lateral 
equilibrium positions are compared in order to identify the optimal flow rate. The most distinct 
difference in equilibrium positions of soft and stiff max cells were observed within the design 
I channel at Re=237, with separation reaching 98% (AUC=0.98, Fig. 4.8 a), hence that was the 
flow rate applied for sorting cells from mixed sample. Additionally, by quantifying number of 
cells in each section of the channel a mock separation efficiency was generated (Fig. 4.8. a & 
b), showing it would be possible to capture 91% of stiff cells in outlet D with >96% purity, 
while soft cells should be mainly distributed between outlets A (recovery: 29%, purity: 99%) 






Predicted outcome for sorting soft (untreated) and stiff max (Glutaraldehyde max) cells in 
design I spiral microchannel with 360 × 60 µm cross-section. (a) First Receiver Operating 
Characteristic (ROC) curves were plotted for lateral equilibrium position for soft cells versus 
stiff max cells, to identify optimal flow rate. The True Positive Rate is defined as the number of 
soft cells found at a given lateral position and divided by the total number of soft cells. The 
False Positive Rate is the corresponding number of stiff max cells divided by the total number 
of soft cells for the same cut-off. To determine which of the applied flow rates ensures the best 
separation efficiency the Area Under the Curve (AUC) was calculated. By quantifying number 
of cells in each section of the channel corresponding to one of four outlets, run as pure 
populations of soft (green) and stiff max (grey), it was possible to generate mock (b) purity and 
(c) recovery to assess possible sorting outcome for the mixed sample. The bars represent 
predicted mean values 
 
For the separation experiment it was necessary to distinguish between soft and stiff 
cells in order to quantify the process performance (purity and recovery). To achieve that, Jurkat 
cells were modified to express green fluorescence protein (GFP), without compromising their 
deformability (Fig. 4.9), which would allow for their detection by flow cytometry. To avoid 
further validation of the impact of Glutaraldehyde on emitted fluorescent signal, transfected 
with GFP Jurkat cells (GFP+) served as the soft subpopulation, mixed with GFP-negative 





RT-FDC characterisation of GFP+ (green) in comparison to GFP- (grey) cells. Equal 
probability contour plots (the same number of cells fall between each pair of contour lines) 
with adjacent histograms of deformation vs cell size (expressed as projected cell area in µm2) 
for GFP+ and GFP- cells Measurements were performed at 0.16 µl/min flow rate in a 
30 µm × 30 µm channel. More than 10000 of total events were acquired and split accordingly 
between each subset. (a) Comparison of GFP+ versus GFP- untreated cells and (b) 
comparison of untreated GFP+ cells and GFP- cells fixed with Glutaraldehyde.  
 
The input cell sample, containing soft GFP+ and stiff max GFP- cells, mixed at around 
50:50 ratio (Fig. 4.10 a), up to a final 1 × 106 cells/ml concertation, were passed through the 
design I spiral channel at Re=237 at three independent occasions. As shown in Fig. 4.10 b, the 
majority (78.5 ± 1.6 %) of the stiff max GFP- cells were hydrodynamically directed to outlet 
D, reaching 80% purity. Soft GFP+ cells were mainly distributed between outlets A 





Characterisation of the deformability-based purification process in the design I spiral 
microchannel, with 360 × 60 µm cross-section. The purification efficiency of untreated soft 
GFP+ cells (green) from the Glutaraldehyde treated stiff max GFP- (grey) after processing in 
the spiral channel. (a) Purity and (b) recovery were generated by quantification of cells 
collected at the outlets (A -closest to the outer wall, B, C and D) at flow rate corresponding to 
Re=237. The process validation was performed at three independent occasions, the bars 
represent mean value and error bars correspond to the standard deviation of the mean.  
 
4.3.4. Impact on cell viability 
Processing in spiral microchannels has been recognised as a gentle technique, with little 
if any impact on cell viability. To take advantage of the 𝐹𝐷 in spiral channels it is necessary to 
work at elevated flow rates, which result in an elevated degree of shear stress potentially 
deteriorating cell quality. Cells after processing in design I and design II spiral at highest 
applied flow rate, were collected from all outlets into one tube and investigated by flow 
cytometry. The earliest detectable signs of apoptosis are membrane asymmetry. In apoptotic 
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cells phosphatidyl serine is translocated from inner to the outer layer of the cell membrane and 
can be identified by its conjugate Annexine V. Necrotic cells are characterised by increased 
cell permeability, which allows propidium iodide, which is not permeant to live cells, to enter 
the cell and bind to DNA. 
Fig. 4.11 shows that cells processing at high flow rates in spiral microchannels does 
not significantly affect cell viability. Viability of control cells, which were not flowed through 
the system, was around 80% with remaining 20% being split between apoptotic and necrotic 




Flow cytometric viability assay. (a) An exemplary scatter plot showing gating strategy for live 
cell (green, negative for both Alexa Fluor 488-annexin V and propidium iodide (PI) 
fluorescence), apoptotic cells (yellow, annexin V-positive and PI-negative) and necrotic (red, 
annexin V-positive and PI-positive). Summary of flow cytometric assessment of the presence of 
live, apoptotic and necrotic Jurkat cells before (control) and after (test) processing in (b) 
design I and (c) design II spiral microchannels at highest applied flow rates, corresponding to 
Re=237 and Re=168, respectively. The process validation was performed at three independent 
occasions, the bars represent mean value and error bars correspond to the standard deviation 
of the mean. For summary of scatter plots for triplicate results please consult Appendix D 
 
4.4. Discussion 
Exploiting the contribution of  𝐹𝐷 in spiral microchannels offers new ways to separate 
cells from complex heterogeneous samples based on their intrinsic mechanical properties. In 
previous reports, the 𝐹𝐷 effect for particles focusing in straight channels has been used either 
solely or in conjugation with other effects, such as viscoelasticity and inertia. At inertia-less 
regimes (where Re numbers remain small) in microchannels, deformability-based separation 
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is possible due to cell-wall interaction, where more deformable cells experience more repulsion 
from the wall in comparison to their stiffer counterparts. This principle was successfully 
employed by Geslinger et al. to separate red blood cells from platelets, where cells were pushed 
against wall using sheath flow.  
Incorporating the effect of inertia increases separation throughput, since it occurs at 
intermediate Re numbers. Hur et al. demonstrated that the 𝐹𝐷 effect in combination with inertial 
effects in straight microchannel with high aspect-ratio cross-section, yields throughputs of ~2.2 
× 104 cells/ min in a single device. Adding curvature to the channel brings two advantages over 
straight channels. Firstly, the presence of Dean flow reduces number of equilibrium positions 
and modifies the preferred locations of the particles depending on their size. Secondly, it 
accelerates particles displacement; particles travel shorter distances to be equilibrated in 
comparison to straight channels with the same cross-section and operating at equivalent flow 
rates. Identifying operating regimes for harnessing the effect of 𝐹𝐷 in inertial focussing 
channels, introduces another important advancement, which could be translated into enhanced 
passive label-free cell sorting.  
In this research, it has been experimentally demonstrated that hydrodynamic effects in 
spiral microchannels can be used to separate cells of the same size but different deformability. 
The effect of 𝐹𝐷 in straight channels has been studied using droplets and vesicles. The degree 
of deformation in droplets depends on viscosity ratio with respect to the surrounding fluid. 
More viscous droplets undergo less deformation thus the lateral push triggered by 𝐹𝐷 is weaker. 
Vesicles, composed of lipid bilayers, are commonly used in biophysics studies as a simplified 
model for cell membrane dynamics and red blood cells. In shear flows vesicles deform, 
adopting an ellipsoidal shape and flowing in a fixed orientation in regards to the flow direction 
and channel wall, while the surrounding membrane is circulating around its interior. This 
internal circular motion is responsible for maintaining their fixed alignment.  
Both of these systems have been widely studied, however they do not reflect the real 
nature of cells and their hydrodynamic behaviour. Cells are surrounded by a lipid bilayer 
underlined with a dynamic cytoskeleton, which primarily determines cell deformability. 
Additionally, most cells contain nucleus, which under sufficiently high shear stress constitutes 
a limiting factor for cell deformability. For all these reasons, the cellular deformability model 
has been developed. Using cells of five degrees of deformability I studied their behaviour 
within two designs of spiral microchannels. Based on the experimental observations two 
conclusions could be drawn.  
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(1) The effect of 𝐹𝐷requires sufficiently high Re numbers (design I: Re=237, design II: 
Re=168). Cells passing through the channel at lower flow rates behave according to their size, 
and thus no significant differences were observed between soft and stiff cells. At elevated flow 
rates stiff cells behaved like rigid reference beads while soft cells enter a characteristic 
defocused state, when they diverge from their previously assembled equilibrium position, near 
the inner wall of the channel, to occupy a much wider section of the channel around the 
centreline, and finally, are re-focused closer to the outer wall at sufficiently high flow rates.  
(2) The effect of 𝐹𝐷 appears to be sensitive to a certain deformability threshold, above 
which the experienced drag reaches it maximal magnitude. At sufficiently high flow rates, all 
soft cells- soft, soft half-max and soft max cells- with insignificant variations between them- 
were focused closer to the outer wall. Interestingly, in design I at Re= 237, stiff max cells 
remained focused in a tight streak close to the inner wall, while stiff half-max cells started 
defocusing into a wider streak in comparison to the positions they occupied at lower flow rates 
(design I: Re=198), suggesting that if the applied flow rate was high enough, they could 
possibly travel to the outer wall side of the channel.  
It has been experimentally verified, that the unique combination of Dean flow and 𝐹𝐷 
can be adapted to separate cells within the microfluidic system, when there is a sufficient 
difference in deformability between cells of interest. Promisingly, the elevated flow rates had 
no impact on cell viability. In order to take a full advantage of the hydrodynamic effects within 
the spiral microchannel, an optimal flow rate has to be identified by experiment. We noted that 
there were discrepancies between predicted and experimental sorting outcome. The focusing 
positions followed by capture in a corresponding outlet is altered when cells of different 
properties are run as a mixture through the system, in comparison to their behaviour when run 
separately as pure populations. We believe that the aberrations are introduced due to 
hydrodynamic interaction of particles upon their entry to the channel, resulting in an intriguing 
effect, creating “trains” of particles (discussed in detail in Chapter 6). Briefly, this dynamic 
self-assembly into trains at the entry of the channel is stabilised by the inertial forces, thus 
particles which joined the “wrong” train at the entry of the channel, cannot escape it, and this 
prevents them from travelling to their expected equilibrium position. Consequently they are 
captured in an unexpected outlet.  
The effect of 𝐹𝐷 in wall-bounded shear flows is associated with shape distortion, e.g. it 
has been reported that droplets with low viscosity exhibit a larger curvature on the side near 
the channel wall that is accounted for the larger repulsing forces acting on the surface of the 
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droplet near the wall. However, as shown in Fig. 4.12, both soft and stiff cells flowing in the 
spiral channel at Re=237, exhibited an undistorted nearly spherical shape. Hur et al. 2011 
reported that highly viscous droplets do not undergo shape alterations, but still they were 
pushed away from the wall in comparison to solid plastic beads of similar sizes. That suggests 
presence of different dynamics contributing to the deformability-based differential drift and 
further study is required to clarify this mechanism.  
 
   
Fig. 4.12 
Characterisation of soft GFP+ (green) and stiff max GFP- (grey) cells passing though the 
design I spiral channel with 360 × 60 µm cross-section at flow rate corresponding to Re=237. 
Cells (a) area and (b) deformation were generated by analysing images captured within the 
channel for each population separately. The data points represent mean value measured for at 
least 10000 events, error bars correspond to standard deviation from the mean. 
 
As shown in Fig. 4.13, flow rates applied in design I and II are substantially higher than 
the majority reported in the literature for particles separation in spiral microchannels. 
Additionally, we apply these flow rates in devices of relatively small hydraulic diameter (Dh), 
generating back pressure reaching MPa range. Our devices are made of SU8 bound PMMA 
(Epigem, UK), while all previously reported designs were made of PDMS bound to a substrate 
e.g. glass. PDMS is a widely used polymer for manufacture of microfluidic chips and a large 
body of work has been done towards identifying best binding techniques. Up to date, it has 
been reported that the strongest bond are achieved with substrates with Si-O groups, with a 
maximum average bond strengths of ~0.4 MPa, which is an order of magnitude lower than 
pressures applied in our systems [145]. Currently, this technical detail makes PDMS chips 
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Summary of operating conditions of spiral channels reported in the literature, up to end of 
2018, in comparison to design I and II (pink). The scatter plot represent applied Re numbers 
versus hydraulic diameter (Dh). The grey dotted lines represent median Re number value 
(excluding design I and II) and lower and upper quartile as labelled on the graph. The pink 





Herein, for the first time, it has been demonstrated that at adequately high Re numbers 
in spiral microchannels the effect of 𝐹𝐷 become significant in the overall process of establishing 
cells equilibrium positions. By studying the hydrodynamic behaviour of the five degree cellular 
deformability model, it has been found that cells of the same size but different deformability 
assemble contrary equilibrium positions within the channel cross-section. Soft cells travel close 
to the outer wall, while their stiff counterparts are focused close to the inner wall of the channel. 
This experimental observation was successfully adapted into passive label-free approach for 
separating cells of different deformability properties, without compromising cells quality. This 
hydrodynamic microfluidic phenomena appears promising and in order to fully exploit it, 
further theoretical investigation of the underlying physics is required. Given these results, a 
novel sorting approach is possible, for simultaneous sorting based on size and deformability 
with one system, with all the advantages offered by the spiral microchannels. This study 
presents a much needed label-free high-throughput (millions of cells/ min, ml of medium/ min) 
scalable and continuous cell sorting approach for samples of clinical importance, such as novel 
stem-cell derived therapeutic products.  
 
4.6. Materials and methods 
4.6.1. Deriving the cellular deformability model 
Cell samples for all experiments were collected at day 2 after seeding when they were 
at the exponential growth phase (cell concentration never exceeded 5 × 105 cell/ml. To derive 
the cellular model for deformability cells were treated with CytochalasinD and Glutaraldehyde. 
Cytochlasin D (Sigma Aldrich) was added directly to cell suspension of 1 × 106 cells/ml 
in whole cell culture medium and incubated for 10 min, in a humidified incubator at 37˚C in 
5% CO2. Prior to the RT-DC measurements as well as experiments in the spiral channels and 
flow cytometry cells were collected by centrifugation at 300 g for 5min and re-suspended in 
0.5% methylcellulose or phosphate-buffered saline without calcium and magnesium (PBS-/-, 
ThermoFisher Scientific), respectively. Cytochlasin D in dimethyl sulfoxide (DMSO, Sigma 
Aldrich) concentration was adjusted to 0.01, 0.1, 1 and 10 µM. Final DMSO concentration in 
the cell sample was yielding 0.25% (v/v) for 0.01, 0.1 and 1 µM Cytochalasin D and 2.5% (v/v) 
for 10µM Cytochalasin D. Cytochalasin D desired concentrations were always maintained in 
cell buffers through-out the experiments due to the reversibility of the effect.  
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Prior to treatment with Glutaraldehyde (Sigma Aldrich) cells were washed twice in 
PBS-/- to remove any residual proteins. Next cells were re-suspended at 1 × 10^6 cell/ml in 
PBS-/- supplemented with Glutaraldehyde to the final concentrations of 0.0001, 0.001, 0.01 
and 0.1% (v/v) and incubated at room temperature for 40 min. After the incubation time cells 
were washed once in PBS-/- and re-suspended either in 0.5% methylcellulose for RT-DC 
(and/or RT-FDC) measurements or PBS-/- for experiments in the spiral channels and flow 
cytometry.  
Size of cells treated with Cytochalasin D and Glutaraldehyde were assessed by flow 
cytometric measurement of the forward light scatter (FSC-A) (BD LSR II, BD, Germany). 
Collected data was further analysed using FlowJo V10 CL. The receiver operating 
characteristic curves (ROC) were generated and the area under the curve (AUC) was calculated 
using GraphPad Prism 6. 
In order to distinguish untreated soft cell from Glutaraldehyde-treated stiff cells, for the 
purpose of separation efficiency quantification, Jurkat cells expressing green fluorescence 
protein (GFP), were kindly provided by Dr Miguel Hermida (Heriot-Watt University, UK) by 
transduction with a second generation lentiviral system generated in house with pHR-SIN 
EGFP and VSV-G and delta 8.2 vectors. To ensure high GFP expression level (~100%) within 
the population GFP-positive cells from the starting population were sorted by FACS 
(FACSAria IIu flow cytometer, Beckton Dickinson Immunocytometry Systems (BD, UK) 
running BD FACSDiva v6 Software) and re-cultured for further experiments. The GFP-
positive cells served as control sample, which was mixed 1:1 with GFP- negative cell treated 
with Glutaraldehyde.  
4.6.2. Cell characterisation RT-FDC 
Cells deformability was assessed using real-time fluorescence and deformability 
cytometry (RT-FDC), in order to distinguish between GFP+ and GFP- cells, when needed. 
Measurements were performed as per Nat. Methods 2018 [125] and Chapter 2. Prior to 
measurements, cells were harvested by centrifugation at 300 g for 5 min and re-suspended in a 
0.05% methylcellulose solution at 1-2 × 106 cell/ml. Jurkat cells were assessed using a PDMS 
chip with a 30 × 30 µm cross-section channel. Cells were introduced into the channel at 0.16 
µl/min. Obtained data was analysed using original RT-FDC software ShapeOut 0.8.4 (available 
at www.zellmechanik.com). Next, the data was extracted from the software and further 
inspected, plotted and fitted using FlowJo V10 CL and GraphPad Prism 6. 
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4.6.3. Cells separation in spiral channels 
Cells suspension at concentration around 1 × 106 cells/ml was processed as described 
in Chapter 2. Cell separation efficiency was quantified by flow cytometry (BD LSR II, BD, 
Germany in order to compare the fraction of each cell population (characterised by a unique 
fluorescent properties) in samples collected at each outlets. Additionally, cell yield was 
assessed by counting number of cells at each outlet using either a standard glass 
haemocytometer or MoxiZ automated cell counter (Orflo, US). Further data analysis was 
performed using GraphPad Prism 6 and FlowJo V10 CL.  
4.6.4. Viability flow cytometric assay  
Cells viability after processing in spiral microchannels was assessed using Alexa 
Fluor® 488 Annexin V/Dead Cell Apoptosis Kit (ThermoFisher Scientific). Control cells as 
well as cells after processing were harvested by centrifugation at 200 g for 5 min and washed 
in cold PBS-/- and stained as per manufacturer’s protocol. Briefly, after washing in PBS cells 
were re-suspended in annexing-binding buffer at around 106 cells/ml. 100 µl aliquote of each 
sample was transferred to fresh centrifuge tube and 5 µL Alexa Fluor® 488 annexin V and 1 
µL 100 µg/mL PI working solution was added to each 100 µL of cell suspensions. Cells were 
incubated in dark at room temperature for 15 min. After the incubation time samples were 
further diluted by adding 400 µl annexin-binding buffer and analysed by flow cytometry (BD 







Tables showing statistical summary (mean and standard deviation from the mean (SD), median, 
25th (Qi) and 75th (Q3) percentile as well as minimal (min) and maximal (max) measured value) 
of lateral equilibrium positions obtained for at least 10000 events for 15 µm beads and cells 
from the cellular deformability model, in design I spiral channel with 360 × 60 µm cross-
section, at five applied Re numbers for replica I out of three, expressed as distance from the 




Hydrodynamic behaviour of cells of five different degrees of deformability (Soft max, soft 
half-max, soft, stiff half-max and stiff) in comparison to reference 15 µm beads, in design I 
spiral channel with 360 × 60 µm cross-section at five different flow rates corresponding to 
Re=79, 119, 158, 198 and 237 (as outlined in the tables on the right). The lateral equilibrium 
positions were measured as a distance from the outer wall (µm) at the end of the spiral channel 
and there were generated by image analysis. Here, it is reported as median (represented as the 
symbols) and the interquartile range (indicated by the short vertical lines). Vertical dotted lines 
indicate four sections of the channel corresponding to four outlets of the channel (0-90 µm- 
outlet A, 90-180 µm- outlet B, etc.). Events belonging to a given section have the highest 
probability of being captured within the corresponding outlet. Tables showing statistical 
summary (mean and standard deviation from the mean (SD), median, 25th (Qi) and 75th (Q3) 
percentile as well as minimal (min) and maximal (max) measured value) of latera equilibrium 





Hydrodynamic behaviour of cells of five different degrees of deformability (Soft max, soft 
half-max, soft, stiff half-max and stiff) in comparison to reference 15 µm beads, in design I 
spiral channel with 360 × 60 µm cross-section at five different flow rates corresponding to 
Re=79, 119, 158, 198 and 237 (as outlined in the tables on the right) . The lateral equilibrium 
positions were measured as a distance from the outer wall (µm) at the end of the spiral channel 
and there were generated by image analysis. Here, it is reported as median (represented as the 
symbols) and the interquartile range (indicated by the short vertical lines). Vertical dotted lines 
indicate four sections of the channel corresponding to four outlets of the channel (0-90 µm- 
outlet A, 90-180 µm- outlet B, etc.). Events belonging to a given section have the highest 
probability of being captured within the corresponding outlet. Tables showing statistical 
summary (mean and standard deviation from the mean (SD), median, 25th (Q1) and 75th (Q3) 
percentile as well as minimal (min) and maximal (max) measured value) of latera equilibrium 








Tables showing statistical summary (mean and standard deviation from the mean (SD), median, 
25th (Qi) and 75th (Q3) percentile as well as minimal (min) and maximal (max) measured value) 
of lateral equilibrium positions obtained for at least 10000 events for 15 µm beads and cells 
from the cellular deformability model, in design II spiral channel with 170 × 30 µm cross-
section, at five applied Re numbers for replica I out of three, expressed as distance from the 




Hydrodynamic behaviour of cells of five different degrees of deformability (Soft max, soft 
half-max, soft, stiff half-max and stiff) in comparison to reference 15 µm beads, in design II 
spiral channel with 170 × 30 µm cross-section at five different flow rates corresponding to 
Re=33, 66, 97, 132 and 168 (as outlined in the tables on the right) . The lateral equilibrium 
positions were measured as a distance from the outer wall (µm) at the end of the spiral channel 
and there were generated by image analysis. Here, it is reported as median (represented as the 
symbols) and the interquartile range (indicated by the short vertical lines). Vertical dotted lines 
indicate four sections of the channel corresponding to four outlets of the channel (0-90. µm- 
outlet A, 90-180 µm- outlet B, etc.). Events belonging to a given section have the highest 
probability of being captured within the corresponding outlet and tables showing statistical 
summary (mean and standard deviation from the mean (SD), median, 25th (Qi) and 75th (Q3) 
percentile as well as minimal (min) and maximal (max) measured value) of latera equilibrium 




Hydrodynamic behaviour of cells of five different degrees of deformability (Soft max, soft 
half-max, soft, stiff half-max and stiff) in comparison to reference 15 µm beads, in design II 
spiral channel with 170 × 30 µm cross-section at five different flow rates corresponding to 
Re=33, 66, 97, 132 and 168 (as outlined in the tables on the right) . The lateral equilibrium 
positions were measured as a distance from the outer wall (µm) at the end of the spiral channel 
and there were generated by image analysis. Here, it is reported as median (represented as the 
symbols) and the interquartile range (indicated by the short vertical lines). Vertical dotted lines 
indicate four sections of the channel corresponding to four outlets of the channel (0-90. µm- 
outlet A, 90-180 µm- outlet B, etc.). Events belonging to a given section have the highest 
probability of being captured within the corresponding outlet and tables showing statistical 
summary (mean and standard deviation from the mean (SD), median, 25th (Qi) and 75th (Q3) 
percentile as well as minimal (min) and maximal (max) measured value) of latera equilibrium 





Summary of flow cytometric viability assay. On the top- an exemplary scatter plot showing 
gating strategy for live cell (green, negative for both Alexa Fluor 488-annexin V and propidium 
iodide (PI) fluorescence), apoptotic cells (orange, annexin V-positive and PI-negative) and 
necrotic (red, annexin V-positive and PI-positive). Summary of flow cytometric assessment of 
the presence of live, apoptotic and necrotic Jurkat cells before (stained control and after 
processing (stained test) in design I spiral channel with 360 × 60 µm cross-section at highest 




Summary of flow cytometric viability assay. On the top- an exemplary scatter plot showing 
gating strategy for live cell (green, negative for both Alexa Fluor 488-annexin V and propidium 
iodide (PI) fluorescence), apoptotic cells (orange, annexin V-positive and PI-negative) and 
necrotic (red, annexin V-positive and PI-positive). Summary of flow cytometric assessment of 
the presence of live, apoptotic and necrotic Jurkat cells before (stained control and after 
processing (stained test) in design I spiral channel with 360 × 60 µm cross-section at highest 




Chapter 5. Purifying stem cell-derived red blood cells: 
Translating cell mechanical properties into complete 
high-throughput label-free downstream processing 
strategy. 
Highlights 
 Combining cells mechanical characteristic and the phenomenon of deformability-
induce lift force (FD) (described in Chapter 4) in spiral microchannels, a complete 
purification strategy for label-free passive mRBC purification has been proposed, 
consisting of two steps: (1) processing in spiral microchannel enhanced by (2) 
membrane filtration, reaching 99% purity.  
 End-product of CB CD34+ cells in vitro erythroid differentiation, derived from two 
additional donors have been characterised and compared to results described in 




In order to address the limiting lack of suitable purification strategies of mRBCs, herein, 
we propose a complete customised label-free downstream processing approach, based solely 
on mRBC profoundly characterised mechanical properties. It is a two-step process consisting 
of cell processing in a spiral microchannel and membrane filtration. As discussed in the 
introduction, due to simplicity in operation, low manufacturing cost and proven scalability by 
parallelisation (allowing processing millions of cells per minute and millilitres of medium per 
minute) inertial focusing in spiral microchannels has been recognised as an attractive approach 
for high-throughput cell sorting [90] for myriad point of care and clinical diagnostics (please 
consult Table 1.3 in Chapter 1). Particles of different sizes interact to a different degree with 
the fluid flow pattern generated within the spiral channel and that leads to particles ordering 
and separation. The deformable nature of cells adds complexity to their ordering within the 
spiral channels and in the previous Chapter 4 and Guzniczak et al. 2018 [118] it was reported 
that at sufficiently high flow rates, particles of the same size but different deformability adopt 
substantially different equilibrium positions within the channel cross-section. 
In this study, for the first time, the previously observed contribution of the 
deformability-induced lift force to the differential focusing of particles of the same size but 
contrasting deformable properties within a spiral channel, has been translated into an effective 
label-free purification protocol for mRBC derived from CB CD34+ cells. This approach offers 
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a viable alternative to FACS and MACS for sorting mRBC at industrial scale in a label-free 
manner up to high purities without compromising cell quality, consequently creating a route to 
bring mRBC into clinical use.  
5.2. Results and Discussion 
5.2.1. Sample characterisation 
As described in Chapter 3, CB CD34+ cells undergo in vitro differentiation into mRBC 
over the course of 21 days protocol by balancing the opposite effects of proliferation-promoting 
factors and differentiation-inducing factors. During this time, cells change their morphology, 
they decrease in size, lose some intracellular structures, start producing haemoglobin and the 
nucleus becomes smaller and more condensed to eventually become expelled during the 
enucleation event [128][129]. In in vivo circumstances, the expelled nuclei are removed by 
macrophages, while during the in vitro erythropoiesis they remain in the culture [146]. 
Although the differentiation process is strictly controlled by adjusting the cell culture 
conditions, some of the stem cells will not differentiate fully, meaning they will remain at 
earlier development stages. Consequently, the end-product of the differentiation protocol is a 
heterogeneous population containing enucleated mRBC, partially differentiated or 
undifferentiated nucleated cells as well as free-floating nuclei.  
The first step to develop the label-free strategy for purifying mRBC from the 
contaminant nucleated cells and free-floating nuclei was to identify if there was a unique set of 
label-free markers (label-free marker means that no modifying agents (e.g. antibodies) have to 
be added in order to reveal them) such as cell size and deformability that would allow 
characterision of each of the subsets within the final product. In order to identify differences in 
cell size and deformability, the cells were characterised using image analysis of cytospin slides 
and flow cytometry (forward light scatter parameter (FSC-A) for relative size measurement) 
and real-time fluorescence and deformability cytometry (RT-FDC) [125], at the end of the 
differentiation procedure. To quantify the degree of the size and deformability overlap, receiver 
operating characteristic (ROC) curves were plotted and the corresponding area under the curve 
(AUC) was calculated. 
5.2.2. Size measurements 
Size measurements of events belonging to one of the three subpopulations have been 
proven challenging due to their heterogeneous nature. RT-DC allows for size measurements 
and it is recommended to do so in the reservoir section of the chip- where cells do not distort 
from their original shape due to negligible shear. Differentiating CB CD34+ were 
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characterised, using RT-FDC, and they were measured in a mixed population fluorescently 
stained to distinguish between enucleated and nucleated cells and nuclei. Currently, it is 
technically impossible to monitor fluorescent signal in the reservoir section. Due to this reason, 
to estimate the size of each subpopulation cells were fixed onto a glass slide and stained for the 
nucleus (purple) and cytoplasm (pink) as shown in Fig. 5.1 a, which allowed to discriminate 
between enucleated and nucleated cells as well as free floating nuclei. Cell size was reported 
as area and expressed in µm2 (Fig. 5.1 b). As per this approach, nuclei are smaller (24.3 ± 7.6 
µm2, mean ± SD) than enucleated (75.7 ± 22.4 µm2) and nucleated (77.3 ± 27.5 µm2) cells. 
However, the same cell population was analysed using flow cytometry and each subset was 
plotted for the forward light scatter (FSC-A) parameter. Fig. 5.1 c (and Appendix E for three 
replicas) shows a clear overlap in size between enucleated cells (pink) and nuclei (grey), while 
nucleated cells (purple) remain the largest within the sample.  
 
Fig. 5.1 
Characterisation of enucleated and nucleated cells as well as expelled nuclei present in the 
end-product of CB CD34+ undergoing in vitro erythropoiesis. (a) An exemplary cytospin 
image of the end product of the differentiation protocol of cord blood CD34+ cells into red 
blood cells. Cytoplasm is stained in pink and nuclei are stained in dark purple. The scale bar 
corresponds to 20 µm. (b) Table summarising size measurement (expressed as cell area in µm2) 
obtained from cytospin image analysis for enucleated cells, nucleated cells as well as free 
floating nuclei (c) Histogram of FSC-A (forward light scatter) parameters measured using flow 
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cytometry, reflecting the relative size of enucleated cells (pink), nucleated cells (purple) and 
the free-floating nuclei (grey). For summary of triplicate results please consult Appendix E 
 
The contradictory findings are most probably the consequence of the nature of sample 
preparation for each technique. In contrast to cytospin, flow cytometry allows size 
measurement for live cells in suspension. FSC intensity produces a voltage which is 
proportional to the cell diameter, however, cell size is not reported in physical units. In the 
cytospin technique deformable enucleated cells spread on the slide more than rigid nuclei, 
consequently appearing larger than they really are. Thus, if the physical value plays an 
important role (e.g. for fine-tuning sorting device dimensions) a supplementary approach to 
flow cytometry is required.  
Combining information obtained from flow cytometric measurements and cytospin 
image analysis, it has been concluded that the cell diameter at the end of the differentiation 
protocol ranges between 5.5 ± 0.8 µm and 9.7 ± 1.7 um, within this range enucleated cells and 
nuclei occupied the smaller side of the spectrum with ~94% size overlap (AUC=0.95, 94 and 
93 for three independent measurements, Fig. 5.2 a). Despite the pronounced FSC-A peak 
resolution between enucleated and nucleated cells, 7-18 % (AUC= 68, 57 and 64, Fig.5.2 a) of 





Receiver Operating Characteristic (ROC) curves were plotted for (a) size (expressed as FSC-
A parameter) and (b) deformability [-] for enucleated versus nucleated cells (purple-dashed)  
and enucleated cells versus nuclei (grey) at the end of the differentiation protocol for three 
replicas for donor I. The True Positive Rate is defined as the number of enucleated cells 
measured for a certain cut-off point (size or deformability) and divided by the total number of 
enucleated cells. The False Positive Rate is the corresponding number of nucleated cells (resp. 
nuclei) divided by the total number of enucleated cells (resp. nuclei) for the same cut-off. The 
Area Under the Curve (AUC) was calculated to quantify the size and deformability overlaps. 
 
5.2.3. Deformability measurements 
RT-FDC is a high-throughput (thousands of events per minute) microfluidic platform 
that enables mechanotype analysis of cells within a heterogeneous sample with no necessity of 
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pre-sorting into pure populations, due to the integration of fluorescent signal for confirmation 
of cell identity [125], as described in Chapter 2.  
Fig. 5.3 a & b displays deformability measurements for enucleated and nucleated cells 
and nuclei. Comparison of events belonging to each subpopulation (indicated by colour-coded 
contour plots in Fig. 5.3 a) reveals that the free-floating nuclei exposed to shear stress behave 
like rigid spheres (D=0.028 ± 0.016, mean ± SD) while enucleated cells deform substantially 
from their original spherical shape (D= 0.289 ± 0.084).  
 
Fig. 5.3 
RT-FDC Characterisation of enucleated (pink) and nucleated (purple) cells as well as expelled 
nuclei (grey) present in the end-product of CB CD34+ undergoing in vitro erythropoiesis. (a) 
Equal probability contour plots (the same number of cells fall between each pair of contour 
lines) of deformation vs cell size (expressed as projected cell area in µm2) for enucleated and 
nucleated cells and nuclei generated using the RT-FDC. Measurements were performed at 
0.12 µl/min flow rate in a 20 µm × 20 µm channel (n=10,000 cells) (b) Box plots summarising 
the deformation of enucleated/nucleated cells and nuclei, where the line in the box represents 
the median, the box itself represents data from lower and upper quartile and the whiskers 
correspond to the lowest and highest extreme values. For summary of triplicate results please 
consult Appendix E 
 
Hence, these subpopulations are almost 100% separated (AUC=0.99, for three replicas, 
Fig. 5.2 b). Nucleated cells also deform (D=0.143 ± 0.062), however as reported previously, 
the presence of the stiff condensed nucleus limits their further deformation and that 
distinguishes more than 90% of them from enucleated cells (AUC=0.91, 0.95 and 0.91, for 




5.2.4. Sorting- principles and optimisation 
Traditionally, spiral-shaped microchannels have been used for sorting cells based on 
size differences. Cells traveling within the channel experience inertial lift force and Dean drag, 
and if cells travel a distance long enough, these forces balance and situate cells at distinct lateral 
equilibrium positions, which depend upon particle size [147][90]. As shown in Fig. 5.3 in the 
design used in this study, smaller cells are positioned closer to the inner wall, and with the 
increasing size, they move closer to the channel centreline. As previously reported [118], at 
sufficiently elevated Re numbers there is a distinct hydrodynamic behaviour of cells of the 
same size but different deformability. At high Re numbers, stiff cells remain focused close to 
the inner wall, while their softer counterparts experience additional drag (the consequence of 
the deformability-induced lift force[117]) and they travel across the channel to be equilibrated 





Proposed label-free strategy for sorting CB CD34+-derived RBC. The input sample contains 
mRBC (enucleated cells) as well as nucleated cells and expelled nuclei. Each population is 
characterised by a unique combination of size and deformability range used for sorting. Nuclei 
are small and rigid, enucleated cells are within the size range of nuclei, but are more 
deformable while nucleated cells are the largest of all. The sorting protocol consists of two 
steps: first, the sample is processed in a spiral microchannel with a rectangular cross-section 
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(170x30 um), 6 loops, 1 inlet and 4 outlets (A, B, C and D). Cells align in the spiral channel at 
distinct lateral equilibrium positions depending on their size and deformability, facilitating 
their capture in one if the four outlets. The majority of the desired enucleated cells is captured 
in outlet D with some contaminant nucleated cells, which are further removed by membrane 
filtration. 
 
In order to identify optimal conditions to take advantage of the deformability-induced 
lift force for the mRBC purification, the device performance has been tested with pre-sorted 
by FACS pure populations of enucleated and nucleated cells and nuclei. Each of the 
subpopulations was run separately at gradually increasing flow rates from 0.2 to 1 ml/min at 
intervals of 0.2 ml/min (Fig. 5.4 a). The separation potential of enucleated cells from nucleated 
(Fig. 5.4 b) and nuclei (Fig. 5.4 c), was estimated for each tested flow rate by generating ROC 
curves and calculating the AUC. At lower flow rates (0.2, 0.4 and 0.6 ml/min) all three 
subpopulations were pushed toward the inner wall. Enucleated and nucleated cells occupy the 
same section of the channel (enucleated: 100 ± 24 µm, 123 ± 22 µm and 131 ± 23 µm, 
nucleated: 110 ± 20 µm, 125 ± 15 µm and 134 ± 11 µm at 0.2, 0.4 and 0.6 ml/min, respectively) 
with a substantial overlap in the assembled lateral equilibrium position (AUC= 0.62, 0.51 and 
0.52, for 0.2, 0.4 and 0.6 ml/min, respectively) closer to the channel centreline. Increasing flow 
rate to 1 ml/min triggered the characteristic shift of more deformable enucleated cells toward 
the outer wall to the equilibrium lateral position at 36 ± 21 µm, while less deformable nucleated 
cells recapitulated the unfocused transition pattern (103 ± 32 µm) observed for enucleated cells 
at 0.8 ml/min (103 ± 33 µm). Except for the 0.2 ml/min flow rate, nuclei always remained 
focused along the inner wall in a fairly tight steam (151 ± 23 µm at 0.4 ml/min, 156 ± 11 µm 
at 0.6 ml/min, 158 ±11 µm at 0.8 ml/min and 154 ± 18 µm at 1ml/min). In conclusion, 
theoretically, operating at 1ml/min would allow separation of 96% of nucleated cells 






Characterising the spiral channel performance with pure populations of enucleated and 
nucleated cells as well as expelled nuclei. (a) The hydrodynamic behaviour of enucleated (pink) 
and nucleated (purple) cells and free-floating nuclei (grey) is assessed in a spiral channel with 
a 30 × 170 µm cross-section at five different flow rates (0.2, 0.4, 0.6, 0.8 and 1 ml/min). Lateral 
equilibrium positions are measured as a distance from the outer wall (µm) at the end of the 
spiral channel. Here, data are reported as median (represented as the longest vertical line) 
and the interquartile range (indicated by the short vertical lines) on top of scatter plots, where 
each dot represents one event. Around 200 events are shown for each subpopulation. Vertical 
dotted lines indicate four sections of the channel corresponding to four outlets of the channel 
(0-42.5 µm- outlet A, 42.5-85 µm- outlet B, etc.). Events belonging to a given section have the 
highest probability of being captured within the corresponding outlet.  
Receiver Operating Characteristic (ROC) curves were plotted for lateral equilibrium position 
for (b) enucleated cells versus nucleated cells and (c) enucleated cells versus nuclei for each 
applied flowrate. The True Positive Rate is defined as the number of enucleated cells found at 
a given lateral position and divided by the total number of enucleated cells. The False Positive 
Rate is the corresponding number of nucleated cells (resp. nuclei) divided by the total number 
of nucleated cells (resp. nuclei) for the same cut-off. To determine which of the applied flow 




5.2.5. mRBC purification process 
Differences in hydrodynamic behaviour of enucleated and nucleated cells, as well as 
nuclei observed at a 1ml/min flow rate, was translated and incorporated into a label-free 
purification process. The heterogeneous end product of the differentiation protocol was 
injected into the spiral microchannel at the optimal flow rate at a concentration of around 3 × 
106 cell/ml. Fig. 5.5a shows an averaged fraction of each subset in the input sample as well as 
collected at the four outlets for three independent replicas. Enucleated cells constituted around 
20-25% of the starting sample and as predicted, due to their deformable nature, the majority 
(92 ± 0.2%, mean ± SD, recovery Fig. 5.5 b) of them were hydrodynamically directed to the 
outlet A (closest to the outer wall). The purity at each outlet was assessed using flow cytometry 
(for summary of scatter plots for triplicate results please consult Appendix F). 
Enucleated cells in the best performing outlet A were enriched 3.2 ± 0.04 (Fig. 5.5 c) 
reaching 71 ± 3% purity (Fig. 5.5 a), where majority of the nuclei were depleted (enrichment 
ratio 0.05 ± 0.02 (Fig. 5.5 c), recovery 1.7 ± 0.43% (Fig. 5.5 b), purity 1.8 ± 0.54% (Fig. 5.5 
a)) and nucleated cells constituted the main contaminant (purity 26.6 ± 2.8%, Fig. 5.5 a).  
Transfusion of nucleated cells poses leucemogenic risk [3], thus this product should be 
further purified if intended for clinical application. That was achieved by adding a filtration 
step after processing in the spiral channel (Fig. 5.3). Cells collected at the outlets A and B were 
passed through 3µm polycarbonate IsoporeTM filter membrane counted and assessed by flow 
cytometry (Appendix G). This enhanced purity of enucleated cells collected at the outlet A to 
99% (Fig. 5.5 d). The high purity, however, was a trade-off for recovery since during this 
process 50-70% of enucleated cells were lost (Fig. 5.5 e). Only 5% of enucleated cells was 
found in outlet B, but the recovery rate after filtration of the sample was much higher than for 
outlet A, reaching 86 ± 13 % (Fig. 5.5 e),  however in return the purity was compromised (93.0  
± 6.61 %, Fig. 5.5 d). For the overall performance of the purification process, I think it is 
sensible to sacrifice a fraction of the cell material in order to maintain highest possible purity 





Characterisation of the label-free mRBC purification process. Separation efficiency of 
enucleated cells (pink) from contaminant nucleated cells (purple) and nuclei (grey) after 
processing in a spiral channel with a 30 × 170 µm2 cross-section and four outlets (A -closest 
to the outer wall, B, C and D) at 1 ml/min flow rate (a, b & c) and enhanced by filtration (d, e 
& f). A filtration step was performed only on cells collected at the best performing outlets (A 
and B). Both approaches were characterised with three parameters: purity, recovery and 
enrichment ratio. The process validation was performed with three replicas, the bars 
representing the mean value and error bars the standard deviation of the mean. Dotted lines 




5.2.6. Filtration justifications 
Prior to identifying the next best approach to remove the contaminant residues in the 
collected samples after processing in the spiral channel, we had to understand their properties.  
Choosing membrane filtration as the purity enhancing step in the mRBC purification workflow 
was motivated with the observation that cell deformability under applied load is determined 
not only by cytoskeletal properties [52] but also the presence and properties of nucleus 
[41][136]. At the very last stages of the differentiation procedure, the enucleated and nucleated 
cells indicate similarities in their cytoskeleton. The actin cortex is downregulated [128] and in 
fluorescent microscopy, it is visible as little aggregates distributed on cell peripheries and that 
determines the soft nature of these cells [41]. The most distinct difference between enucleated 
and nucleated cells, however, is the presence of the nucleus. While under sufficiently high load, 
like during the RT-FDC experiments, the deformation of nucleated cells is limited by the 
presence of the nucleus [41]. As shown in Fig. 5.6 a when cells enter the RT-FDC measurement 
channel, the enucleated cells assemble the tear-like shape and their minor axis (4.3 ± 0.81, 
mean ± SD) perpendicular to the flow direction) is shorter than nuclei minor axis (5.0 ± 0.38), 
on the contrary nucleated cells assemble the bullet-like shape and their minor axis length (6.42 
± 0.9) remains above the nuclei. The nucleus is a rigid structure restricting the degree to which 
a nucleated cell deform from its original shape under applied load. Nuclei within nucleated 
cells as well as the free floating nuclei captured in the outlet A were sized by image analysis 
of cytospin slides (Fig.5.6 b). The nuclei within nucleated cells mean minor axis was 4.8 ± 0.8 
µm, with the minimal measured value of 2.8 µm. The free floating nuclei were of similar sizes 






(a) Minor axis (y-axis, perpendicular to the flow direction within the RT-DC chip) of 
enucleated cells (pink), nucleated cells (purple) and nuclei (grey) in the input sample, 
measured by RT-DC in the measurement channel section. Measurements were performed at 
0.12 µl/min flow rate in a 20 µm × 20 µm channel. More than 10,000 events were acquired and 
split accordingly between each subset. Box plots summarising the length of minor axis [µm] 
for enucleated and nucleated cells and nuclei, where the line in the box represents the median, 
the box itself represents data from lower and upper quartile and the whiskers correspond to 
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the lowest and highest extreme values. The dotted line indicates mean minor axis length for 
nuclei. To get further insight into the properties of contaminants found in the outlet A cytospin 
image analysis was perform to extract useful parameters describing (b) nucleated cell and (c) 
nuclei.  
 
The sizes of the free-floating nuclei and the nuclei within nucleated cells did not allow 
them to pass through 3 µm membrane pores and hence they should have been retained on the 
top of the filter.  
This study did not aim to develop new membrane filtration methodology, thus initially 
we tested six commercially available membranes, three with 5 µm pore size and three with 3 
µm pore size.  
1. 5µm SVPP Durapore (Merck, cat. SVLP04700 ) 
2. 5µm Polyster PETE (SterliTech, cat. PET5047100) 
3. 5µm NYLON (cat. NY5047100) 
4. 3 µm SIGMA (Sigma, cat. 23339483) 
5. 3 µm ISOPORETM (Merc, cat. TSTP04700) 
6. 3 µm NUCLEOPRETM (Whatman, cat. WHA110412) 
All membranes were tested specifically with the end product of the CB CD34+ erythroid 
differentiation. A mixed population containing enucleated and nucleated cell as well as nuclei 
was passed through the filter membranes fitted onto syringe adapter and cell material retention 
on the membranes was assessed by performing a cell count (Table 5.1). 5µm NYLON and 3 
µm SIGMA were discriminated from further tests due to high retention, 99.95% and 99.75%, 
respectively, of input cells, did not go through the membrane. The cut-off point of the 5µm 
Polyster PETE membrane was larger than the largest cells found in the input sample and that 






Summary of performance of the six initially tested filter membrane. Membrane type column 
indicates pore size and brand name of tested membranes. Input and output columns show cell 
concentration before and after filtration, respectively, and recovery column indicates a 
fraction of input sample that passed through the filter with no distinction into the three subsets.  
 
Next, input sample as well as samples collected after filtration through the best performing 
3 µm ISOPORETM, 3 µm NUCLEOPRETM and 5µm SVPP Durapore membranes, were 
characterised using standard flow cytometric assay (Fig. 5.7). In order to identify the most 
suitable membrane, sizes of enucleated and nucleated cells, as well as nuclei from samples 
collected after filtration, were compared with sizes of their counterpart subsets found in the 
outlet A, after processing in the spiral channel. Box plots of FSC-A parameter were generated 
separately for enucleated (Fig. 5.7 a) and nucleated (Fig. 5.7 b) cells and the free-floating 
nuclei (Fig. 5.7 c), then ROC cures were generated and AUC was calculated (Fig. 5.7 d, e & 
f).  
The assumption for desired enucleated cells was that AUC for the best performing 
membrane should be either closest to 0.5 (meaning exactly the same size range) or 1 with the 
shift toward small sizes within the measured size range. In contrast, for contaminant particles, 
like nucleated cells and nuclei, AUC ideally should be equal to 1, with the population shift 
towards the larger sizes. Based on these assumptions we found that the best performing 
membrane was the 3 µm ISOPORETM, the size range of enucleated cells passing through the 
membrane was almost 100% aligned with enucleated cells found in the outlet A (AUC=0.54, 
Fig. 5.7 a), which should minimise the additional cell losses. Moreover, the 3 µm ISOPORETM 
had a very sharp cut-off point for nucleated cells and nuclei, with 75% of all events remaining 
in the minimal side of the spectrum (shown as box plot in Fig. 5.7 b & c) and being 
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substantially smaller than that nucleated cells (AUC=93, Fig. 5.7 e) and nuclei (AUC=89, Fig. 
5.7 f) found in outlet A.  
 
Fig. 5.7 
Comparison of sizes of (a) enucleated cells, (b) nucleated cells and (c) free floating nuclei 
captured in the outlet A and after passing through 3µm ISOPORETM (ISO), 3µm 
NUCLEOPRETM (NUCLE) and 5µm SVPP Durapore (DURA). Box plots summarising the 
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FSC-A parameter indicating relative sizes for enucleated and nucleated cells and nuclei, where 
the line in the box represents the median, the box itself represents data from lower and upper 
quartile and the whiskers correspond to the lowest and highest extreme values. The dotted line 
indicates mean FSC-A for an adequate subset found in the outlet D. Receiver Operating 
Characteristic (ROC) curves were plotted for the sizes expressed as FSC-A parameters 
comparison between (d) enucleated cells, (e) nucleated cells and (f) nuclei found in the outlet 
D and passed through passing through 3µm ISOPORETM (solid line), 3µm NUCLEOPRETM 
(dashed line) and 5µm SVPP Durapore (dotted line). The True Positive Rate is defined as the 
number of events (enucleated/ nucleated/ nuclei) found in the outlet D for a certain FSC-A cut-
off point divided by the total number of events (enucleated/ nucleated/ nuclei, respectively). 
The False Positive Rate is defined as the number of events (enucleated/ nucleated/ nuclei) 
found in samples after filtration, divided by the total number of events (enucleated/ nucleated/ 
nuclei, respectively). In order to quantify size overlap, the Area Under the Curve (AUC) was 
calculated. 
 
5.2.7. Donor-to-donor variability and reproducibility  
The indigenous properties of cells, such as size and deformability, have been recognised 
as promising inexpensive label-free markers [45]. In some cases, alterations in cell mechanical 
properties are correlated with their molecular activity, such as cell cycle regulation [149][46] 
and differentiation [41][150][151]. Label-free biomarkers are cost-effective since there is no 
need to add costly antibodies to reveal cell identity markers and number of processing steps 
(staining, washing) is reduced [137], thus they are seen as a potential route to develop 
industrially-viable processes for large-scale high-throughput cell enrichment [152][153][154], 
e.g. like in this study purifying stem-cell derived RBC. This approach is not suitable in many 
cases due to the lack of the correlation of the desired molecular phenotype and the 
mechanotype, thus the first step in designing any customised label-free purification strategy is 
profound characterisation and understanding of properties of a given sample.  
Luckily, the enucleated and nucleated cells and the free-floating nuclei found in the 
end-product of the CB CD34+ differentiation protocol could be distinguished based on their 
size and deformability. CB CD34+, among other cell types used as a starting material, offer 
relatively high enucleation rate and yields providing numerous units of mRBC. However, CB 
CD34+ expansion potential is limited, meaning that cells obtained from one donor constitute a 
finite source and that creates a difficulty in adapting this approach for routine standardised 
processing [155].  
Variation in donor-dependent hematopoietic differentiation potential of CB CD34+ has 
not been widely addressed, hence we characterised the end product of CB CD34+ in vitro 
erythropoiesis from three donors, two described in this study (donor I- Fig. 5.1, Fig 5.2 and 
Fig. 5.3 and Appendix B, donor II- Appendix H and Appendix I) and an additional donor 
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was described elsewhere [41] and Appendix J. Our findings show that there was some degree 
of intrinsic variability in size and deformability characteristics between them (Table 5.2- a 
summary table for all three donors) which influenced the label-free purification outcome (Fig. 
5.5 for donor I, Appendix K for donor II, Appendix L for donor III and Table 5.2 for the 
summary).  
In general, the size expressed as projected cell area [µm2] remains roughly within the 
same range for each donor (24.3 ± 7.6 – 77.3 ± 27.5, 26.1 ± 7.5 – 67.8 ± 20.7 and 20.9 ± 1.5 – 
63.5 ± 6.7 µm2, for donor I, II and III, respectively). The relative size measured by flow 
cytometry as FSC-A parameter, show that nucleated cells always remind the largest in the 
samples and that was true across all three donors. It was also true across the three researched 
donors that there were discrepancies in the relative size of enucleated cells and nuclei. 
Enucleated cells derived from donor I substantially overlapped with sizes of nuclei (AUC=0.63 
± 0.6, Fig. 5.2) and the little shift was towards larger side of the spectrum. For donor II 
enucleated cells were the smallest within the sample, while as shown in Appendix J the 
subpopulation of enucleated cells derived from donor III was larger than the subpopulation of 
the expelled nuclei ( AUC=0.93 ± 0.01) with a substantial overlap in terms of size with 
nucleated cells (AUC=0.59 ± 0.03) 
Despite the size differences, nuclei always remain the most rigid within the sample 
while the enucleated cells are the most deformable. However, the degree to which enucleated 
cells can deform vary between donors, mean deformation of enucleated cells derived from the 
best performing donor III was 0.33 ± 0.03 [41] (Table 5.2), which is comparable to deformation 
measured for peripheral blood red cells measured in RT-DC (D=0.35 ± 0.03, Appendix M.). 
In contrast, deformation of enucleated cells derived from donor II (D=0.21 ± 0.07), which also 
had the lowest expansion (data not shown) and enucleation rate among all tested donors, was 
closer to the deformability of nucleated cells from donor III (D= 0.17 ± 0.03, Table 5.2) than 
to enucleated cells from donor II and RBC (Appendix M). Additionally, the overall cell 
isolation process depends on the relative abundance of the target cells in the input sample. For 
all three donors the purity of enucleated cells varied (Table 5.2), donor I ~20%, donor II <10% 




Donor  I II III 
Where it was 
described 
Fig.5.1, Fig.5.2, Fig.5.3, 
Fig.5.5, Appendix B Appendix H & I &K 
Guzniczak et al. 2017 
and  Appendix J & L 
Enucleated 




75.7 ± 22.4 60.6 ± 18.5 52.8 ± 5.3 
Nucleated 




77.3 ± 27.5 67.8 ± 20.7 63.5 ± 6.7 
Nuclei 












mean ± SD 
deformation [-] 
0.29 ± 0.05 0.21 ± 0.07 0.33 ± 0.03 
Nucleated 
mean ± SD 
deformation [-] 
0.14 ± 0.04 0.10 ± 0.04 0.17 ± 0.03 
Nuclei 
mean ± SD 
deformation [-] 
0.03 ± 0.01 0.03 ± 0.01 0.03 ± 0.01 
Nucleated 
mean ± SD 
nucleus/cytoplas
m ratio 
0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.1 




21.7 ± 0.7 % 8.3 ± 0.7 % 34.8 ± 4.5 % 
Outlet A  
Enucleated 
PURITY 
71.0 ± 3.4% 62.0 ± 3.4% 71.3 %* 
Outlet A  
Enucleated 
RECOVERY 





Table summarising size and deformability properties for three researched donors (donor I, 
donor II and donor III) as well as the performance of the purification process in the spiral 
microchannel. All reported values are averaged results for three replicas, except for donor III 
outlet A Enucleated PURITY and RECOVERY marked with “*”- performance of the spiral 
channel for donor III was validated only once.  
 
In order to verify if these difference had and influence on the label-free purification 
performance (donor I- Fig. 5.5, donor II- Appendix K, donor III- Appendix L), mRBC derived 
from all three donors were processed in the spiral channel at 1ml/min and the process 
characterisation metrics were compared (Table 5.2). The generic conclusion is that the high 
quality end-product of differentiation constitutes good quality starting material for the label-
free purification resulting in highest recovery rates (>90%) and purity (>70%). Among the 
researched donors, donor III could be classified as an exemplary donor due to high enucleation 
rate, good quality of enucleated cells comparable to PB RBC (Appendix M) and their clearly 
distinguishable mechanotype. In contrast, smaller stiffer and less abundant enucleated cells 
derived from donor II were more troublesome to purify. Their recovery and purity in the outlet 
A were ~10% lower in comparison to donor I and III (Table 5.2). Stiffer enucleated cells from 
donor II, probably, experience less of the effect of the deformability induced lift force and they 
assemble the lateral equilibrium position closer to the channel centreline resulting in their 
partial capture in the outlet B (recovery 12.3%, Appendix K b). Additionally, due to the 
prevalence of contaminant nucleated cells and nuclei, the filter membrane was more prone to 
fouling and that resulted in 17% lower recovery rate of enucleated cells (Appendix K e) in 
comparison to the donor I.  
In conclusion, CB CD34+ derived from the same donor, behave in a uniform way 
during the in vitro differentiation into RBC- even when processed in batches. The 
differentiation process for each batch is recapitulated either exactly or with very close 
similarities in terms their expansion and enucleation rate, levels of expression of CD235a and 
well as characteristics of their label-free markers (size and deformability). However, not all 
researched donors had the same capacity to differentiate into enucleated mRBC. In this study, 
we showed that erythroid differentiation did not occur at the same levels for all studied donors. 
This means that the cells origin is probably the major determinant of variation in hematopoietic 
differentiation of CB CD34+ cells and that could be the limiting factors for implementing 
standardised label-free purification protocols.  
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The issue of limited proliferative capacity has been addressed by the scientific 
community by introducing iPSC cells [156] as well as creating immortalised adult erythroid 
cell line (BEL-A)[23], presenting an interesting alternative to CB and PB hematopoietic stem 
cells as a potentially unlimited source of erythroid progenitors. Consequently, both of the 
approaches create a route to manufacture standardised mRBC with highly reproducible pheno- 
and mechnotypes. To achieve that, technical hurdles specific for each approach have to be 
overcome, GMP compliance has to be addressed and their safety and efficacy have to be proven 
[157].  
 
5.2.8. Processing impact on cells 
Inertial microfluidic techniques are considered as a gentle method for biological 
samples processing, with a vast literature evidence supporting unaffected cell quality (e.g. 
viability, cell membrane integrity, proliferation or altered gene expression) after processing 
[158]. In this study, the novel deformability-induced lift force (FD) was used to sort mRBC in 
spiral microchannel, and as described in Chapter 4, in order to reveal the effect of FD, elevated 
flow rates are required. To investigate if the hydrodynamically-induced mechanical stress on 
the cells exerted any adverse effect on the mRBC phenotype, cell integrity and global gene 
expression profile were studied.  
Populations of mRBC derived from donor I and II, at concentration of 3-4 × 106 cell/ml 
were processed in the design II (170 × 30 µm cross-section) spiral microchannel at 1 ml/ min 
flow rate, and eluents from all outlets were collected into one vial (test sample) and their quality 
was compared against unprocessed cells (control).  
Cell integrity of the control and processed cells was investigated via trypan blue 
exclusion assay. Live cells are impenetrable for trypan blue, while damaged cells with impaired 
cell membrane integrity uptake trypan blue and they appear blue. As shown in Fig. 5.8, the 






Viability of mRBC derived from (a) donor I and (b) donor II, before (control) and after (test) 
processing in design I (170 × 30 µm cross-section) spiral microchannel at 1 ml/min flow rate, 
as measured by Trypan Blue exclusion assays. Bars represent mean fraction of live (green) or 
dead (blue) cells found in the samples, measured at three independent experimental occasion. 
Error bars correspond to the standard deviation of the mean.  
 
Next, the global gene expression patterns were investigated in control and test samples, 
using poly-A selection method to detect if the relatively high flow rates (in comparison to 
reports from literature- please consult Fig. 4.12 for summary of Re numbers) trigger more 
subtle changes at molecular level.  
Please note that the bioinformatic analysis and data interpretation was performed 
by Neil A. Robertson (MRC DTP PhD Studentship). After sequencing, a standard pipeline 
was run that seeks to describe the variance and correlative behaviour across the data before 
classifying those genes that are differentially expressed in each core comparison. Sample by 
sample correlation analysis was performed to attempt to ascertain how strongly or weakly each 
sample correlates across the range of gene expression values (Spearman Correlation Clustering, 
hierarchically clustered). Strong tendency for samples to cluster by sample group (donor I and 





Heatmap of sample correlation. Correlations between each pairwise combination of samples 
is shown. The correlations were calculated using Spearman Correlation based on all gene 
expression values. The level of correlation (Spearman Correlation Coefficient) is represented 
by colour intensity, with strong positive correlation in red, no correlation in light pink and 
strong anti-correlation in blue. The plot has been hierarchically clustered on both axis using, 
Spearman distances, with UPMGA agglomeration and mean reordering. 
 
We then sought to describe the individual changes in gene expression using CuffDiff. 
Here, a small number of genes changing significantly (p-value < 0.05) as a result of cell 
processing– 40 and 42 changing genes in samples from donor I and donor II, respectively, was 
observed. This was eclipsed by the scale of changes between sample groups with over 2400 





Bar chart showing the number of significantly (p-value < 0.05) upregulated (up) and 
downregulated (down) genes, between donor I (and donor II respectively) cells processed is 
the spiral microchannel compared to control sample as well as donor II control and processed 
cells compared to control and processed cells derived from donor I.  
 
Heatmaps of significantly differentially expressed genes (please see Appendix O), show 
that although genes change in relatively robust patterns, their expression changes are rarely 
recapitulated within treatment groups. Additionally, as shown in the violin plots (Fig. 5.11) for 
the most up- and downregulated genes (top three each of up and down regulated selected by 
smallest p value), the level of changes are small when compared to the spread in the expression 
levels between replicates.  
In summary, it has been confirmed that mRBC after processing within the spiral 
microchannel at sufficiently high flow rate to take advantage of the effect of FD for cells 
focusing, retain high degree of viability and that there is no distinct gene expression alteration. 
That confirms that the proposed approach for using the spiral microchannel for mRBC sorting, 
is indeed a suitable and safe technique for processing these cells.  
 
N u m b e r  o f C u ffD iff  d iffe r en tia lly

















D o no r II sp ira l vs  D o no r I sp ira l
D o no r II c o ntro l vs  D o no r I c o ntro l
D o no r II sp ira l vs  D o no r II c o ntro l
D o no r I sp ira l vs  D o no r I c o ntro l
U p
D o w n
U p
D o w n
U p
D o w n
U p





Violin plots showing three most significantly (selected by the lowest p-value)  upregulated and 
downregulated genes after processing in the design II (170 × 30 µm cross-section) at 1 ml/min 
flow rate in comparison to control cells, for both donor I and II.  Each dot is one sample, with 
sample groups given on the x-axis and gene expression on the y-axis. The mean and standard 
error for each sample group is given as a red dot and line. The spread of the samples within a 




5.3. Conclusion and future outlook 
In this work, we successfully developed a passive label-free high-throughput and 
complete purification strategy for CB CD34+- derived red blood cells. Using advancements in 
the microfluidic RT-FDC approach for high-throughput cell mechnotyping the heterogeneous 
end-product of CB CD34+ in vitro erythropoiesis was characterised and label-free identity 
markers were identified and formulated for the target enucleated cells as well as contaminant 
nucleated cells and expelled nuclei. Next these label-free markers were used as a motivation 
for developing and optimising the label-free purification strategy, which consists of two steps: 
(1) processing raw sample in spiral microchannel where most of the contaminant material is 
depleted (enrichment ratio ~0.5 for both nucleated cells and nuclei, below the input baseline) 
and high recovery (>90%) of the target enucleated cells up to high (>70%) but not satisfactory 
purities, further enhanced by adding (2) membrane filtration step resulting in removal of ~99% 
of the potentially harmful impurities (mainly nucleated cells since >98% of nuclei were 
removed by the spiral microchannel). The membrane filtration requires further optimisation 
and development since in this study due to the usage of dead-end filtration which is prone to 
membrane fouling, led to the recovery of 30-50 % of enucleated cells.  
In the demonstrated approach, 3-4 × 106 cells/ min are processed by a single device 
when operating at the optimal 1ml/min flow rate. The current throughput seems reasonable for 
processing cells that are routinely cultured within similar concentration range in large volumes. 
At present, mRBC culture is routinely carried in static culture conditions, facilitating maximal 
cell concentration at around 5 × 106 cells/ml [11], as Timmins et al. 2009 estimated, that would 
take 9000 T175 cm2 flasks to produce a single blood unit [14]. This approach definitely is not 
sustainable and cost effective. To overcome the limitation mRBC cultured at minimum 50 × 
106 cell/ml should decrease required volume of medium to 40 litres and consequently the total 
cost to around $8000 per blood unit [14][3][11]. The downstream processing proposed in this 
study has the capacity for further scale-up by two means: increasing cell sample concentration 
(the estimated concentration limit for this particular system is at 20×106 cells/ml, 𝛼=1, please 
see Equation (17)) and system parallelisation. Stacking microfluidic devices (stack of 20 
devices reported [159]) is a common practice resulting in a rapid and efficient throughput 
improvement.  
All current protocols for the manufacture of RBC from stem cells face the same 
technological challenge of low enucleation rate. The most efficient solution is co-culture with 
macrophages, which eliminate the expelled nuclei by the means of phagocytosis. This is an 
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organic solution but it comes with its own technological costs, such as finding ways to retrieve 
the macrophages from the culture and the complexity of a co-culture system with feeder layer 
impairs scaling-up. Hence, a significant research effort is invested into understanding the 
enucleation process and identifying and isolating key factors responsible for the process 
[25][31]. In the most optimistic scenario, even if the enucleation rate would be improved to 
reach the desirable 100% and nucleated cells would not be present in the end-product of the in 
vitro erythropoiesis, in the absence of macrophages the expelled nuclei will still remain within 
the sample. Having a robust label-free procedure for mRBC purification at high-throughput 
with no impact on cell quality will consequently be of significant importance for bringing 
mRBC a step closer to clinical use.  
 
5.4. Materials and methods 
 The differentiation protocol, flow cytometric staining protocol and cytospin slides 
preparation were performed as per Chapter 2 
5.4.1. Flow cytometry  
Fluorescently-stained cells were analysed on a flow cytometer (BD LSR II, BD, 
Germany). Obtained data were processed using FlowJo V10 CL. The receiver operating 
characteristic curves (ROC) were generated and the area under the curve (AUC) was calculated 
and further data analysis was performed using GraphPad Prism 6. 
5.4.2. Real-time fluorescence and deformability cytometry (RT-FDC) 
Correlation between the molecular markers and mechnotype was assessed using real-
time fluorescence and deformability cytometry (RT-FDC) [125]. Measurements were 
performed as per Nat. Methods 2018 [125] and as described in Chapter 2. Briefly, prior to 
measurements, CB CD34+ in the end of the differentiation protocol were harvested by 
centrifugation at 200 g for 5 min and re-suspended in a 0.05% methylcellulose solution 
(CellCarrier, Zellmechanik Dresden, Germany) 1-2 × 106 cell/ml. Differentiated CB CD34+ 
cells, due to their small size, were characterised in 20 × 20 µm cross-section channel at 0.12 
µl/min flow rate. Due to the fragile nature of these cells, they were stained directly in 
CellCarrier by adding 5 mM DRAQ5™ Fluorescent Probe (BD) (to obtain a final concentration 
of 5 µM) per 100 µl buffer volume. Cells were incubated for 2 min, in darkness at room 
temperature and analysed immediately after the staining. Gating strategy for the enculated and 
nucleated cell as well as nuclei was applied as per Appendix N. Obtained data was analysed 
using original RT-FDC software ShapeOut 0.8.4 (available at www.zellmechanik.com). Next, 
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the data was extracted from the software and further inspected and plotted using FlowJo V10 
CL and GraphPad Prism 6. 
5.4.3. Cytospin analysis 
Images were analysed using bespoke LabView software developed by Dr Graeme 
Whyte (Heriot Watt University) which detected the outline of the cells and nuclei by 
thresholding. The detected objects were classified into nucleated cells, enucleated cells and 
free floating nuclei, and the measurements of the morphological features extracted for further 
processing. 
5.4.4. Cell processing 
The current differentiation protocol involves human serum as a supplement to cell 
culture media. It provides high concentrations of growth factors, macromolecules, carrier 
proteins for lipids, trace elements, attachment and spreading factors, nutrients and hormones 
[160] and it plays a crucial role in the process. We found, similarly to others [161], that our 
devices are being clogged instantaneously when serum is presented in the processing buffer 
[161], thus we recommend exchanging the buffer to serum-free for the processing time. Our 
buffer of choice was PBS-/- supplemented with 0.1% biocompatible surfactant Pluronic F-68 
[162] (TermoFisher Scientific, cat. 24040032). It was motivated with PBS-/- compatibility with 
technical requirements of quality control assays such as flow cytometry [163] and cell counts 
performed using MoxiZ automated cell counter as well as improved image quality [54]. 
Presence of phenol red (pH indicator in basal medium) impairs reads from both flow cytometry 
and automated cell count, thus cells processed in the basal medium could not be directly 
sampled for the quality control tests. Pluronic F-68 was added to surrogate the serum protective 
mechanism from mechanical damages (e.g. due to shear stress generated within the spiral 
microchannel) [160][164][162]. For a further application, cells can be processed in serum-free 
medium or any other buffer of choice, as long as the medium viscosity is not significantly 
different than the viscosity of water at room temperature, which is necessary to generate the 
large velocity gradient as a mean of manipulating particles in inertial microsystems.  
Cells suspended in PBS-/- supplemented with 0.1% Pluronic F-68 at a concentration 
around 3-4 × 106 cells/ml was introduced into the device with a mid-pressure syringe pump 
(neMESYS 1000N, Cetoni, Germany) through 1/1600 PTFE tubing of 0.5 mm internal 
diameter (Thames Restek, UK). Cell concentration is a critical factor influencing focusing 
within the spiral microchannel. If the concentration is too high, so-called steric crowding effect 
occurs, meaning that there is physically not enough space for particles to focus in a tight single 
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stream. In order to identify if the crowding effect will occur the length fraction 𝛼 (number of 






where 𝑉𝐹is the volume fraction of particles in the solution, a is particle diameter, W is the 
channel width and H is the channel height. For 𝛼 > 1, focusing to a single stream cannot be 
expected due to steric interactions between particles [91]. Assuming that all the particles in the 
input sample were of the size of the largest nucleated cells (Ø~10 µm), at concentrations 
between 3-5 × 106 cells/ml, 𝛼 varies between 0.153-0.255, satisfying the condition necessary 
to avoid the steric crowding effect.  
Hydrodynamic behaviour of cells was assessed in terms of lateral equilibrium position 
as described in Chapter 2. Lateral position within the channel was recorded for more than 
10,000 events at three independent occasions, for each researched condition, using a custom-
written program ShapeIn and quantified using ShapeOut version 0.8.4 (available at 
www.zellmechanik.com). To enhance the purification efficiency cells collected at the outlet A 
& B were passed through 3 µm polycarbonate IsoporeTM filter membrane (Merc, UK) fitted 
onto plastic adapter for syringe filtration. Cell suspension was loaded into a 5 ml plastic syringe 
and pumped through the filter membrane at 2 ml/ min using a syringe pump (neMESYS, 
Cetoni, Germany). Cell separation efficiency was quantified by flow cytometry (BD LSR II, 
BD, Germany) in order to compare the fraction of each cell population (characterised by unique 
fluorescent properties- please see the “Flow cytometry” section) in samples collected at each 
outlet. Additionally, cell yield was assessed by counting a number of cells at each outlet using 
either a standard glass haemocytometer or MoxiZ automated cell counter (Orflo, US). In order 








of each cell type in each outlet, where [C] is enucleated cell/ nucleated cell/ nuclei number per 
ml. 
 
𝑃𝑢𝑟𝑖𝑡𝑦[𝐶]𝑜𝑢𝑡𝑙𝑒𝑡𝑖 =  
[𝐶]𝑜𝑢𝑡𝑙𝑒𝑡𝑖
[𝐸𝑛𝑢𝑐𝑙𝑒𝑎𝑡𝑒𝑑 + 𝑁𝑢𝑐𝑙𝑒𝑎𝑡𝑒𝑑 + 𝑁𝑢𝑐𝑙𝑒𝑖]𝑂𝑢𝑡𝑙𝑒𝑡𝑖
× 100% (18) 




𝐸𝑛𝑟𝑖𝑐ℎ𝑚𝑒𝑛𝑡 𝑟𝑎𝑡𝑖𝑜 =  
[𝐶/(𝐸𝑛𝑢𝑐𝑙𝑒𝑎𝑡𝑒𝑑 + 𝑁𝑢𝑐𝑙𝑒𝑎𝑡𝑒𝑑 + 𝑁𝑢𝑐𝑙𝑒𝑖)]𝑜𝑢𝑡𝑙𝑒𝑡𝑖
[𝐶/(𝐸𝑛𝑢𝑐𝑙𝑒𝑎𝑡𝑒𝑑 + 𝑁𝑢𝑐𝑙𝑒𝑎𝑡𝑒𝑑 + 𝑁𝑢𝑐𝑙𝑒𝑖)]𝑖𝑛𝑙𝑒𝑡
 (19) 
Data analysis and plotting were performed using GraphPad Prism 6 and FlowJo V10 CL. 
5.4.5. Trypan blue exclusion assay 
100 µl of cell suspension (control/ after processing in the spiral channel) was mixed 
with an equal part of 0.4% trypan blue dye (Gibco, UK), to obtain 1:2 dilution, incubated for 
less than three minutes at room temperature, loaded onto a glass haemocytometer and counted 
using a light microscope (AXIO Scope.A1 Zeiss, Germany).  
5.4.6. Global gene expression  
The global gene expression test by poly-A selection was outscored to Edinburgh 
Clinical Research Facility (https://www.edinburghcrf.ed.ac.uk/Genetics) and run according to 
their internal SOPs. 
The bioinformatic analysis (performed by Neil A. Robertson (MRC DTP PhD 
Studentship)) comprised of trimming N bases and the filtering of poor-quality reads (phred-
score <= 30) with trim-galore before aligning with HISAT2 to the GRCh38 human genome 
(Ensembl version 94).  Post alignment, reads were sorted with samtools before quantifying 
explicit normalised expression (FPKM) with the Cufflinks suite.  Differential expression 









Three replicas of flow cytometric and RT-FDC measurements of the end-product of CB CD34+ 
derived from donor I- in vitro differentiation into red blood cells. (a) Histograms of FSC-A 
parameter reflecting relative sizes of enucleated (pink) and nucleated (purple) cells as well as 
the free-floating nuclei (grey), measured by flow cytometry. The number of events on each 
diagram is around 10,000 - split accordingly between each subpopulation. (b) Equal probability 
contour plots (the same number of cells fall between each pair of contour lines) of deformation 
vs cell size (expressed as projected cell area in µm2) for each enucleated and nucleated cells 
and nuclei generated using RT-FDC for three replicas. (c) A summary table showing the 
statistical summary of deformation of each subset found in the end product of the 







Summary of flow cytometric assessment of the presence of enucleated cells, nucleated cells 
and expelled nuclei in the input samples as well as samples collected at each outlet (A, B, C 
and D) after processing them at 1ml/min flow rate in the spiral channel, for three independent 
sorting occasions. Enucleated cells are DNA- and CD235a+, nucleated cells are DNA+ and 
CD235a+, free-floating nuclei are DNA+ and CD235+, however, they express lower levels of 
CD235a than nucleated cells. Each scatter plot displays around 10000 events split accordingly 








Summary of flow cytometric assessment of the presence of enucleated cells, nucleated cells 
and expelled nuclei in samples collected in (a) outlet C and (b) outlet D and passed through 
the 3µm ISOPORETM for three independent replicas. Enucleated cells are DNA- and CD235a+, 
nucleated cells are DNA+ and CD235a+, free-floating nuclei similarly to nucleated cells are 
DNA+ and CD235+, however, they express lower levels of CD235a than nucleated cells. Each 
scatter plot for “outlet D filtered” displays around 5000 events split accordingly between each 
subpopulation, while events in “outlet C filtered” events were so rare that the sample size is 










Three replicas of flow cytometric and RT-FDC measurements of the end product of CB CD34+ 
derived from donor II- in vitro differentiation into red blood cells. (a) Histograms of FSC-A 
parameter reflecting relative sizes of enucleated (pink) and nucleated (purple) cells as well as 
the free-floating nuclei, measured by flow cytometry. The number of events on each diagram 
is around 10000 split accordingly between each of the subpopulations. (b) Table summarising 
size measurement (expressed as cell area in µm2) obtained from cytospin image analysis for 
enucleated cells, nucleated cells, as well as free floating nuclei (c) Equal probability contour 
plots (the same number of cells fall between each pair of contour lines) of deformation vs cell 
size (expressed as projected cell area in µm2) for each enucleated and nucleated cells and 
nuclei, generated using the RT-FDC for three replicas. (d) A summary table showing the 
statistical summary of deformation of each subset found in the end product of the 









Receiver Operating Characteristic (ROC) curves were plotted for (a) size (expressed as FSC-
A parameter) and (b) deformability [-] for enucleated versus nucleated cells (purple-dashed)  
and enucleated cells versus nuclei (grey) at the end of the differentiation protocol for three 
replicas for donor II. The True Positive Rate is defined as the number of enucleated cells 
measured for a certain cut-off point (size or deformability) and divided by the total number of 
enucleated cells. The False Positive Rate is the corresponding number of nucleated cells (resp. 
nuclei) divided by the total number of enucleated cells (resp. nuclei) for the same cut-off. The 








Relative size measurements by flow cytometry (FSC-A) for donor III (a) Histograms of FSC-
A parameter reflecting relative sizes of enucleated (pink) and nucleated (purple) cells as well 
as the free-floating nuclei (grey). The number of events on each diagram is around 10000 split 
accordingly between each of the subpopulations. Receiver Operating Characteristic (ROC) 
curves were plotted for (b) size (expressed as FSC-A parameter) for enucleated versus 
nucleated cells (purple-dashed)  and enucleated cells versus nuclei (grey) at the end of the 
differentiation protocol for three replicas for donor III. The True Positive Rate is defined as the 
number of enucleated cells measured for a certain cut-off point (size or deformability) and 
divided by the total number of enucleated cells. The False Positive Rate is the corresponding 
number of nucleated cells (resp. nuclei) divided by the total number of enucleated cells (resp. 
nuclei) for the same cut-off. The Area Under the Curve (AUC) was calculated to quantify the 







Characterisation of the label-free mRBC purification process for donor II. The purification 
efficiency of enucleated cells (pink) from the contaminant nucleated cells (purple) and nuclei 
(grey) after processing in  the spiral channel with the 30 × 170 µm cross-section and four outlets 
(A -closest to the inner wall, B, C and D) at 1 ml/min flow rate as well as after (a, b & c) 
processing in the spiral channel and (d, e & f) enhanced by filtration. Filtration step was 
performed only on cells collected at the best performing outlets C and D. Both approaches were 
characterised with three parameters: purity, recovery and enrichments ratio. The process 
validation was performed at three independent occasions, the bars represent mean value and 
error bars correspond to the standard deviation of the mean. The dotted lines on the enrichment 







Characterisation of label-free mRBC purification process in the spiral channel for donor III. 
The purification efficiency of enucleated cells (pink) from the contaminant nucleated cells 
(purple) and nuclei (grey) after processing in the spiral channel with the 30 × 170 µm cross-
section and four outlets (A -closest to the inner wall, B, C and D) at 1 ml/min flow rate.. The 
process was characterised three parameters (a) purity, (b) recovery and (c) enrichments ratio. 
The process validation was performed only once. The dotted lines on the enrichment ratio 








Comparison of mRBC derived from CB CD34+ from three donors (I, II and III) with RBC 
from peripheral blood. Equal probability contour plots (the same number of cells fall between 
each pair of contour lines) of deformation vs cell size (expressed as projected cell area in µm2) 
for enucleated cells derived from each researched donor (pink) and packed RBC purchased 








Gating strategy applied to characterise the end product of CB CD34+ in vitro erythropoiesis. 
The sample collected at the end of the differentiation protocol was stained with a nuclear stain 
DRAQ-5 to check for the presence of a nucleus. Each subpopulation can be characterised by a 
combination of size and fluorescent signal. Enucleated cells are inherently negative for DNA 
(DRAQ-5-DNA -), nucleated cells are larger than the free floating nuclei and both are DRAQ-
5-DNA+. Events between 0-15 µm2 were assumed to be cell debris and they were excluded 
from the analysis. (a) Scatter plot of the area [µm2] vs deformability [-] for a control unstained 
sample for more than 20000 acquired events. (b) Scatter plot of DRAQ-5-DNA vs area [µm2] 
for the unstained sample. The gate splits the scatter plot into DNA-negative region on the left 
hand side and DNA-positive region on the right hand side. (c) Scatter plot for the sample 
stained with DRAQ-5 for the presence of DNA. Gates for each subpopulations are shown as 












Hierarchically clustered heatmap of the significantly differentially expressed genes for the 
comparisons: donor I spiral and donor I control and donor II spiral and donor II control, for all sample 
in the sample groups: donor I spiral, donor I control, donor II spiral and donor II control. Samples 
are on the x axis and genes on the y axis. Colour intensity represents expression level, with 
blue representing low expression, and red representing high expression. Expression levels have 
been row scaled into z−scores. The y-axis (both plots) and x-axis (right plot) have been 





Chapter 6. Bioprocess considerations Part I- predicted 
versus experimental results 
Highlights 
 Heterogeneous mixtures of particles (of different sizes) behave differently within spiral 
microchannels that their homogenous components tested as pure populations.  
 The fluid flow pattern within spiral microchannel generated by the channel geometry 
is reshaped by presence of particles, which translates downstream into altered 
hydrodynamic behaviours.  
 Large particles introduce additional vortices capturing smaller particles in “trains of 
particles” impacting their predicted equilibrium position, while smaller particles have 




Inertial focusing in spiral microchannels has been adapted to separate various biological 
specimens from heterogeneous samples based upon their size, shape and deformability [90]. 
Particle focusing within a spiral microchannel is determined by the particles properties and 
their interplay with the fluid. In curved channels, the amplitude of Dean vortices is 
characterised by the Dean number (as defined in Equation (8)). In a given channel, 𝐷𝑒 can be 
consequently changed by adjusting the Reynolds number (𝑅𝑒) (see Equation (1))- 𝐷𝑒 
increasing with increasing 𝑅𝑒 [165][166][99].  
Currently, there is no robust numerical model that would allow precise prediction of 
equilibrium lateral positions which is crucial for identifying optimal flowrates for efficient 
separation and recovery. Consequently, the common practice is to quantify and describe the 
hydrodynamic behaviour for each subset (characterised by unique size and/or deformability) 
found within a heterogeneous sample, separately, as pure pre-sorted populations [83]. 
However, the impact of having mixed populations has not been investigated in depth in the 
literature.  
In this study, the spiral channel ends with four balanced outlets (A, B, C and D), 
meaning that the channel itself could be divided into four sections along channel width 
(respectively, 0-42.5 µm, 42.5-85 µm, 85-127.5 µm and 127.5-170 µm measured from the outer 
wall), corresponding to these four outlets. Due to the laminar flow regime, particles found in 
each section at the end of the spiral channel, proceed, with negligible error, to the corresponding 
outlets. Hence, we assumed that if pure populations found in the end product of in vitro 
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erythropoiesis of CB CD34+ cells behaved in a certain way and they were found in the certain 
section of the spiral channel, they certainly should be captured in a corresponding outlet when 
tested as mixed populations. However, as shown in Fig. 6.1, the actual sorting performance, 
presented here as cell recovery [%] in each outlet, was different from predicted results. For 
each subpopulation, it is true that more events than anticipated (9.2% for enucleated cells, 
18.9% for nucleated cells and 1.4% for nuclei) travelled to the outlet A and for nuclei and 
nucleated cells a shift towards the outer wall was observed, with a substantial depletion (16% 
for nucleated cells and 24% for nuclei) from the outlet D. 
 
Fig. 6.1  
Table summarising predicted and experimental outcome of mRBC purification in the spiral 
channel at 1ml/min flow rate. Predicted recovery had been estimated by assessing 
hydrodynamic behaviour of pure pre-sorted populations of enucleated cells, nucleated cells 
and nuclei. Predicted recovery was generated by counting the number of cells/ nuclei found at 
lateral equilibrium positions within virtual boundaries of four section within the channel, 
which correspond to the four outlets.  
 
Particles focusing within the spiral microchannel is a complex process, where not only 
the distinct fluid flow pattern interacts with particles, but also the presence of particles shapes 
and disturbs the flow pattern and depending on particles properties, particle-particle interaction 
occurs [91]. The effect of particle-particle interaction is minimised by maintaining the optimal 
particles concentration to prevent their steric interaction (steric crowding effect), which can be 
estimated by calculating the number of particles diameters per channel length- the length 
fraction 𝛼 as defined in Equation (17). For 𝛼 > 1, focusing to a single stream cannot be 
expected due to steric interactions between particles [91]. For more troublesome biological 
particle adhesion/ aggregation preventing additives like biocompatible surfactant Pluronic F-
68 [162] and EDTA (ethylene diamine tetra-acetic acid) [167], are used. The cell-cell 
interaction in this study was minimised by working at cell concentrations ensuring 𝛼 ≪ 1 and 





Maximum separation efficiency of mRBC is achieved at 1ml/min flow rate. At this 
condition cells travel within the channel at ~3 m/s velocity, making all present subpopulations 
indistinguishable in the imaging set-up used in this study. Hence, to further understand the 
differences between the predicted and experimental separation outcome, we researched if there 
was a difference in the hydrodynamic behaviour of pure and mixed populations using a model 
system consisting of cells of Jurkat cell line (round, Ø13 ± 2µm, grown in suspension) and 4 
µm spherical polystyrene beads. In order to reflect heterogeneous properties of events found in 
the end-product of the in vitro erythroid differentiation, mechanical properties of Jurkat cells 
were altered by fixing with 0.1% glutaraldehyde, known for its cross-linking property resulting 
in cell stiffening without altering cell size [168]. 
Soft (control, untreated) and stiff (fixed with glutaraldehyde) cells, as well as 4 µm 
beads, were passed though the spiral channel as pure populations at five previously tested flow 
rates (0.2, 0.4, 0.6, 0.8 and 1 ml/min), their equilibrium lateral position within the channel was 
assessed by image analysis (Fig. 6.2 a). In order to assess optimal flow rate for separating 4µm 
beads from soft and stiff cells Receiver Operating Curves (ROC) curves were generated and 
Area under the Curve (AUC) was calculated (Fig. 6.2 b for separating 4µm beads from soft 
cells and Fig. 6.2 c for separating 4 µm beads from stiff cells) and it was established that at the 
flow rate of 0.4 ml/min, streak of 4µm beads would be physically 100% (AUC=1) separated 





Sorting optimisation with pure populations of 4µm beads (green), soft cells (orange) and stiff 
cells (blue). (a) Hydrodynamic behaviour of 4µm beads, soft and stiff cells assessed in the 
spiral channel with the 30 × 170 µm cross-section at five different flow rates (0.2, 0.4, 0.8 and 
1 ml/min). The lateral equilibrium position was measured as a distance from the outer wall 
(µm) at the end of the spiral channel and it was generated by image analysis. Here, it is 
reported as median (represented as the longest vertical lines) and the interquartile range 
(indicated by the short vertical lines) on the top of scatter plots, where each dot represent one 
event. Receiver Operating Curves for (b) 4 µm beads versus soft cells and (c) 4 µm beads 
versus stiff cells, for each applied flow rate, were generated. The True Positive Rate is defined 
as the number of 4 µm found at a given lateral position and divided by the total number of 4 
µm beads. The False Positive Rate is the corresponding number of soft cells (resp. stiff cells) 
divided by the total number of 4µm beads for the same cut-off. To determine which of the 
applied flow rates ensures the best separation efficiency the Area Under the Curve (AUC) was 
calculated.  
 
To verify the predicted outcome, cells and beads collected at the outlets were quantified 
by flow cytometry to determine their purity and by performing cell count in order to calculate 






Outcome of processing (a) 4 µm beads (green), (b) soft cells (orange) and (c) stiff cells (blue) 
in the spiral channel with the 30 × 170 µm cross-section and four outlets (A -closest to the 
outer wall, B, C and D) at 0.4 ml/min flow rate. Recovery of each population was assessed at 
three independent occasions, the bars represent mean value and error bars correspond to the 
standard deviation of the mean. The dotted vertical lines represent sections of the channel 
corresponding to outlets A/ B/ C/ D as indicated above the diagrams. Additionally, exemplary 
images for each population were acquired. The scale bar corresponds to 50 µm. (d) Table 
summarising predicted and experimental outcome of processing each population in the spiral 
channel. Predicted recovery was generated counting number of beads/ cells found at lateral 
equilibrium positions within virtual boundaries of four section within the channel, which 
correspond to the four outlets.  
 
At the optimal 0.4 ml/min flow rate, 4 µm beads were focused in a tight streak at 159 
± 1.9 µm measured from the outer wall, and as expected 100% of beads were collected in outlet 
D (Fig. 6.3 a). Meanwhile soft (Fig. 6.3 b) and stiff (Fig. 6.3 c) cells were equilibrated closer 
to the channel centre (77 ± 18.2 µm and 86 ± 26.8 µm for soft and stiff cells respectively).  
Due to their large size in comparison to the channel cross-section, cells are 
geometrically pushed toward the channel centreline and they occupy a relatively wide section 
in the middle of the channel. Consequently, they were mostly found in the middle outlets C 
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and B. 63 ± 2.9 % soft cells and 36 ± 3.7 % stiff cells travelled to outlet B and 27 ± 2.5 % of 
soft and 48 ± 6.3 % stiff cells were found in outlet C. Only a small portion of both cell types 
was directed to the outmost outlets A and D. These experimental results were in line with the 
predicted recovery of beads/ cells in each outlet, with a minimal (0.5 ± 0.7%) error (Fig. 6.3 
d). Predicted recovery was generated by counting the number of beads/ cells found at lateral 
equilibrium positions within virtual boundaries of the four sections within the channel which 
correspond to the four outlets. 
Next, two types of mixtures were prepared, 4 µm beads with soft cells (Fig. 6.4) and 4 
µm beads with stiff cells (Fig. 6.5). Beads and cells were meant to be mixed at three different 
beads/cells ratios: 75:25, 50:50 and 25:75, however due to an error live cells were mixed with 
beads at ratios closer to 40:60, 60:40 and 25:75- for the easiness of reading, the original values 
are used throughout the text. All six mixtures were run through the spiral channel at 0.4 ml/min 
and the separation efficiency was assessed by quantifying the portion of beads and cells in each 
outlet and calculating the recovery rate.  
For both conditions, soft cells and 4 µm bead and stiff cells and 4 µm beads it was 
found that with the decreasing beads to cells ratio, the number of beads recovered in outlet D 
decreases, from predicted 100% for pure beads population, down to 53 ± 4.3 % and 62 ± 1 % 
when beads were mixed 25:75 with soft (Fig. 6.4 a) and stiff cells (Fig. 6.5), accompanied by 
a small increase (0.3-1.3%) of soft cells retrieved in outlet D, observed for all three conditions. 
Throughout the experiments with soft cells, the most noticeable changes was recorded in outlet 
B, with 4.7%, 14.5% and 9.3% depletion of cells for samples mixed at 75:25, 50:50 and 25:75 
receptively, in favour of flanking outlets C and A. when cells outnumbered beads (50:50 and 
25:75).  
A similar pattern was observed for stiff cells (Fig. 6.5), for the 50:50 (Fig. 6.5 b) and 
25:75 (Fig. 6.5 c) samples, where the number of stiff cells collected in the outlet D increased 
slightly by 2.3-6.5 %, while for the 75:25 sample (Fig. 6.5 a) the number dropped by 3.5%. 
For all three conditions stiff cells were depleted from outlets B and C in favour of the outlet A 





Characterisation of separation of 4 µm beads (green) from soft cells (orange) in the spiral 
channel with the 30 × 170 µm2 cross-section and four outlets (A -closest to the outer wall, B, 
C and D) at 0.4 ml/min flow rate. 4µm beads and soft cells were mixed at three different 
beads/cells ratios: (a) 75:25, (b) 50:50 and (c) 25:75 to the final concentration of 1×106 events 
/ml. Please note that due to an error live cells were mixed with beads at ratios closer to 40:60, 
60:40 and 25:75- for the easiness of reading, the original values are used throughout the text. 
Purity [%] was assessed quantifying the portion of beads and cells in the inlet sample, as well 
as samples collected at each outlet and recovery [%] of each population, was assessed. The 
process was characterised at three independent occasions, the bars represent mean value and 
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error bars correspond to the standard deviation of the mean. The dotted vertical lines represent 
sections of the channel corresponding to outlets A/ B/ C/ D of as indicated above the diagrams. 
Additionally, exemplary images for each population were acquired. The scale bar corresponds 
to 50 µm. (d) Table summarising predicted and experimental outcome of processing each 
population in the spiral channel. Predicted recovery was generated counting number of beads/ 
cells found at lateral equilibrium positions within virtual boundaries of four section within the 






Characterisation of separation of 4 µm beads (green) from stiff cells (blue) in the spiral 
channel with the 30 × 170 µm cross-section and four outlets (A -closest to the outer wall, B, C 
and D) at 0.4 ml/min flow rate. 4µm beads and soft cells were mixed at three different 
beads/cells ratios: (a) 75:25, (b) 50:50 and (c) 25:75 to the final concentration of 1×106 events 
/ml. Purity [%] was assessed quantifying the portion of beads and cells in the inlet sample, as 
well as samples collected at each outlet and recovery [%] of each population, was assessed. 
The process was characterised at three independent occasions, the bars represent mean value 
and error bars correspond to the standard deviation of the mean. The dotted vertical lines 
represent sections of the channel corresponding to outlets A/ B/ C/ D as indicated above the 
diagrams. Additionally, exemplary images for each population were acquired. The scale bar 
corresponds to 50 µm. (d) Table summarising predicted and experimental outcome of 
processing each population in the spiral channel. Predicted recovery was generated counting 
number of beads/ cells found at lateral equilibrium positions within virtual boundaries of four 
section within the channel which correspond to the four outlets.  
 
6.3. Discussion 
In order to utilise the inertial effect in microchannels for particles ordering, such 
systems have to operate at intermediate Re [94]. In microfluidic systems operating within 
hydrodynamic regimes, where inertia is no longer negligible, particles constitute an active 
component of the system, shaping and altering fluid flow pattern [94]. As proposed by Amini 
et al. 2012 [169] for straight microchannels, with rectangular cross-section, the interplay 
between fluid flow and particles results from a combination of fluid inertia, fluid flow around 
the particle, particle rotation and particle to channel confinement ratio. Amini et al. 2012 
verified experimentally two important hydrodynamic cases: (1) when particles dimensions are 
approaching those of the microchannel, they rotate in response to the flow field. Consequently, 
fluid streamlines approaching the rotating particle are diverted to a new cross-sectional position 
by so-called particle-induced convection. That causes the formation of a secondary flow, which 
resembles the characteristic of Dean flows found in curvilinear microchannels. (2) The cross-
sectional lateral equilibrium position of particles large enough to trigger the particle-induced 
convection is not affected by the downstream consequences of the secondary flows. This 
statement is in line with the results observed in this study. Only negligible minute changes in 
hydrodynamic behaviour of Jurkat cells (both soft and stiff) were observed in mixed samples, 
while up to 50% of 4 µm beads diverged from their primary cross-sectional lateral equilibrium 
position. This suggests that in a heterogeneous in size sample (e.g. mRBC), the presence of 
large (approaching channel dimensions) particles has a significant impact on the fluid 
streamline topology in the whole system and that in return modifies the predicted performance 
of the system. As highlighted numerous times in this study, cells intrinsic deformability adds 
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complexity to their hydrodynamic behaviour within inertial focusing (IF) devices. 
Interestingly, ~10% more 4 µm beads were affected by the presence of soft cells, in comparison 
to the stiff cells. The cells deformability contribution to the overall IF is not fully-understood 
yet, but on multiple occasions, we appreciated its importance in harnessing the full-potential 
of IF. 
Additionally, it is visible that cells flowing through the spiral microchannel travel in an 
ordered fashion, creating “trains” of cells with evenly distributed spaces between cells. This 
intriguing phenomena has been reported previously for inertial flows and is called interparticle 
spacing and to date, it is poorly understood [170]. However, W. Lee et al. 2010 proposed that 
the interparticles spacing is another consequence of particle-induced convection [171]. 
 
Fig. 6.6 
Exemplary images of soft Jurkat cells and 4 µm beads mixed at 50:50, flowing through the 
spiral microchannel at 400 µl/min flow rate assembled in trains. 4µm beads (stowaway 
particles) joined the train positioned at lateral equilibrium position close to the channel 
centreline, typical for Jurkat cells. Images were taken at the end of the spiral channel and the 
scale bar represents 50 µm.  
 
Viscous disturbance flow generated by a rotating particle under confinement acts on a 
neighbouring approaching particle, repelling it a certain distance which is stabilised by inertial 
lift force (once particles assemble into the train with defined interparticles spacing this state is 
preserved by the action of inertial lift force). Consequently, even if there is no direct physical 
contacted between particles (e.g. due to aggregation), hydrodynamic particle-particle 
interaction occurs due to the mechanism of self-assembly into either pairs or trains of particles. 
Hence, the pattern of particles ordering within the spiral microchannel is determined not only 
by inertial lift forces and secondary Dean flow (focusing position) but also it is modulated by 
the hydrodynamic particle-particle interaction (interparticles spacing). In all mixed systems 
tested in this study, we did not identify cells joining trains of 4 µm beads focused near the inner 
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wall of the channel, in contrast, “stowaway” beads were commonly found at different 
configurations (as shown in Fig. 6.6) in trains of cells positioned close to the channel centreline.  
In the light of this study and literature reports discussed above, it can be hypothesised 
that in the mRBC sample, smaller rigid nuclei were affected by the presence of larger nucleated 
cells in a similar fashion as 4 µm beads by Jurkat cells. Nuclei were substantially (24%) 
depleted from outlet A, on account of outlet B and C, where majority of nucleated cells were 
found. Additionally, the lower magnitude difference between the predicted and the 
experimental outcome for enucleated and nucleated cells across all outlets, could be a 
consequence of the, so far, uncontrollable and unpredictable train of particles formation.  
6.4. Conclusion 
In conclusion, we experimentally investigated possible causes of differences in 
hydrodynamic behaviour of pure and mixed populations of particles of different sizes and 
deformability. In mixed samples, in the presence of particles whose diameter approaches the 
size of the channel, commonly negligible rotation of particles causes disturbances and 
modification in the focusing pattern for smaller particles, which translate into significant 
changes in the sorting performance. The rotation-induced secondary flows cause fluid mixing 
across the channel introducing aberrations into the fluid flow pattern. Additionally, the 
rotation-induced secondary flows promote hydrodynamic particle-particle interaction resulting 
in particles self-assembly in trains. These forces have been implicated as a cause of focusing 
alterations for smaller particles, adversely affecting particle separation in the spiral 
microchannel. The mixing effect is desirable for certain applications (e.g. for fluid mixing and 
switching in sample preparation protocols prior to flow cytometry). However, these poorly 
understood factors altering focusing positions of particles in inertial sorters can constitute a 
significant technical issue. Profound understating of these effects would aid better control over 
inertial devices performance and facilitate making inertial focusing a mainstream technology 
in the future. 
6.5. Materials and methods 
6.5.1. Sample preparation 
Cells from the same batch were collected when at their exponential growth phase, split 
into fresh cell culture flask to maintained researched conditions. Prior to treatment with 
Glutaraldehyde (SigmaAldrich) cells were washed twice in PBS-/- (phosphate buffered saline 
without calcium and magnesium, Gibco) to remove any residual proteins. Next cells were re-
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suspended at 1 × 106 cell/ml in PBS-/- supplemented with 0.1% (v/v) Glutaraldehyde) and 
incubated at room temperature for 40 min. After the incubation time cells were washed once 
in PBS-/- and re-suspended accordingly in PBS-/- supplemented with 0.1% Pluronic F-68 
(ThermoFisher Scientific) for experiments in the spiral channels  
Nine types of samples were prepared at a final concentration of 1×106 particles/ml in 
PBS-/- supplemented with 0.1% Pluronic F-68:three pure suspensions of 4µm beads, soft 
(untreated) Jurkat cells, stiff (glutaraldehyde-treated) Jurkat cells, three mixtures of 4µm beads 
and soft cells and three mixtures of 4 µm beads (Magasphere Ltd.) and stiff cells. Mixtures of 
beads and cells were prepared at three different beads: cells ratio, 75:25, 50:50 and 25:75.  
6.5.2. Hydrodynamic behaviour in spiral microchannel 
Hydrodynamic behaviour of all nine samples was tested in a spiral microchannel with 
170 × 30 µm cross-section, 6 loops, 1 inlet and four outlets as described in Chapter 2. As 
shown in Table 6.1, 4 µm beads do not achieve the desirable 𝑅𝑒𝑝>1 at flow rates lower than 1 
ml/min, but we verified experimentally that despite the unsatisfactory 𝑅𝑒𝑝, at lower flow rates 




Summary of useful parameters for optimising spiral microchannel performance. 𝑅𝑒 is channel 
Reynolds number, 𝑅𝑒𝑝 is particle Reynolds number, De is Dean number.  
 
Cell separation efficiency was quantified by flow cytometry in order to compare the 
fraction of each cell population (characterised by size difference measured as forward light 
scatter parameter FSC-A, as shown in Fig. 6.7) in samples collected at each outlets. Cell yield 
was assessed by counting a number of cells at each outlet using either a standard glass 





An exemplary histogram of forward light scatter (FSC-A) parameter measured for 4 µm beads 
(green) and soft Jurkat cells (orange), reflecting their relative sizes. Displayed gating was used 
to quantify purity of each subpopulation in samples collected at four outlets after processing 
in the spiral microchannel.  
 









of each particle type [𝑃], and 
 
𝑃𝑢𝑟𝑖𝑡𝑦[𝑃]𝑜𝑢𝑡𝑙𝑒𝑡𝑖 =  
[𝑃]𝑜𝑢𝑡𝑙𝑒𝑡𝑖




indicating a fraction of each subset in a sample collected after processing. Data analysis and 




Chapter 7. Bioprocessing considerations Part II- 
medium choice- impact of Poloxamer 188 (Pluronic F-
68) additive on cell mechanical properties 
Highlights 
 Commonly used additive Pluronic F-68 can change mechanical properties of cells and 
consequently alter their processing.  
 This effect has been quantified for cell types commonly used in the microfludic field: 
red blood cells (RBC) and a lymphoblastic cell line-Jurkat and human embryonic 
kidney (HEK) cells.  
 The RT-DC approach enabled fast processing of cells, leading to an accurate picture of 
the time (1-5 hours) and concentration (0.01%, 0.05% and 1%) -dependence of cell 
deformability in the presence of additives. 
 
Published work 
Ewa Guzniczak, Melanie Jimenez, Matthew Irwin, Oliver Otto, Nicholas Willoughby, and 
Helen Bridle, Impact of Poloxamer 188 (Pluronic F-68) Additive on Cell Mechanical 
Properties, Quantification by Real-Time Deformability Cytometry. Biomicrofluidics 
12 (4), 44118 (2018).- reproduced with the permission of AIP Publishing. for the authors 
contributions please consult research thesis submission form.  
 
7.1. Introduction 
The label-free purification strategy proposed in this study was designed specifically for 
stem cell- derived red blood cells (mRBC) purification. As described in Chapters 3 & 5, the 
current manufacture protocol involves human serum as a supplement to cell culture media. We 
found, similarly to others, that our devices tend to clog when serum is presented in the 
processing buffer [161], thus we recommend exchanging the buffer to serum-free for the 
processing time. Additionally, our devices were clogging due to channel cross-section merely 
larger than a couple of cell diameters. One of the most commonly accepted solutions to prevent 
clogging issues is the use of additives such as poloxamers, dextran or methylcellulose [172]. 
Our buffer of choice was PBS-/- (phosphate buffered saline without calcium and 
magnesium) supplemented with 0.1% biocompatible surfactant Pluronic F-68 [162] 
(TermoFisher Scientific, cat. 24040032). It was motivated with PBS-/- compatibility with 
technical requirements of quality control assays such as flow cytometry [163] and cell counts 
performed using MoxiZ automated cell counter as well as improved image quality [54]. 
Presence of phenol red (pH indicator in basal medium) impairs reads from both flow cytometry 
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and automated cell count, thus cells processed in the basal medium could not be directly 
sampled for the quality control tests. Moreover, Pluronic F-68 was added to surrogate the serum 
protective mechanism from mechanical damages (e.g. due to shear stress generated within the 
spiral microchannel)[160][164][162].  
Pluronic F-68 is a biocompatible amphiphilic and nonionic compound consisting of a 
central polyoxypropylene (POP) block, flanked on both sides by hydrophilic chains of 
polyoxyethylene (POE) [173]. This surface-active macromolecule (molecular weight 8400) is 
used as an antifoam agent in stirred cell culture vessels and large scale bioreactors 
[174][175][164] among numerous other applications (e.g. as antithrombotic [176] or anti-
inflammatory [177] agents, as an artificial blood emulsifier [178] or skin wound cleanser [179].   
Pluronic F-68 and other poloxamers have been adopted as a coating agents and 
additives in microfluidic systems engineered for cell analysis [180], lysis [181], separation 
[182] and detection [183], in microconstrictions for assessing cell mechanical properties [54] 
and digital microfluidics [184]. Poloxamers added to a flow buffer can coat glass [185], silicon 
[186], PDMS [187] and PMMA [188] - materials commonly used for microfluidic fabrication. 
This kind of treatment prevents clogging, reagents adsorption, protein fouling, cell-cell 
interaction, reduces electro-osmotic flow and can provide cell protection against a high degree 
of shear stress [189]. This repair and protective mechanism of Pluronic on cells is not fully-
understood yet, however, some literature evidence suggests direct interaction with cell 
membrane causing cell stiffening [190][191].  
As mentioned previously, mechanical cell properties are seen as a potential marker for 
label-free separation with applications in large-scale bioprocessing. However, the observation 
that Pluronic can stiffen cells suggests that the use of such additives could potentially impact 
upon the performance of mechanical based purification approaches. Thus, we investigated the 
effect of Pluronic F-68 on cells commonly used in microfluidic studies: Jurkat cells, red blood 
cells and human embryonic kidney (HEK) cells. The aim was to quantify if the addition of 
Pluronic F-68 significantly influenced cell mechanotype, which could have implications for 
mechanical phenotype based downstream cellular processing in spiral microchannels. For the 
first time, observed changes were quantified using real-time deformability cytometry (RT-DC) 
[46] to assess the short-term impact of Pluronic F-68, in comparison to controls with and 




7.2. Results  
7.2.1. Effect of Pluronic on Jurkat cells size and deformability- time-dependency 
To understand the short-term effect of the Pluronic F-68 additive on cell mechanotype, 
we measured the size and deformability of Jurkat cells cultured either in cell culture medium 
containing serum or phosphate-buffered saline (PBS-/-) and I compared them against cells 
whose medium was supplemented with 1% Pluronic F-68. The choice of a serum-free 
experiment is motivated by experience with microfluidic systems. Most tissue culture systems 
contain serum, which easily clogs microfluidic chips (due to the high protein content), and 
therefore replacing cell culture medium with PBS -/- for the time of the experiments is a 
common practice [192][54][193]. The RT-DC measurements were taken each hour for 3 hours. 
The chosen time-scale was motivated by an average longevity of experiments in microfluidic 
systems used in our laboratory.  
Fig. 7.1 a & b shows time-dependent changes in cell deformability. The effect of 
Pluronic F-68 was normalised to the untreated control. For both conditions addition of Pluronic 
F-68 causes significant changes after 3 hrs of addition. The alteration of deformability, 
expressed here as differential deformation (DD) (please see materials and methods for details) 
of cells cultured in serum (Fig. 7.1 a), progresses slowly but gradually for the first two hours 
causing initially slight (> 5%), almost negligible (p-value no significant), stiffening. Incubating 
cells for 3 hrs in the presence of Pluronic F-68 causes significant (p-value <0.01) decreases of 
cell deformability (~ 23%). Specifically, it drops within 3hrs from DD=0.051 ± 0.0017 to 
DD=0.039 ± 0.0045 (DD expressed as mean of three experimental replicates ± standard error 
of the mean). 
Interestingly, when medium containing serum is replaced with PBS-/- (control from 
Fig. 7.1 b) cell deformability drops by ~22% from the original DD= 0.051 ± 0.0017 to DD= 
0.040 ± 0.0015 within less than 15 min of medium replacement and it equilibrates within an 
hour at DD=0.032 ± 0.0016. During the first two hours Pluronic F-68-treated sample and PBS-
/- control are indistinguishable. After 3 hrs of incubation Pluronic F-68-treated sample diverges 





Fig. 7.1  
Effect of Pluronic F-68 on cells of Jurkat cell line mechanical properties was quantified using 
real-time deformability cytometry (RT-DC) and flow cytometry. Cells from four conditions: 
Jurkat cells in serum (green)- extracted directly from tissue culture containing serum; Jurkat 
cells in serum +1% (w/v) Pluronic F-68 (gray)- cells cultured in medium containing serum 
supplemented with 1% Pluronic F-68; Jurkat cells in PBS -/-  (blue)- cells incubated in PBS-
/- without serum and Jurkat cells in PBS-/- + 1% Pluronic F-68 (red)- cells incubated in PBS-
/-  supplemented with 1% Pluronic F-68, without serum, were examined. Deformation was 
measured every hour for three hours. (a & b) Time-depended response graphs show mean 
differential deformation (DD) values of three experimental replicates. Error bars correspond 
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to the standard error of the mean (SEM). P-values were calculated using the linear mixed 
model (*p-value <0.01, ** p-value<0.001, n/s no significant). (c & d) Exemplary contour plots 
show outlines of assessed populations (more than 4000 events per population) for deformation 
versus size (expressed as projected cells area in µm2) recorded in the measurement channel 
section of the RT-DC chip. All samples were examined at 0.04µl/s flow rate in a 20x20µm2 
cross section RT-DC channel after 3 hrs of incubation. (e & f) Cell size was assessed using 
forward light scatter parameter (FSC-A) measured using flow cytometer for 10000 cells. 
Receiver Operating Characteristic (ROC) curves were plotted for size expressed as FSC-A. 
The True Positive Rate is defined as the number of control cells measured for a certain size 
cut-off point and divided by the total number of control cells. The False Positive Rate is the 
corresponding number of Pluronic F-68- treated cells divided by the total number of treated 
cells for the same cut-off. The Area Under the Curve (AUC) was calculated to quantify the size 
overlap between control and treated cells after 3 hours. 
 
The RT-DC technique is based on image analysis allowing for size measurement, which 
is expressed as a projected cell area reported in µm2, as shown in the contour plots Fig. 7.1 c 
& d. Although accurate, the technique can at times be sensitive to the changes in focus setting. 
Hence rather than reporting the projected cell area we used flow cytometry to quantify forward 
light scatter (FSC-A) - a measurement of the amount of a laser beam that passes around the cell 
- providing a relative cell size. Fig. 7.1 e & f show acquired values of FSC-A for all conditions. 
To quantify the degree of size overlap Receiver Operating Curves (ROC) curves were 
generated and the corresponding Area Under the Curve (AUC) was calculated. Supplementing 
medium with Pluronic F-68 has a negligible effect on cell size, and it remains unchanged for 
both cells in serum (AUC=0.52) and cells in PBS-/- (AUC=0.54). 
 
7.2.2. Effect of Pluronic on Jurkat cell size and deformability- concentration dependency  
Recommended poloxamer additive concentrations depend on the purpose and intended 
application. Proposed working concentrations for cell culture vary between 0.1% and 1% w/v 
[194][195][164]. Here we examined the effect of different Pluronic F-68 concentrations (0.1, 
0.5 and 1% w/v) on Jurkat cells, incubated for 3hrs in supplemented medium with and without 
serum and compared to untreated controls.  
Fig. 7.2 shows the effect of different Pluronic F-68 concentrations on Jurkat cells in 
serum exerted in terms of cell deformability. Lower concentrations (0.1% and 0.5%) do not 
trigger changes in cell deformability within the first 3 hours of exposure. Cell size (expressed 
as FSC-A measured by flow cytometry) remains unaffected as reported in Fig. 7.2 b 
(AUC=0.53 for 1%, AUC=0.50 for 0.5% and AUC=0.54 for 0.1% Pluronic F-68).  
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Jurkat cells in PBS -/- (Fig. 7.2 c) are slightly more sensitive to the presence of Pluronic 
F-68 since small (~ 6%) but consistent changes (standard error of the mean SEM= 0.0007 for 
three replicates of the experiment, p-value <0.01) are observed after 3 hours of exposure to 
0.5% Pluronic F-68. Similarly to the previous samples, cell size remains unaffected for all 
conditions (Fig. 7.2 d).  
 
 
Fig. 7.2  
Cells of Jurkat cell line were used to examine concentration-dependent deformability and size 
alteration caused by Pluronic F-68 additive. Cells were incubated for 3 hours in medium 
containing serum and PBS-/- supplemented with 0.1 (yellow), 0.5 (orange) and 1% (grey) 
Pluronic F-68. (a & c) Concentration-dependent graphs show Jurkat cells’ response to 
increasing concentration of Pluronic F-68 in comparison to untreated control. The data points 
represent mean differential deformation (DD) values of Jurkat cells treated with Pluronic F-
68 measured on three separate occasions. The bar graphs represent the standard error of the 
mean (SEM), the significance of results was calculated using the linear mixed model (* p-value 
<0.01, ** p-value<0.001, n/s no significant). (b & d) To assess if treatment with Pluronic F-
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68 causes changes in size, cells were characterised by flow cytometry for the forward light 
scatter (FSC-A) for 10000 cells from each condition. Receiver Operating Characteristic (ROC) 
curves were plotted for size expressed as FSC-A. The True Positive Rate is defined as the 
number of control cells measured for a certain size cut-off point and divided by the total number 
of control cells (green). The False Positive Rate is the corresponding number of Pluronic F-
68- treated cells divided by the total number of treated cells for the same cut-off. The Area 
Under the Curve (AUC) was calculated to quantify the size overlap between control and treated 
cells. Data for all samples was collected at 0.04µl/s flow rate in a 20x20µm2 cross section RT-
DC channel.  
 
7.2.3. Effect of Pluronic F-68 on RBCs size and deformability  
In previous works the effect of Pluronic F-68 on red blood cells (RBCs) was examined 
for diseased erythrocytes in sickle anaemia, where it was discovered that Pluronic F-68 
minimises cell-cell adherence and blood viscosity [196][197]. Here we focused on the impact 
of pluronic on mechanical properties and we compared the deformation of packed RBCs stored 





Fig. 7.3  
Deformability and size of isolated packed red blood cells (RBC) treated with 1% Pluronic F-
68 (red) were compared to untreated control (grey). Both samples were examined at  0.12 µl/ 
min flow rate in 20×20µm2 cross-section RT-DC channel. (a) Time-dependent alteration in 
deformability as a response to 1% Pluronic F-68 is presented as mean differential deformation 
(DD) values measured on three separate occasions. The error bars are standard error of the 
mean. P-values were calculated using the standardized mixed model (*p-value <0.01, n/s no 
significant). (b) Contour plots (for more than 2000 cells from each population) were drawn, 
presenting cell deformability vs projected cell area (µm2). (c) Representative images of cells 
extracted from the channel and reservoir section of the RT-DC chip for cells incubated for 3 
hours. (d) To assess if treatment with Pluronic F-68 causes changes in size, cells (10000 events 
for each condition) were characterised by flow cytometry for the forward light scatter (FSC-
A). Receiver Operating Characteristic (ROC) curves were plotted for size expressed as FSC-
A. The True Positive Rate is defined as the number of control cells measured for a certain size 
cut-off point and divided by the total number of control cells (green). The False Positive Rate 
is the corresponding number of Pluronic F-68- treated cells divided by the total number of 
treated cells for the same cut-off. The Area Under the Curve (AUC) was calculated to quantify 
the size overlap between control and treated cells.  
 
Fig. 7.3 a & b demonstrate that the stiffening effect observed for Jurkat cells, when 
incubated for a short time (up to 3 hours) in poloxamer additives, is also shown by RBCs, 
however to a smaller degree. Decrease in RBCs deformation from its original value DD= 0.164 
± 0.008 is visible after 2 hours of incubation (DD=0.148 ± 0.006). Initially cell deformation 
drops by ~ 10% (p-value <0.01) to reach ~-16% (DD= 0.135 ± 0.008, p-value <0.01) after 3 
hours of exposure to Pluronic F-68. RBCs are not spherical, while in suspension they are 
biconcave discs and when exposed to shear in laminar flow, they streamline and assemble the 
tear-like shape as shown in Fig. 3 c. To assess if exposure to Pluronic F-68 causes changes to 
the size, RBCs from both conditions at the 3 hrs time-point were assessed by flow cytometry 
for the FSC-A parameter (Fig. 3 d). A ROC curve with AUC= 0.52 was generated to confirm 
that cell size is unaffected by short-term exposure to Pluronic F-68.  
 
7.2.4. Effect of Pluronic F-68 on adherent HEK cells 
Human embryonic kidney (HEK) cells are adherent cells commonly used in cell 
biology [198]. Due to the wide-spread application of HEK cells, we used this cell line to 
research if there is a short-term (1-3 hrs exposure) effect of Pluronic F-68 exerted on adherent 
cells, using the same methodology as presented above. Deformability of cells cultured in 
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medium with serum, incubated in PBS-/- as well as PBS-/- supplemented with 1% Pluronic F-
68 was examined (Fig. 7.4 a & b). Prior to the measurement cells were harvested into 
suspension by enzymatic treatment with TrypLETM (Fig. 7.4 c). The enzymatic harvest protocol 
requires serum removal, to prevent enzyme inhibition. The serum is removed by replacing cell 
culture medium with PBS-/- and washing with PBS-/- in order to remove traces of the protein-
rich serum.  
 
Fig. 7.4  
Effect of Pluronic F-68 on adherent HEK cells deformability was quantified using real-time 
deformability cytometry. Cells from three conditions: HEK cells in serum (green)- harvested 
directly from tissue culture containing serum, HEK cells in  PBS -/-  (red)- cells incubated in 
PBS-/- without serum for 1, 2 and 3 hrs and HEK cells in PBS-/- + 1% Pluronic F-68 (blue)- 
cells incubated in PBS-/-  supplemented with 1% Pluronic F-68, without serum, were examined 
in 20 × 20 µm2 cross-section RT-DC channel at 0.04µl/s flow rate. (a) Time-dependent 
response graphs show mean differential deformation (DD) values of three experimental 
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replicates. Error bars correspond to the standard error of the mean (SEM). P-values were 
calculated using the linear mixed model (*p-value <0.01, ** p-value<0.001, n/s no 
significant). (b) Exemplary contour plots show outlines of assessed populations for 
deformation vs size (expressed as projected cells area in µm2) recorded in the measurement 
channel section of the RT-DC chip for more than 4000 cells. (c) Prior to the measurement cells 
were harvested into suspension using enzymatic treatment. Representative images obtained at 
×20 magnification show morphology of adherent cells and cells in suspension. (d) Cell size 
was assessed by flow cytometry for the forward light scatter (FSC-A) for 10000 cells from each 
condition. Receiver Operating Characteristic (ROC) curves were plotted for size expressed as 
FSC-A. The True Positive Rate is defined as the number of control cells measured for a certain 
size cut-off point and divided by the total number of control cells (green). The False Positive 
Rate is the corresponding number of treated cells (either in PBS-/- or PBS-/- +1% Pluronic F-
68 respectively) divided by the total number of treated cells for the same cut-off. The Area 
Under the Curve (AUC) was calculated to quantify the size overlap between control and treated 
cells. 
 
Fig. 7.4 a shows changes in deformation measured by RT-DC for HEK cells cultured 
in PBS-/- (red) and PBS-/- supplemented with 1% Pluronic F-68 (blue) for 3 hours and 
compared control cells (green) cultured in whole cell culture medium. There was no significant 
(p-value n/s) change observed between PBS-/- cells (DD=0.029 ± 0.0078) and PBS-/- + 1% 
Pluronic F-68 (DD=0.034 ± 0.0058). The most dramatic change in deformation (~-63% after 
3 hrs, p-value<0.001) was triggered by replacing whole medium (DD=0.079 ± 0.0093) with 
PBS-/-. To assess if replacing cell culture medium with PBS-/- and PBS-/- supplemented with 
1% Pluronic F-68 triggers any changes in size, cells were assessed by flow cytometry for FSC-
A parameter (Fig. 7.4 d). Despite the dramatic change in cell deformation caused by replacing 
whole medium with PBS -/- there is no size alteration (AUC=0.52). Similarly, supplementing 
PBS-/- buffer with 1% Pluronic F-68 does not contribute to cell size alteration (AUC=0.51). 
 
7.2.5. Hydrodynamic behaviour in spiral microchannel  
Exposure of Jurkat cells and RBC to 1% Pluronic F-68 for 3 hours triggered statistically 
significant changes in their deformability. In order to understand practical significance of the 
induced changes we compared hydrodynamic behaviour of control and Pluronic-treated cells 
within microfluidic systems used in this study. As described previously, spiral microchannels 
are sensitive to cell deformability due to contribution of the deformability-induced lift force, 
which together with inertial lift force and Dean force stabilises cells at certain equilibrium 
positions. At elevated flow rates deformable cells experience the effect of a deformability-
induced lift force, first manifested with defocusing, when cells occupy large section of the 
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channel, followed by assembly into a new equilibrium position on the opposite side of the 
channel (shift from inner wall to outer wall). Jurkat cells were tested in a design I spiral 
microchannel with 360 × 60 µm cross-section at five flow rates (1., 1.5, 2., 2.5 and 3 ml/min). 
RBC were tested in a design II spiral microchannel with 170 × 30 µm cross section at flow 
rates ranging between 0.2- 1 ml/min. The lateral equilibrium position was generated by image 
acquisition in the end of the spiral microchannels and it is expressed here as distance from the 
outer wall (µm). To quantify differences in cells behaviour ROC curves were generated and 
AUC was calculated for control versus Pluronic-treated samples.  
As shown in Fig. 7.5 a, and quantified in Fig. 7.5 b, the focusing pattern for control 
Jurkat cells cultured in serum and their counterparts treated with Pluronic F-68, is similar (AUC 
varies between 0.51-0.63). At lower flow rates (1, 1.5 and 2 ml/min) they remain focused closer 
to the inner wall (respectively, 261 ± 36, 277 ± 38 and 264 ± 55 µm for control cells and 248 
± 41, 273 ± 41 and 257 ± 59 µm for Pluronic-treated cells). At 2.5 ml/min they experience the 
characteristic defocusing, occupying wide section of the channel (control: 214 ± 68 µm and 
treated: 211 ± 71 µm) to be shifted closer to the inner wall at 3 ml/min (control: 143 ± 59 and 





(a) Hydrodynamic behaviour of control Jurkat cells cultured complete medium containing 
serum (green) and Jurkat cells incubated for 3 hrs in a complete medium with serum and 
supplemented with 1% pluronic F-68, assessed in a spiral microchannel with 360 × 60 µm 
cross-section at five different flow rates (1, 1.5, 2, 2.5 and 3 ml/min). Box plots summarising 
lateral equilibrium positions, measured as a distance from the outer wall (µm), where the line 
in the box represents the median, the box represents data from lower and upper quartile and 
the whiskers correspond to the lowest and highest extreme values 
(b) Receiver Operating Characteristic (ROC) curves were plotted for lateral equilibrium 
position for control versus Pluronic-treated cells, for each applied flow rate. The True Positive 
Rate is defined as the number of control cells found at a given lateral position and divided by 
the total number of control cells. The False Positive Rate is the corresponding number of 
Pluronic-treated cells divided by the total number of control cells for the same cut-off. To 
quantify differences in the assembled equilibrium positions the Area Under the Curve (AUC) 
was calculated. For summary of triplicate results please consult Appendix P 
 
Exchanging complete medium containing serum to PBS-/- causes a 22% drop in Jurkat 
cells’ deformability within first hour, which is comparable to the change induced by 3 hrs 
exposure to 1% Pluronic F-68 in presence of serum. Deformability of Jurkat cells in PBS-/- 
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decreases by another 29% after 3 hrs exposure to Pluronic F-68 and this change (as shown in 
Fig. 7.6 a) contributed to alteration of response to increased flow rate, which is a trigger for 
the characteristic defocusing before shifting sides of the channel. At lower flow rates (1, 1.5 
and 2 ml/min) both control and treated cells are focused close to the inner wall (control: 253 ± 
46, 271 ± 52 and 242 ± 73, treated cells: 248 ± 40, 275 ± 43 and 255 ± 60 µm), with little 
differences in their equilibrium position (AUC= 0.56, 0.51 and 0.53 at 1, 1.5 and 2 ml/min, 
respectively, Fig. 7.6 b). At 2.5 ml/min, control cells defocus, occupying a wide section close 
to the channel centre (176 ± 77 µm), substantially (AUC=0.85) shifting from Pluronic-treated 
cells, which  lagged their response to the deformability-induced lift force and remaining 
focused close to the inner wall (275 ± 50 µm). Finally, at 3 ml/min, both control and treated 
cells were found closer to the outer wall, (control: 118 ± 58 µm, treated: 139 ± 61 µm), 
suggesting that Pluronic-treated cells require higher than 2.5ml/min flow rate to trigger the 
defocused transition state, but 3 ml/min is sufficient for the full-shift.  
 
Fig. 7.6 
(a) Hydrodynamic behaviour of control Jurkat cells incubated for 3 hrs in PBS-/- (blue) and 
Jurkat cells incubated for 3 hrs in PBS-/- and supplemented with 1% pluronic F-68, assessed 
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in a spiral microchannel with 360 × 60 µm cross-section at five different flow rates (1, 1.5, 2, 
2.5 and 3 ml/min). Box plots summarising lateral equilibrium positions, measured as a distance 
from the outer wall (µm), where the line in the box represents the median, the box represents 
data from lower and upper quartile and the whiskers correspond to the lowest and highest 
extreme values (b) Receiver Operating Characteristic (ROC) curves were plotted for lateral 
equilibrium position for control versus Pluronic-treated cells, for each applied flow rate. The 
True Positive Rate is defined as the number of control cells found at a given lateral position 
and divided by the total number of control cells. The False Positive Rate is the corresponding 
number of Pluronic-treated cells divided by the total number of control cells for the same cut-
off. To quantify differences in the assembled equilibrium positions the Area Under the Curve 
(AUC) was calculated. For summary of triplicate results please consult Appendix R 
 
As shown in Fig. 7.7, control and Pluronic-treated RBC repeated the pattern of 
hydrodynamic behaviour observed for PBS-/- versus PBS-/- supplemented with 1%  Pluronic 
F68 Jurkat cells. At lower flow rates (0.2, 0.4 and 0.6 ml/min), both control and treated RBC 
were focused close to the inner wall (control: 112 ± 20, 122 ± 14 and 123 ± 19 µm, treated: 
110 ± 20, 122 ± 15 and 125 ± 15 µm, respectively). Increasing flow rate to 0.8 ml/min triggered 
the defocusing of control RBC, substantially (AUC=0.73) shifting them at 100 ± 30 µm, in 
relation to Pluronic-treated RBC, which remained focused closer to the inner wall (122 ± 19 
µm). Again, at the maximal applied flow rate, control and treated cells experienced the full 
shift toward the outer wall of the channel, being equilibrated at almost identical (AUC=50) 






(a) Hydrodynamic behaviour of control RBC (grey) and RBC incubated for 3 hrs in PBS-/- and 
supplemented with 1% pluronic F-68, assessed in a spiral microchannel with 170 × 30 µm 
cross-section at five different flow rates (0.2, 0.4, 0.6, 0.8 and 1 ml/min). Box plots summarising 
lateral equilibrium positions, measured as a distance from the outer wall (µm), where the line 
in the box represents the median, the box represents data from lower and upper quartile and 
the whiskers correspond to the lowest and highest extreme values. (b) Receiver Operating 
Characteristic (ROC) curves were plotted for lateral equilibrium position for control versus 
Pluronic-treated cells, for each applied flow rate. The True Positive Rate is defined as the 
number of control cells found at a given lateral position and divided by the total number of 
control cells. The False Positive Rate is the corresponding number of Pluronic-treated cells 
divided by the total number of control cells for the same cut-off. To quantify differences in the 
assembled equilibrium positions the Area Under the Curve (AUC) was calculated. For summary 
of triplicate results please consult Appendix S 
 
7.3. Discussion and conclusion 
In this study it was demonstrated that Pluronic F-68 alters cell mechanical properties, 
causing cell stiffening with no impact on cell size. The short-time (1-3 hours) effect was 
examined for cells of Jurkat (suspension) cell line, red blood cells and adherent HEK cells. It 
was established that cell deformability undergoes significant alteration within the first hours of 
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exposure to Pluronic F-68, even at concentrations as low as 0.5% w/v for cells in suspension 
without serum. Adherent HEK cells do not show the stiffening trend as observed for Jurkat 
cells and RBCs.  
We speculate that results could be explained with the cell preparation protocol, since 
prior to RT-DC measurements (similarly to other common microfluidic applications) HEK 
cells have to be harvested into suspension. We believe that the harvesting procedure exerts a 
more dramatic effect than the Pluronic treatment itself. By imaging HEK cells we observed 
that cell detachment is followed by changes in cytoskeleton (Fig. 7.8), known to substantially 
contribute to cell mechanical properties [199].  
More specifically, when cells adhere to a surface the F-actin (in green in Fig. 7.8) 
spreads creating angular shapes surrounding the cell nucleus (in blue in Fig. 7.8). When cells 
are harvested into suspension F-actin rearranges to maintain a spherical shape, the 
characteristic sharp-corners being replaced with some irregular round local accumulations of 
F-actin and smooth appearance.  
The cell mechanical response to treatment with Pluronic F-68 are relatively small and 
due to the biocompatible nature of Pluronic they are physiologically negligible (with no effect 
on cell size and viability). However, it must be considered that cell deformability can be 
significantly affected by the poloxamer additive as well as serum removal from the 
experimental system and it can introduce implications to performance of a deformability-
sensitive microfluidic system, like the spiral microchannels used throughout this study. Jurkat 
cells and RBC incubated for 3 hrs in PBS-/- supplemented with 1% Pluronic F-68 experienced 
less of the effect of deformability-induced lift force at elevated flow rates in comparison to 
their controls, causing a delay in entering the defocused transition state.  
The exact mechanism of altering cell deformability is not fully understood yet, however 
it has been shown that Pluronic F-68 decreases plasma membrane fluidity [200], probably due 
to its surfactant properties, enabling pluronic to integrate into the lipid bilayer of the cell [190]. 
Additionally, Gigout et al. tracked Pluronic F-68 uptake within Jurkat cells discovering that 
fluorescently-tagged Pluronic F-68 is continually transferred into the cell, enclosed in 
endosomes, and transported alongside the endocytotic pathway. Based on these results they 
suggested that the stiffening effect could be explained partially by the alteration of the cell 
membrane and cytoplasm properties, as a consequence of high pluronic content accumulated 







To visualise changes in HEK cells cytoskeleton in the transition from the adherent to the 
suspended state during cell harvest required for RT-DC measurements, cytoskeletal protein F-
actin (green) and nuclei (blue) were stained with fluorophores and visualised using confocal 




Cell deformability is gaining recognition as a novel cell state marker. Reduced cell 
deformability is commonly associated with a pathological phenotype, e.g. in malaria [50][201], 
sickle-cell disease [202] and thalassemia [203]. Additionally, deformability is seen as a 
valuable label-free marker associated with various cell activities, such as cell cycle regulation 
[149], differentiation [150], metastasis [204] and leukocyte activation [205]. As discussed in 
Chapter 1, many available technologies for deformability analysis (Atomic Force Microscopy, 
microconstrictions, optical stretchers, micropipette aspiration, magnetic bead twisting) require 
prolonged operational time to gain a reasonable number of measurements. Our findings 
highlight the importance of seeking high-throughput technologies, as well as careful 
consideration of experimental conditions to measure deformability changes and analyse 
mechanical phenotype.   
7.4. Materials and methods  
7.4.1. Real-time deformability cytometry 
Cell mechanical properties were assessed using a Real-Time Deformability Cytometer 
(RT-DC) as described in previous works [206][46][79] and Chapter 2. Cells were pumped 
into the channel at two different flow rates: 0.04 (Jukrat and HEK) and 0.12 (red blood cells) 
µl/s, generating a shear stress (corresponding to approximately 1.2 and 4 kPa, respectively) 
resulting in cell deformation. RT-DC data were analysed using the ShapeOut 0.8.4 software 
(available at www.zellmechanic.com). Further analysis were performed using MatLab R2016b 
and GraphPad Prism 7. P-values were calculated using the linear mixed model. 
 
7.4.2. Viability study 
Jurkat cells viability was assessed using the Live/Dead Viability/Cytotoxicity kit for 
mammalian cells (Life Technologies Ltd.) as per the manufacturer's manual. The flow 
cytometric analysis was performed with excitation at 488 nm. Live cells stained with calcein 
emit green fluorescence (530/30 bandpass) while dead cells appear red (610/20 bandpass) due 
to staining with ethidium homodimer. Cells were analysed on a FACSCalibur machine (BD 
Bioscience) immediately after staining and obtained raw data was analysed using FlowJo V10 
CL software. 
7.4.3. Sample preparation- Jurkat cells 
Impact of Pluronic F-68 was examined for four different conditions: a control incubated 
in medium with serum, a sample from complete medium supplemented with Pluronic F-68, 
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cells incubated in PBS-/- (phosphate buffered saline without calcium and magnesium, Gibco, 
cat. 10010023) and PBS-/- containing Pluronic F-68 and incubated for a desired time (1, 2 and 
3 hrs) in a humidified incubator at 37°C in 5% CO2. The chosen time scale is motivated by an 
approximate time required to perform experiments using microfluidic systems and ensuring 




Cells of Jurkat cell line were used to assess if there is an adverse effect of chosen incubation 
conditions that could compromise cell viability. Cells were incubated for 3 hrs in PBS-/- (a) 
and a 1% solution of Pluronic F-68 (b). Ratio of live/ dead cells were assessed by flow 
cytometric assay, performed each hour on a portion of cells extracted from incubated flasks 
and compared with a control (cells extracted directly from a cell culture cultivated in a 
presence of serum). Dead cells emit red fluorescence (610/20 bandpass) detected in FL-3 




7.4.4. Sample preparation- red blood cells 
Packed purified red blood cells (RBCs) from healthy donors stored in a serum-free 
buffer were purchased from Cambridge Bioscience Ltd. Cells were stored at 4°C and cells from 
three batches were used for experimental work within a week of collection. Cells for 
experiments were counted on a haemocytometer and cell density was adjusted to 10×106 
cells/ml by addition of an adequate PBS-/- volume (experimental control) or PBS-/- 
supplemented with Pluronic F-68 to a 1% (w/v) final concentration. Prepared cells were 
incubated at 4°C prior to measurements on RT-DC then collected by centrifugation at 500 × g 
for 5 min and re-suspended in 0.5% methylcellulose. 
7.4.5. Sample preparation- HEK cells 
Impact of Pluronic F-68 was examined for three different conditions: a control 
incubated in medium with serum, a sample, cells incubated in PBS-/- and cells incubated in 
PBS-/- supplemented with 1% Pluronic F-68. HEK cells from the same batch were collected 
for RT-DC measurements by harvesting them into suspension using TrypLETM (ThermoFisher 
Scientific). Prior to the TrypLETM treatment cells were washed twice in PBS-/- and an 
appropriate volume (5ml for 75 cm2 flask) of TrypLETM was added. Cells were incubated in a 
humidified incubator at 37°C in 5% CO2
 for 5 min. After the monolayer dissociation complete 
medium containing serum was added to inactivate the TrypLETM and wash cells of the surface 
of the flask. Next, cells were transferred into 15ml centrifuge tube and they were collected by 
centrifugation at 300 × g for 5 min, the supernatant was discarded and cells were re-suspended 
in 0.5% solution of methylcellulose at 1×106 cell/ml. A control containing serum was collected 
straight from the cell culture flask. The remaining two samples were cultured for 1, 2 and 3 hrs 
in either (PBS-/-) (serum-free experiment) or PBS -/- supplemented with 1% (w/v) cell culture 
grade Pluronic F-68 (ThermoFisher Scientific) (treated sample) and incubated for a desired 
time in a humidified incubator at 37°C in 5% CO2 and harvested prior to measurements as 
described above. All obtained data results from three independent replicates, from cells of the 
same cell line coming from different batches.  
7.4.6. Microscopy 
HEK cells were also examined for cytoskeletal re-arrangements in their adherent and 
suspended state by examining F-actin. Cells (adherent and harvested in suspension HEK in 
serum control, HEK incubated for 3 hrs in PBS and PBS supplemented with 1% Pluronic F-
68) were stained for 30 min at room temperature against F-actin with Actin Green 488 Ready 
Probes reagents (Life Technologies, cat. R37110). 10 minutes before the end of the incubation 
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time, Hoechst 33342 (Sigma Aldrich, cat. 14533) was added to a final 10ng/ml concentration 
to visualise cell nucleus. To avoid additional cytoskeletal re-arrangements due to cell 
preparation for microscopy, cells after treatment were fixed in 4% paraformaldehyde (PFA) 
(ThermoFisher Scientific, cat. 28906). Acquisition was performed on a Leica SP5 SMD (Single 
Molecule Detection) confocal laser-scanning microscope using a 63 × 1.4NA HCX PL Apo oil 
immersion objective lens. The Actin Creen 488 was excited using a tuneable white light laser 
operating at 488 nm and 80 MHz pulse rate. Hoechtst 33342 was excited with a pulsed 405 nm 
laser at 40 MHz pulse rate. Emission was detected with a photon multiplier tube (PMT). 
 
7.4.7. Assessing hydrodynamic behaviour of Pluronic-treated Jurkat cells and RBC in 
spiral microchannel 
To research if changes in cells deformability caused by Pluronic F-68 treatment could 
influence their focusing positions with spiral channel we assessed hydrodynamic behaviour of 
Jurkat cells in serum, Jurkat cells in serum + 1% Pluronic incubated for 3 hrs, Jurkat cells in 
PBS-/- incubated for 3 hours and Jurkat cells in PBS-/- supplemented with 1% pluronic F-68, 
incubated for 3 hrs, RBC in PBS-/- and RBC in PBS-/- supplemented with 1% Pluronic F-68. 
Jurkat cells were incubated in a humidified incubator at 37°C in 5% CO2, while RBC were 
incubated at 4°C. Jurkat cells were tested in a spiral channel with 360 × 60 µm cross-section 
(design A) at flow rates ranging between 1 -3 ml/min. RBC were tested in a device with 170 × 
30 µm cross-section (design B) at flow rates ranging between 0.2 – 1 ml/min.  
Both Jurkat cells and RBC suspensions at concentration around 1 × 106 cells/ml were 
introduced into the device as described in Chapter 2. Cell separation efficiency was quantified 
by flow cytometry in order to compare the fraction of each cell population (characterised by a 
unique fluorescent properties) in samples collected at each outlets. Further data analysis was 







Tables showing statistical summary (mean and standard deviation from the mean (SD), median, 
25th (Q1) and 75th (Q3) percentile as well as minimal (min) and maximal (max) measured 
value) of lateral equilibrium positions obtained for at least 10000 events for Jurkat cells in 
serum and Jurkat cells in serum +1% Pluronic F-68, in design II spiral channel with 360 × 60 
µm cross-section, at five applied flow rates for replica I out of three, expressed as distance 







Replica II (a) Hydrodynamic behaviour of control Jurkat cells cultured complete medium 
containing serum (green) and Jurkat cells incubated for 3 hrs in a complete medium with serum 
and supplemented with 1% pluronic F-68, assessed in a spiral microchannel with 360 × 60 µm 
cross-section at five different flow rates (1, 1.5, 2, 2.5 and 3 ml/min). Box plots summarising 
lateral equilibrium positions, measured as a distance from the outer wall (µm), where the line 
in the box represents the median, the box represents data from lower and upper quartile and the 
whiskers correspond to the lowest and highest extreme values (b) Receiver Operating 
Characteristic (ROC) curves were plotted for lateral equilibrium position for control versus 
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Pluronic-treated cells, for each applied flow rate. The True Positive Rate is defined as the 
number of control cells found at a given lateral position and divided by the total number of 
control cells. The False Positive Rate is the corresponding number of Pluronic-treated cells 
divided by the total number of control cells for the same cut-off. To quantify differences in the 
assembled equilibrium positions the Area Under the Curve (AUC) was calculated. (c) Tables 
showing statistical summary (mean and standard deviation from the mean (SD), median, 25th 
(Qi) and 75th (Q3) percentile as well as minimal (min) and maximal (max) measured value) of 
latera equilibrium positions obtained for at least 10000 events for Jurkat cells in serum and 
Jurkat cells in serum +1% Pluronic F-68 at five applied flow rates for replica II out of three, 





Replica III (a) Hydrodynamic behaviour of control Jurkat cells cultured complete medium 
containing serum (green) and Jurkat cells incubated for 3 hrs in a complete medium with serum 
and supplemented with 1% pluronic F-68 (grey), assessed in a spiral microchannel with 360 × 
60 µm cross-section at five different flow rates (1, 1.5, 2, 2.5 and 3 ml/min). Box plots 
summarising lateral equilibrium positions, measured as a distance from the outer wall (µm), 
where the line in the box represents the median, the box represents data from lower and upper 
quartile and the whiskers correspond to the lowest and highest extreme values (b) Receiver 
Operating Characteristic (ROC) curves were plotted for lateral equilibrium position for control 
versus Pluronic-treated cells, for each applied flow rate. The True Positive Rate is defined as 
the number of control cells found at a given lateral position and divided by the total number of 
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control cells. The False Positive Rate is the corresponding number of Pluronic-treated cells 
divided by the total number of control cells for the same cut-off. To quantify differences in the 
assembled equilibrium positions the Area Under the Curve (AUC) was calculated. (c) Tables 
showing statistical summary (mean and standard deviation from the mean (SD), median, 25th 
(Q1) and 75th (Q3) percentile as well as minimal (min) and maximal (max) measured value) of 
lateral equilibrium positions obtained for at least 10000 events for Jurkat cells in serum and 
Jurkat cells in serum +1% Pluronic F-68, at five applied flow rates for replica III out of three, 






Tables showing statistical summary (mean and standard deviation from the mean (SD), median, 
25th (Q1) and 75th (Q3) percentile as well as minimal (min) and maximal (max) measured 
value) of latera equilibrium positions obtained for at least 10000 events for Jurkat cells in PBS-
/- and Jurkat cells in PBS-/- +1% Pluronic F-68, in design I spiral channel with 360 × 60 µm 
cross-section, at five applied flow rates for replica I out of three, expressed as distance from 





Replica II (a) Hydrodynamic behaviour of control Jurkat cells incubated for 3 hrs in PBS-/- 
(blue) and Jurkat cells incubated for 3 hrs in PBS-/- and supplemented with 1% pluronic F-68 
(red), assessed in a spiral microchannel with 360 × 60 µm cross-section at five different flow 
rates (1, 1.5, 2, 2.5 and 3 ml/min). Box plots summarising lateral equilibrium positions, 
measured as a distance from the outer wall (µm), where the line in the box represents the 
median, the box represents data from lower and upper quartile and the whiskers correspond to 
the lowest and highest extreme values (b) Receiver Operating Characteristic (ROC) curves 
were plotted for lateral equilibrium position for control versus Pluronic-treated cells, for each 
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applied flow rate. The True Positive Rate is defined as the number of control cells found at a 
given lateral position and divided by the total number of control cells. The False Positive Rate 
is the corresponding number of Pluronic-treated cells divided by the total number of control 
cells for the same cut-off. To quantify differences in the assembled equilibrium positions the 
Area Under the Curve (AUC) was calculated. (c) Tables showing statistical summary (mean 
and standard deviation from the mean (SD), median, 25th (Qi) and 75th (Q3) percentile as well 
as minimal (min) and maximal (max) measured value) of latera equilibrium positions obtained 
for at least 10000 events for Jurkat cells in PBS-/- and Jurkat cells in PBS-/- +1% Pluronic F-
68 at five applied flow rates for replica II out of three, expressed as distance from the outer 





Replica III (a) Hydrodynamic behaviour of control Jurkat cells incubated for 3 hrs in PBS-/- 
(blue) and Jurkat cells incubated for 3 hrs in PBS-/- and supplemented with 1% pluronic F-68 
(red), assessed in a spiral microchannel with 360 × 60 µm cross-section at five different flow 
rates (1, 1.5, 2, 2.5 and 3 ml/min). Box plots summarising lateral equilibrium positions, 
measured as a distance from the outer wall (µm), where the line in the box represents the 
median, the box represents data from lower and upper quartile and the whiskers correspond to 
the lowest and highest extreme values (b) Receiver Operating Characteristic (ROC) curves 
were plotted for lateral equilibrium position for control versus Pluronic-treated cells, for each 
applied flow rate. The True Positive Rate is defined as the number of control cells found at a 
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given lateral position and divided by the total number of control cells. The False Positive Rate 
is the corresponding number of Pluronic-treated cells divided by the total number of control 
cells for the same cut-off. To quantify differences in the assembled equilibrium positions the 
Area Under the Curve (AUC) was calculated. (c) Tables showing statistical summary (mean 
and standard deviation from the mean (SD), median, 25th (Qi) and 75th (Q3) percentile as well 
as minimal (min) and maximal (max) measured value) of latera equilibrium positions obtained 
for at least 10000 events for Jurkat cells in PBS-/- and Jurkat cells in PBS-/- +1% Pluronic F-
68 at five applied flow rates for replica III out of three, expressed as distance from the outer 






Tables showing statistical summary (mean and standard deviation from the mean (SD), median, 
25th (Q1) and 75th (Q3) percentile as well as minimal (min) and maximal (max) measured 
value) of latera equilibrium positions obtained for at least 10000 events for RBC in PBS-/- and 
RBC in PBS-/- +1% Pluronic F-68, in design II spiral channel with 170 × 30 µm cross-section, 







Replica II (a) Hydrodynamic behaviour of control RBC (grey) and RBC incubated for 3 hrs 
in PBS-/- and supplemented with 1% pluronic F-68 (red), assessed in a spiral microchannel 
with 170 × 30 µm cross-section at five different flow rates (0.2, 0.4, 0.6, 0.8 and 1 ml/min). 
Box plots summarising lateral equilibrium positions, measured as a distance from the outer 
wall (µm), where the line in the box represents the median, the box represents data from lower 
and upper quartile and the whiskers correspond to the lowest and highest extreme values. (b) 
Receiver Operating Characteristic (ROC) curves were plotted for lateral equilibrium position 
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for control versus Pluronic-treated cells, for each applied flow rate. The True Positive Rate is 
defined as the number of control cells found at a given lateral position and divided by the total 
number of control cells. The False Positive Rate is the corresponding number of Pluronic-
treated cells divided by the total number of control cells for the same cut-off. To quantify 
differences in the assembled equilibrium positions the Area Under the Curve (AUC) was 
calculated. (c) Tables showing statistical summary (mean and standard deviation from the mean 
(SD), median, 25th (Q1) and 75th (Q3) percentile as well as minimal (min) and maximal (max) 
measured value) of latera equilibrium positions obtained for at least 10000 events for RBC in 
PBS-/- and RBC in PBS-/- +1% Pluronic F-68, at five applied flow rates for replica II out of 





Replica III (a) Hydrodynamic behaviour of control RBC (grey) and RBC incubated for 3 hrs 
in PBS-/- and supplemented with 1% pluronic F-68 (red), assessed in a spiral microchannel 
with 170 × 30 µm cross-section at five different flow rates (0.2, 0.4, 0.6, 0.8 and 1 ml/min). 
Box plots summarising lateral equilibrium positions, measured as a distance from the outer 
wall (µm), where the line in the box represents the median, the box represents data from lower 
and upper quartile and the whiskers correspond to the lowest and highest extreme values. (b) 
Receiver Operating Characteristic (ROC) curves were plotted for lateral equilibrium position 
for control versus Pluronic-treated cells, for each applied flow rate. The True Positive Rate is 
defined as the number of control cells found at a given lateral position and divided by the total 
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number of control cells. The False Positive Rate is the corresponding number of Pluronic-
treated cells divided by the total number of control cells for the same cut-off. To quantify 
differences in the assembled equilibrium positions the Area Under the Curve (AUC) was 
calculated. (c) Tables showing statistical summary (mean and standard deviation from the mean 
(SD), median, 25th (Qi) and 75th (Q3) percentile as well as minimal (min) and maximal (max) 
measured value) of latera equilibrium positions obtained for at least 10000 events for RBC in 
PBS-/- and RBC in PBS-/- +1% Pluronic F-68, at five applied flow rates for replica III out of 





Chapter 8. Summary and future outlook  
The overarching goal of this project was to develop a novel purification method to isolate 
mRBC from the contaminant by-products of the differentiation protocol, while maintaining 
their integrity and quality, in a timely (processing millions of cells/min and mls of medium/ 
min) label-free (no modifying agents added) and continuous manner. To meet these 
requirements, I investigated label-free separation in spiral microchannels based on cells’ 
endogenous properties such as size and deformability. The main achievements of my work 
included: 
1. First study to track cell mechanotype changes during mRBC production with a high-
throughput approach, utilising data from over 10000 cells, to determine that size and 
deformability could be exploited as label-free markers for mRBC purification.  
2. Demonstrating, for the first time, applicability of spiral microchannels for 
deformability-based separation. 
3. Translating the mechanical properties identified in point 1 and findings from point 2 
into a complete bespoke label-free downstream process for isolation of enucleated 
mRBC, up to high purities (99%). 
4. Identifying and researching factors influencing performance of the process and impact 
of the processing conditions on cell quality. 
To assess the changing mechanotype of CD34+ undergoing differentiation into mRBC, I 
used cutting-edge technology- RT-DC- for contactless assessment of cells deformation in a 
high-throughput fashion. I observed that cells undergoing the 21 day differentiation protocol, 
become progressively softer due to re-arrangements in cytoskeleton and decreasing nucleus to 
cytoplasm ratio. At the end of the protocol, subpopulations found in the heterogenous mixture, 
enucleated mRBC and nucleated cells together with free-floating nuclei, can be characterised 
and classified based on the unique combination of size and deformability. These results 
confirmed that mRBC could be purified from the nucleated cells and nuclei populations, based 
strictly on their label-free makers. These findings are detailed in Guzniczak. et al. 2017 [41] 
Since size and deformability were confirmed to be suitable label-free markers, spiral 
channels were investigated as a means of size-based separations. Successful size based 
separations have been previously demonstrated in a range of applications and it has been noted 
that deformability of cells influences performance. However, in this study, for the first time, I 
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demonstrated the deformability-induced lift force (FD) can be utilised for cellular separation. I 
developed a unique cellular model to demonstrate that cells of identical size could be separated 
purely based on deformability. I identified that in order to take advantage of the effect of FD 
for particles focusing and ordering in the spiral geometry, sufficiently high flow rates are 
required (3ml/min in design I and 1 ml/min in design II). Cells are dynamic structures 
responding to mechanical stresses such as hydrodynamic compressibility by rearranging their 
cytoskeletal structures to offset the stresses. This causes generation of FD, which, in 
combination with inertial lift forces and Dean drag, pushes cells of the same size but different 
deformability properties, to contrary lateral equilibrium positions within the channel cross-
section. This principle has been successfully adapted to enhance and conduct label-free and 
continuous cell separation in spiral microchannels. 
A bespoke spiral channel (design II, with 170 µm × 30 µm rectangular cross-section, 6 
loops and one inlet) has been used for the purification of mRBC by means of utilising the 
impact of FD. By using the differences in dynamic equilibrium positions it was possible to 
enrich the enucleated mRBC up to 70 % purity, recovering >90% of the input cells. These 
results varied from predicted (>95% purity) performance of the device, initially validated using 
pure populations of pre-sorted enucleated and nucleated cells and nuclei, due to particle 
interactions. In order to improve the purity, a membrane filtration step has been added to the 
process. This inclusion was motivated by the fact that the degree of deformation could be 
measured by looking at changes in the minor axis. Under conditions where there are no applied 
deforming forces the minor axis of enucleated and nucleated cells are comparable. Because 
deformability and size are coupled, when a deforming force is exerted, the enucleated cells 
minor axis shortens more than for nucleated cells and a 2-3 µm difference is revealed. The size 
difference revealed by applied stress constituted the basis for cell separation using a porous 
physical barrier (ISOPORETM membrane) with a cut-off size of 3µm. This approach improved 
cell purity to 99%, but at a cost of losing 70% of input cells which were retained at the 
membrane.  
In the proposed approach, 3-4 × 106 cells/ min are processed by a single device when 
operating at the optimal 1ml/min flow rate. The current throughput seems reasonable for 
processing cells that are routinely cultured within similar concentration range in large volumes. 
Up to date, mRBC culture is routinely carried in static culture conditions, facilitating maximal 
cell concentration at around 5 × 106 cells/ml [11]. As Timmins et al. 2009 estimated, this would 
require 9,000 T175 cm2 flasks to produce a single blood unit [14]. To overcome this limitation, 
mRBC cultured at 50 × 106 cell/ml should decrease the required volume of medium to 40 litres 
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and consequently the total cost to around $8000 per blood unit [14][3][11]. The downstream 
processing proposed in this study has the capacity for further scale-up to process such volumes 
by two means: increasing cell sample concentration (the estimated concentration limit for this 
particular system is at 20×106 cells/ml, 𝛼=1) and system parallelisation. Stacking microfluidic 
devices (stack of 20 devices reported [159]) is a common practice resulting in a rapid and 
efficient throughput improvement.  
Spiral microchannels have been positively validated as a practical solution for mRBC 
purification. However, one of the remaining bottlenecks with such microsystems is their 
tendency to clog due to a channel cross-section that is merely larger than a couple of cell 
diameters. One of the most commonly accepted solutions to prevent clogging issues is the use 
of additives such as Pluronic F-68. I investigated the effect of this biocompatible surfactant on 
cells commonly used in microfluidic studies, like Jurkat and HEK cells and red blood cells. 
This published research [162] provides a substantial explanation of the additive impact on cell 
mechanotype, which should be considered prior to experiments and measurements performed 
using the microfluidics technologies.  
By taking advantage of thoroughly characterised mechanical properties, a label-free passive 
platform for cost-effective mRBC downstream processing has been successfully developed. 
This study provided robust proof of principle and the next logical step would involve 
translation into industrial scale processing. Prior to the successful transition, a profound 
understanding of the basis of inertial focusing in spiral microchannels is required, including 
the hydrodynamic particle-particle interactions, particle-medium interactions and the 
mechanism of the FD action. That requires development of computational methods, which 
would allow to precisely model and optimise process performance. Bringing mRBC into clinics 
requires reproducible unit operations. CB CD34+ cells are a limited source of mRBC and as 
verified in this study, starting cell material derived from different donors give a final product 
characterised by different pheno- and mechanotypes, thus implementation of universal 
downstream protocols is currently challenging. The field of stem cell-derived therapeutic 
products is maturing and with introduction of iPSC and immortalised erythroid cell lines, it 
should be possible to produce large quantities of standardised mRBC and integrate technology 
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